COVID-19 Evidence Reviews
as of 10/4/22
menu
 
 

Clinical Characteristics
 
= living review
= draft/preprint   |  
= meets mimimum quality standards   |  

A review with this mark was peer-reviewed, described systematic search and study selection, and included critical appraisal of primary studies.
latest update
date
report
select
9/30/22
Thapa Magar S, Lokhandwala HI, Batool S, et al. | Cureus
Aim: To investigate COVID-19's neurological manifestations and potential risk variables linked to the emergence of neurological symptoms and signs.
CLINICAL CHARACTERISTICS
9/30/22
Aziz AA, Aziz MA, Saleem M, et al. | Cureus
Aim: To determine the clinical, imaging, and laboratory features in adult patients with COVID-19 infection and AP and to determine if there is any relationship between AP and COVID-19 infection.
CLINICAL CHARACTERISTICS
9/30/22
Yang L, Li J, Wei W, et al. | Front Public Health
Aim: To consolidate evidence from systematic reviews and meta-analyses investigating the impact of the coronavirus disease?2019 (COVID-19) on kidney health, and the associations between kidney diseases and clinical outcomes in COVID-19 patients.
CLINICAL CHARACTERISTICS
9/30/22
Bepouka B, Odio O, Mayasi N, et al. | Infect Drug Resist
Aim: To summarize information on the prevalence, risk factors, and outcomes of patients with happy hypoxia to improve their management.
CLINICAL CHARACTERISTICS
9/28/22
Zuin M, Rigatelli G, Bilato C, et al. | J Cardiovasc Med
Aim: To evaluate the mortality risk in COVID-19 Italian patients complicated by acute pulmonary embolism in the short-term period.
CLINICAL CHARACTERISTICS
9/28/22
Manolache NG, Mjaess G, Diamand R, et al. | Prog Urol
Aim: To evaluate the effect of androgen deprivation therapy (ADT) on the incidence of infection and severity of SARS-CoV-2 in prostate cancer patients.
CLINICAL CHARACTERISTICS
9/26/22
Dhungel B, Rahman MS, Rahman MM, et al. | Int J Environ Res Public Health
Aim: To estimate the pooled R0 for early COVID-19 outbreaks and identified the impact of study-related factors such as methods, study location and study period on the estimated R0.
UPDATED
CLINICAL CHARACTERISTICS
9/26/22
Lao US, Law CF, Baptista-Hon DT, et al. | J Clin Med
Aim: To evaluate the association between statin use and mortality, intensive care unit (ICU) admission and mechanical ventilation in COVID-19 patients.
CLINICAL CHARACTERISTICS
9/20/22
Pata D, Buonsenso D, Valentini P | Mediterr J Hematol Infect Dis
Aim: To identify clinical and laboratory characteristics that allow healthcare workers to differentiate COVID-19 from influenza.
CLINICAL CHARACTERISTICS
9/20/22
Hatami H, Qaderi S, Shah J, et al. | Int J Prev Med
Aim: To summarize the data on different ways of managing COVID-19 outbreaks.
CLINICAL CHARACTERISTICS
9/20/22
Westphal A, Kalinowski E, Hoferichter CJ, et al. | Front Psychol
Aim: To summarize the existing empirical findings on K?12 teachers' stress and burnout during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
9/19/22
Bronz G, Fare PB, Lava SAG, et al. | J Autoimmun
Aim: To determine whether COVID-19 or vaccination against SARS-CoV-2 may be temporally related to a new-onset, or a flare, of an immunoglobulin A-mediated disorder.
CLINICAL CHARACTERISTICS
9/19/22
Marcec R, Dodig VM, Radanovic I, et al. | Rev Med Virol
Aim: To investigate the potential impact of IVIg on mortality and length of hospitalisation in adult COVID-19 patients.
CLINICAL CHARACTERISTICS
9/19/22
Kloping YP, Hidayatullah F, Rahman ZA, et al. | World J Mens Health
Aim: To evaluate whether SARS-CoV-2 infection affects the male reproductive system.
CLINICAL CHARACTERISTICS
9/19/22
Llana T, Zorzo C, Mendez-Lopez M, et al. | Appl Neuropsychol Adult
Aim: To analyze the existing evidence of objective memory impairments in long-COVID-19, as well as to explore associations between memory performance and their epidemiological, clinical, and pathological features.
CLINICAL CHARACTERISTICS
9/19/22
Voleti N, Reddy SP, Ssentongo P | Front Cardiovasc Med
Aim: To compare the incidence of myocarditis in COVID-19 vaccines and in severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection groups.
CLINICAL CHARACTERISTICS
9/19/22
Liang H, Zhang M, Chen M, et al. | Asia Pac J Public Health
Aim: To summarize the latest literature on the trends and incidence of ocular trauma during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
9/19/22
Khidir RJY, Ibrahim BAY, Adam MHM, et al. | Int J Health Sci
Aim: To provide a narrative review of the different presentations and mechanisms involved in hyponatremia reported in patients with COVID-19 infection.
CLINICAL CHARACTERISTICS
9/19/22
Kaubisch LT, Reck C, von Tettenborn A, et al. | J Affect Disord
Aim: To investigate trauma-related symptoms in the course of the COVID-19 pandemic and the association of the pandemic and its containment measures with trauma-related disorders or symptoms.
CLINICAL CHARACTERISTICS
9/19/22
Cong B, Deng S, Wang X, et al. | J Glob Health
Aim: To understand the impact of influenza/RSV co-infection on clinical disease severity among COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
9/8/22
Sharma R, Kumar A, Majeed J, et al. | Egypt Heart J
Aim: To find out the role of drugs acting on RAAS, particularly ACEi/ARBs in the deaths of COVID-19 patients.
CLINICAL CHARACTERISTICS
9/8/22
Lee JH, Yim J, Park J | Respir Res
Aim: To estimate the pooled prevalence of the pulmonary sequelae of COVID-19, as demonstrated by pulmonary function testing (PFT) and chest computed tomography (CT) performed at least 6 months after initial infection.
UPDATED
CLINICAL CHARACTERISTICS
9/7/22
Arif A, Chavarria Y, Qamar MA, et al. | Neuropsychiatr Dis Treat
Aim: To study the clinical picture of NORSE secondary to COVID-19 infection.
CLINICAL CHARACTERISTICS
9/6/22
Toro-Huamanchumo CJ, Hilario-Gomez MM, Pinedo-Castillo L, et al. | New Microbes New Infect
Aim: To evaluate the clinical and epidemiological characteristics in patients with COVID-19 reinfection.
UPDATED
CLINICAL CHARACTERISTICS
9/6/22
Chen Z, Peng Y, Wu X, et al. | Front Public Health
Aim: To identify and assess in-hospital data on comorbidities and complications of COVID-19 that are associated with various levels of disease severity, progression, and mortality in China during centralized isolation and hospitalization.
UPDATED
CLINICAL CHARACTERISTICS
9/6/22
Ghasemi S, Dashti M, Fahimipour A, et al. | Eur J Dent
Aim: To review the evidence on COVID-19 associated mucormycosis (CAM) to investigate what are the contributing factors to the outcome of mucormycosis in COVID-19 patients.
CLINICAL CHARACTERISTICS
9/6/22
Gallardo VJ, Shapiro RE, Caronna E, et al. | Headache
Aim: To study the relationship between coronavirus disease 2019 (COVID-19) mortality and headache among patients evaluated for COVID-19 in Emergency Departments and hospitals.
CLINICAL CHARACTERISTICS
9/2/22
Zinellu A, Mangoni AA | Expert Rev Clin Immunol
Aim: To review the evidence on the association between the neutrophil, lymphocyte, and platelet count, neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR), and COVID-19 progression and mortality.
UPDATED
CLINICAL CHARACTERISTICS
9/2/22
Shahramian I, Parooie F, Salarzaei M | Pol Przegl Chir
Aim: To evaluate the prevalence of acute cholecystitis (AC) and review its possible management options during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
9/2/22
Khairwa A, Jat KR | Forensic Sci Med Pathol
Aim: To evaluate autopsy findings in COVID-19 paediatric cases.
CLINICAL CHARACTERISTICS
9/2/22
Zewde MG, Alpert N, Taioli E | JNCI Cancer Spectr
Aim: To determine whether cancer is an independent risk factor for COVID-19 mortality.
CLINICAL CHARACTERISTICS
8/30/22
Woller SC, de Wit K, Robert-Ebadi H, et al. | Res Pract Thromb Haemost
Aim: To report the evidence on the prognostic biomarkers for identifying hospitalized patients with COVID?19 at higher risk of developing VTE.
CLINICAL CHARACTERISTICS
8/30/22
Maleki M, Maarefvand M, Nazeri AR, et al. | Iran J Otorhinolaryngol
Aim: To describe the impact of COVID-19 on the auditory-vestibular system and communication problems in subjects with hearing impairment.
CLINICAL CHARACTERISTICS
8/30/22
Li Y, Luo W, Liang B | Front Nutr
Aim: To evaluate the trace element status in COVID-19 disease by conducting a meta-analysis.
CLINICAL CHARACTERISTICS
8/30/22
Zhao R, Shi J, Song Y, et al. | Therap Adv Gastroenterol
Aim: To summarize laboratory features in COVID-19 with GI symptoms and non-GI symptoms.
CLINICAL CHARACTERISTICS
8/29/22
Nagarajan R, Krishnamoorthy Y, Rajaa S, et al. | Prev Chronic Dis
Aim: To determine the association of chronic liver disease (CLD), a comorbid condition, with severity of disease and death among COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
8/29/22
Wal P, Dwivedi J, Wal A, et al. | Curr Diabetes Rev
Aim: To examine the data on the link between diabetes and COVID-19, the pathogenesis of diabetes, and treatment of COVID-19 infection in diabetic patients.
CLINICAL CHARACTERISTICS
8/29/22
Islam MA, Cavestro C, Alam SS, et al. | Cells
Aim: To systematically evaluate the characteristics (clinical, neuro-radiological aspects, and laboratory features) and outcomes of encephalitis in COVID-19 patients, as well as the possible causative mechanisms of CNS damage.
UPDATED
CLINICAL CHARACTERISTICS
8/29/22
Montealegre L, Amador E, Pulido T, et al. | J Hypertens
Aim: To determine through the systematic review the survival rate of patients infected by SARS-CoV-2 and previously diagnosed with arterial hypertension and/or diabetes.
CLINICAL CHARACTERISTICS
8/29/22
Torge D, Bernardi S, Arcangeli M, et al. | Pathogens
Aim: To conduct a histopathological overview of COVID-19 structural and ultrastructural alterations in different organs and tissues, excluding the respiratory system.
CLINICAL CHARACTERISTICS
8/29/22
Abu Hammour K, Abu Farha R, Manaseer Q, et al. | Arch Rheumatol
Aim: To evaluate clinical features, diagnostic tests, current therapeutic management, and outcomes of MIS-C cases in children and adolescents reported in the literature and to evaluate the common points between the MIS-C and KD.
CLINICAL CHARACTERISTICS
8/29/22
Dorantes-Acosta E, Ávila-Montiel D, Domínguez Rojas J, et al.  | Front Pediatr
Aim: To determine COVID-19 mortality rates in LAC pediatric cancer patients.
CLINICAL CHARACTERISTICS
8/29/22
Parthasarathi A, Padukudru S, Arunachal S, et al. | Vaccines
Aim: To assess the relationship between on-admission NLR values and COVID-19-related disease severity and mortality outcomes.
UPDATED
CLINICAL CHARACTERISTICS
8/26/22
Jalili M, Sayehmiri K, Ansari N, et al. | Adv Respir Med
Aim: To examine the association between the risk of atherosclerosis, and influenza virus (IV-A and IV-B) and COVID-19 infections in this study.
CLINICAL CHARACTERISTICS
8/26/22
Zavalaga-Zegarra HJ, Palomino-Gutierrez JJ, Ulloque-Badaracco JR, et al. | Trop Med Infect Dis
Aim: To investigate the CAR values with respect to the severity and mortality of COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
8/26/22
Ke Y, Zhu Y, Chen S, et al. | Infect Dis Ther
Aim: To explore circulating pneumoproteins in the diagnosis, severity, and prognosis of COVID-19 by meta-analysis.
CLINICAL CHARACTERISTICS
8/26/22
Ulloque-Badaracco JR, Alarcon-Braga EA, Hernandez-Bustamante EA, et al. | Trop Med Infect Dis
Aim: To evaluate the association of fibrinogen-to-albumin ratio and blood urea nitrogen-to-albumin ratio with the severity and mortality of COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
8/26/22
Terlizzi V, Motisi MA, Pellegrino R, et al. | Front Pediatr
Aim: To highlight the main risk factors for severe COVID-19 in patients with CF.
CLINICAL CHARACTERISTICS
8/25/22
Baral PK, Aziz MA, Islam MS | Health Sci Rep
Aim: To find out the significant risk factors and the extent of similarities in CAM and CAA pathogenesis, tracing points to control and manage these infections.
CLINICAL CHARACTERISTICS
8/25/22
Nagraj S, Varrias D, Hernandez Romero G, et al. | Stroke
Aim: To provide an accurate and reliable estimate of stroke incidence among patients with COVID-19 by assessing strokes reported as outcome or adverse events in RCTs in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
8/24/22
Chaudhary H, Nasir U, Syed K, et al. | Hematol Rep
Aim: To provide a comprehensive summary of the available evidence regarding COVID-19-associated TTP with a brief mention of a case at our healthcare center.
CLINICAL CHARACTERISTICS
8/23/22
Khalid Ahmed S, Gamal Mohamed M, Abdulrahman Essa R, et al. | Int J Cardiol Vasc Heart
Aim: To provide a comprehensive overview of takotsubo cardiomyopathy (TCM) associated with COVID-19 vaccines.
UPDATED
CLINICAL CHARACTERISTICS
8/22/22
Bepouka B, Odio O, Mangala D, et al. | Cureus
Aim: To determine the mortality rate of COVID-19 among diabetes patients in SSA. 
CLINICAL CHARACTERISTICS
8/22/22
Gupta K, Kaur G, Pathak T, et al. | Gene
Aim: To explore the current knowledge about the genetic influence on susceptibility to SARS-CoV-2 infection and progression to severe disease conditions.
CLINICAL CHARACTERISTICS
8/18/22
Radivojevic A, Abu Jad AA, Ravanavena A, et al. | Cureus
Aim: To assess the relationship between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced hepatic dysfunction and the clinical outcome in patients infected with COVID-19.
CLINICAL CHARACTERISTICS
8/18/22
Drzymalla E, Green RF, Knuth M, et al. | Clin Immunol
Aim: To evaluate health outcomes in people with PI and COVID-19.
CLINICAL CHARACTERISTICS
8/18/22
Favara G, Barchitta M, Maugeri A, et al. | J Glob Health
Aim: To assess the impact of the SARS-CoV-2 infection on the risk of death among PLHIV and HIV- seronegative people.
CLINICAL CHARACTERISTICS
8/18/22
Ostovan VR, Tabrizi R, Bazrafshan H, et al. | Curr Fungal Infect Rep
Aim: To identify the risk factors that affect the mortality rate of patients with CAM.
CLINICAL CHARACTERISTICS
8/16/22
Iryaningrum MR, Supriyadi R, Lawrensia S, et al. | Indian J Nephrol
Aim: To delineate better the association between diabetes and mortality among patients with CKD and COVID-19.
CLINICAL CHARACTERISTICS
8/15/22
Freitas T, Ibrahim A, Lourenço A, et al. | Hip Int
Aim: To determine whether patients with PFF affected by COVID-19 have a higher risk of postoperative mortality.
CLINICAL CHARACTERISTICS
8/15/22
Yu W, Guo Y, Zhang S, et al. | J Med Virol
Aim: To assess the pooled proportion of non-severe disease and asymptomatic infection among COVID-19 patients infected with Omicron and Delta.
CLINICAL CHARACTERISTICS
8/15/22
Dobrijevic Z, Robajac D, Gligorijevic N, et al. | EXCLI J
Aim: To investigate the association of VDR and IFITM3 polymorphisms with COVID-19 severity.
UPDATED
CLINICAL CHARACTERISTICS
8/15/22
Kabia AU, Li P, Jin Z, et al. | J Hypertens
Aim: To review the evidence on the effects of hypertension on the prognosis of COVID-19.
CLINICAL CHARACTERISTICS
8/12/22
Che BW, Chen P, Yu Y, et al. | Asian J Androl
Aim: To explore whether mild/asymptomatic COVID-19 affects semen quality and sex-related hormone levels.
CLINICAL CHARACTERISTICS
8/12/22
Dondi A, Sperti G, Gori D, et al. | Eur J Pediatr
Aim: To determine the type, prevalence, time of onset, and evolution of cutaneous manifestations associated with COVID-19 in newborns, children, and adolescents, after excluding multisystem inflammatory syndrome in children (MIS-C).
CLINICAL CHARACTERISTICS
8/12/22
Dobrijevic Z, Robajac D, Gligorijevic N, et al. | EXCLI J
Aim: To investigate the association of VDR and IFITM3 polymorphisms with COVID-19 severity.
CLINICAL CHARACTERISTICS
8/12/22
Kabia AU, Li P, Jin Z, et al. | J Hypertens
Aim: To review the evidence on the effects of hypertension and age as well as the use of ACEI/ARB treatment on the outcomes of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
8/11/22
Che BW, Chen P, Yu Y, et al. | Asian J Androl
Aim: To explore whether mild/asymptomatic COVID-19 affects semen quality and sex-related hormone levels.
UPDATED
CLINICAL CHARACTERISTICS
8/11/22
Vishwajeet V, Krishna H, Ghatak S, et al. | Saudi J Kidney Dis Transpl
Aim: To summarize the renal histopathological findings in COVID-19 from the published case report and case series.
CLINICAL CHARACTERISTICS
8/10/22
Tripathi AK, Pilania RK, Bhatt GC, et al. | Pediatr Nephrol
Aim: To evaluate the incidence of AKI, mortality, and the need for kidney replacement therapy (KRT) in patients with MIS-C.
CLINICAL CHARACTERISTICS
8/10/22
Donovan MR, Miglani A, Lal D, et al. | Laryngoscope Investig Otolaryngol
Aim: To describe factors associated with IFS in patients with COVID?19.
CLINICAL CHARACTERISTICS
8/10/22
Tossetta G, Fantone S, Delli Muti N, et al. | J Hypertens
Aim: To understand the potential involvement of SARS-CoV-2 in preeclampsia onset.
CLINICAL CHARACTERISTICS
8/10/22
Holmes Z, Courtney A, Lincoln M, et al. | Skin Health Dis
Aim: To assess rash morphologies associated with COVID?19 and their relationship with disease severity.
CLINICAL CHARACTERISTICS
8/10/22
Kim DK, Park JJ, Yang WJ, et al. | J Korean Med Sci
Aim: To characterize the relationship between ADT and the severity of COVID-19 in patients with prostate cancer.
UPDATED
CLINICAL CHARACTERISTICS
8/10/22
Mishra P, Parveen R, Bajpai R, et al. | J Prev Med Public Health
Aim: To investigate the association of lower levels of vitamin D and comorbidities with the risk of COVID-19 infection.
UPDATED
CLINICAL CHARACTERISTICS
8/9/22
Sarfraz M, Sarfraz A, Sarfraz Z, et al. | Ann Med Surg
Aim: To identify the contributing factors of confirmed pediatric COVID-19 patients.
CLINICAL CHARACTERISTICS
8/9/22
Namavarian A, Eid A, Ziai H, et al. | Laryngoscope
Aim: To identify FNP clinical characteristics and recovery outcomes among patients acutely infected with COVID-19.
CLINICAL CHARACTERISTICS
8/8/22
Alves EAS, Salazar TCDN, Silvino VO, et al. | Nutr Clin Pract
Aim: To evaluate the association between phase angle and adverse clinical outcomes in hospitalized patients with coronavirus disease-2019 (COVID-19).
UPDATED
CLINICAL CHARACTERISTICS
8/8/22
Georgakopoulou VE, Gkoufa A, Garmpis N, et al. | Ann Saudi Med
Aim: To review and analyze all reported cases of COVID-19 associated acute pancreatitis, reporting the demographics, clinical characteristics, laboratory and imaging findings, comorbidities and outcomes.
UPDATED
CLINICAL CHARACTERISTICS
8/5/22
Mollalign H, Chala D, Beyene D | Infect Drug Resist
Aim: To summarize the clinical features and treatment outcomes of coronavirus and tuberculosis co-infected patients.
CLINICAL CHARACTERISTICS
8/3/22
Turki A, Abbas KS, Makram AM, et al. | Acta Neurol Belg
Aim: To systematically review the clinical picture, laboratory/imaging findings, treatment options, and prognostic factors of FNP in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
8/2/22
Purja S, Oh S, Kim E | Front Neurol
Aim: To compile studies involving COVID-19 patients with neurological manifestations who have undergone polymerase chain reaction (PCR) testing for SARS-CoV-2 in cerebrospinal fluid (CSF) and reported the patient's anosmia status for identifying neurological aspects of COVID-19 and exploring the COVID-19 infected patients with or without anosmia in relation to their CSF PCR assay results.
CLINICAL CHARACTERISTICS
8/2/22
Huang H, Chen J, Fang S, et al. | Front Neurol
Aim: To investigate the association between previous stroke and the risk of severe coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
8/2/22
Luo X, Lv M, Zhang X, et al. | J Evid Based Med
Aim: To present a comprehensive picture of the clinical symptoms of COVID-19 using an evidence map.
UPDATED
CLINICAL CHARACTERISTICS
8/2/22
Hong W, White PL, Backx M, et al. | Clin Imaging
Aim: To conduct a systematic review and an individual patient-level image analysis of CT findings of COVID-19-associated pulmonary aspergillosis (CAPA).
CLINICAL CHARACTERISTICS
8/2/22
Alshaikh FS, Godman B, Sindi ON, et al. | PLoS One
Aim: To determine current prevalence of bacterial coinfection and antibiotic prescribing in COVID-19 patients.
CLINICAL CHARACTERISTICS
8/1/22
Chou OHI, Mui J, Chung CT, et al. | Clin Res Cardiol
Aim: To investigate the rates of carditis in children and adolescents receiving COVID-19 vaccines.
UPDATED
CLINICAL CHARACTERISTICS
8/1/22
Zuin M, Rigatelli G, Bilato C, et al. | J Cardiovasc Med
Aim: To review the evidence on the prevalence and prognostic implications of coronary artery disease (CAD) in patients infected by the novel coronavirus 2019 (COVID-19) disease.
CLINICAL CHARACTERISTICS
8/1/22
Du Z, Wang S, Bai Y, et al. | Transbound Emerg Dis
Aim: To conduct a systematic review of viral dynamic parameters used in within-host models by calibrating the model to the viral load data measured from upper respiratory specimens.
CLINICAL CHARACTERISTICS
7/29/22
Bhowmik KK, Barek MA, Aziz MA, et al. | Health Sci Rep
Aim: To highlight the correlation of numerous biomarkers, including D?dimers, CRP, serum ferritin, lactate dehydrogenase (LDH), random blood sugar (RBS), absolute neutrophil count (ANC), neutrophil to lymphocyte ratio (NLR), serum creatinine, and hemoglobin with the severity of COVID?19 patients in Bangladesh and how their values change based on the intensity of the illness.
CLINICAL CHARACTERISTICS
7/29/22
Sah SK, Shariff A, Pathakamuri N, et al. | PLoS One
Aim: To find the prevalence of fungal secondary infections among COVID-19 patients and patient outcomes in terms of recovery or all-cause mortality following antifungal therapy (AFT) in such patients.
UPDATED
CLINICAL CHARACTERISTICS
7/29/22
Balaouras G, Eusebi P, Kostoulas P | PLoS One
Aim: To collect and meta-analyze available studies on the relationship between SARS-CoV-2 infection and different blood groups, as well as Rhesus state. 
CLINICAL CHARACTERISTICS
7/29/22
Hayat U, Ashfaq MZ, Johnson L, et al. | Kans J Med
Aim: To determine the clinical outcomes of COVID-19 among MAFLD patients compared to the non-MAFLD group.
CLINICAL CHARACTERISTICS
7/28/22
Zakariaee SS, Salmanipour H, Naderi N, et al. | Clin Transl Imaging
Aim: To evaluate the association of CT-SS with mortality of COVID-19 patients using systematic review and meta-analysis.
CLINICAL CHARACTERISTICS
7/28/22
Hung KC, Ko CC, Wang LK, et al. | Diagnostics
Aim: To evaluate the prognostic value of PNI for predicting the severity and mortality in patients diagnosed with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/28/22
Santos AP, Gonçalves LC, Oliveira ACC, et al. | Antibiotics
Aim: To assess the prevalence of co-infection in patients admitted to ICUs with SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
7/28/22
Palomo-Toucedo IC, Lopez-Sanchez MJ, Reina-Bueno M, et al. | Int J Environ Res Public Health
Aim: To determine the most frequent dermatological signs, in the lower limbs, produced by SARS-CoV-2.
CLINICAL CHARACTERISTICS
7/28/22
Rabaan AA, Bakhrebah MA, Mutair AA, et al. | Vaccines
Aim: To establish the comparison of health complication noted in vaccinated and non-vaccinated individuals (COVID-19 infected patients) to identify the association between vaccination and the multiorgan failure based on the data obtained from case studies, research articles, clinical trials/Cohort based studies and review articles published between 2020-2022. 
CLINICAL CHARACTERISTICS
7/28/22
Korres G, Kitsos DK, Kaski D, et al. | Brain Sci
Aim: To review the reported prevalence of dizziness and vertigo symptoms as part of COVID-19 disease and discuss the potential neurotropic mechanisms of SARS-CoV-2.
CLINICAL CHARACTERISTICS
7/27/22
Seyedjavadi SS, Bagheri P, Nasiri MJ, et al. | Front Microbiol
Aim: To evaluate the various aspects such as symptoms, diagnosis, and the most frequent etiological agents of patients with fungal co-infecting COVID-19, treatment, and outcome.
CLINICAL CHARACTERISTICS
7/19/22
Silva BM, Assis LCS, Batista Junior MC, et al. | J Bras Nefrol
Aim: To relate the development of COVID-19 associated-AKI with comorbidities, medications, and the impact of mechanical ventilation.
CLINICAL CHARACTERISTICS
7/19/22
Mohammadi S, Gouravani M, Salehi MA, et al. | Neuroradiology
Aim: To aggregate the results of the studies which reported imaging of the olfactory system of patients with COVID-19 versus controls.
UPDATED
CLINICAL CHARACTERISTICS
7/18/22
Lin L, Chen Y, Han D, et al. | Front Cardiovasc Med
Aim: To assess the clinical manifestations and outcomes of cardiorenal syndrome or the presence of both cardiac and renal complications in the 2019 coronavirus disease (COVID-19) patients.
CLINICAL CHARACTERISTICS
7/18/22
El-Qushayri AE, Reda A, Dahy A, et al. | Rev Med Virol
Aim: To provide better insight into the efficacy of mechanical thrombectomy (MT) in managing COVID-19 patients suffering from a stroke.
CLINICAL CHARACTERISTICS
7/18/22
Almulla AF, Supasitthumrong T, Tunvirachaisakul C, et al. | BMC Infect Dis
Aim: To systematically review and meta-analyze the status of the TRYCAT pathway, including the levels of TRP and kynurenine (KYN) and the activity of IDO, as measured by the ratio of KYN/TRP.
CLINICAL CHARACTERISTICS
7/14/22
Barberato SH, Bruneto EG, Reis GS, et al. | Arq Bras Cardiol
Aim: To summarize the main echocardiographic findings in patients with Covid-19.
CLINICAL CHARACTERISTICS
7/14/22
Arayici ME, Kipcak N, Kayacik U, et al. | J Cancer Res Clin Oncol
Aim: To determine both the incidence and ICU (Intensive Care Unit) admission rates and mortality in SARS-CoV-2 infected cancer patients.
UPDATED
CLINICAL CHARACTERISTICS
7/14/22
Tohmasi S, Kabutey NK, Maithel S, et al. | Ann Vasc Surg Brief Rep Innov
Aim: To assess the incidence, risk factors, interventions, and outcomes of acute aortoiliac arterial thrombosis in patients with active SARS-CoV-2 infections.
CLINICAL CHARACTERISTICS
7/12/22
Girma D, Dejene H, Adugna L, et al. | Infect Drug Resist
Aim: To summarize the CFR of COVID-19 and factors contributing to mortality in Ethiopia.
CLINICAL CHARACTERISTICS
7/12/22
Sawadogo W, Tsegaye M, Gizaw A, et al. | BMJ Nutr Prev Health
Aim: To quantify the association between overweight or obesity and COVID-19-related hospitalisations (including hospital admission, intensive care unit (ICU) admission, invasive mechanical ventilation (IMV)) and death, and to assess the magnitude of the association and the potential dose–response relationships.
UPDATED
CLINICAL CHARACTERISTICS
7/12/22
Caironi V, Pitoia F, Trimboli P | Front Endocrinol
Aim: To analyze and summarize data about COVID-19 vaccination and thyroid disease.
CLINICAL CHARACTERISTICS
7/7/22
Dieter C, Brondani LA, Leitao CB, et al. | PLoS One
Aim: To identify genetic polymorphisms that are likely to contribute to COVID-19 pathogenesis.
UPDATED
CLINICAL CHARACTERISTICS
7/7/22
D'Ecclesiis O, Gavioli C, Martinoli C, et al. | PLoS One
Aim: To assess the evidence on SARS-CoV2 infection and Covid-19 in relation to deficiency and supplementation of vitamin D.
UPDATED
CLINICAL CHARACTERISTICS
7/6/22
Malinga DM, Laher AE, McDowall J, et al. | Curr Urol
Aim: To explore the potential relationship between priapism and COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/6/22
Hammoud H, Bendari A, Bendari T, et al. | Cureus
Aim: To provide a comprehensive picture of the SARS-CoV-2 histopathological features of different body organs in postmortem autopsies.
CLINICAL CHARACTERISTICS
7/5/22
Chao M, Menon C, Elgendi M | Front Med
Aim: To investigate the prevalence of common COVID-19 symptoms in pregnant women and compared the ranked list of symptoms to articles of various sizes.
CLINICAL CHARACTERISTICS
7/5/22
Parvu S, Müller K, Dahdal D, et al. | Eur Rev Med Pharmacol Sci
Aim: To elaborate the possible mechanisms influencing cardiovascular damage, myocardial injury and thromboembolic disease process in particular.
CLINICAL CHARACTERISTICS
7/5/22
Li P, Guan Y, Zhou S, et al. | Sci Prog
Aim: To review the clinical features and risk factors in patients undergoing maintenance hemodialysis (MHD) who also acquired coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
7/5/22
Zong K, Peng D, Yang H, et al. | Front Immunol
Aim: To determine the factors that contribute to poor antibody response in organ transplant recipients after receiving the 2-dose severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine.
UPDATED
CLINICAL CHARACTERISTICS
6/23/22
Kao YS, Lin KT | Radiol Med
Aim: To investigate the predictive power of a CT-based radiomics model in determining COVID-19 severity.
CLINICAL CHARACTERISTICS
6/23/22
Joshi D, Gyanpuri V, Pathak A, et al. | Curr Pain Headache Rep
Aim: To discuss the case-reports having neuropathic pain during and after COVID-19 infection.
CLINICAL CHARACTERISTICS
6/21/22
Singh R, Rathore SS, Khan H, et al. | Front Endocrinol
Aim: To estimate the association of obesity with the severity and mortality in coronavirus disease 2019 (COVID-19) patients.
CLINICAL CHARACTERISTICS
6/21/22
Khanal R, Raj Bhattarai S, Basnet K, et al. | Interdiscip Perspect Infect Dis
Aim: To review the evidence on the cardiac implications of COVID-19, both in terms of cardiac factors predisposing to the disease and cardiac complications of the disease.
UPDATED
CLINICAL CHARACTERISTICS
6/21/22
Batu ED, Sener S, Ozen S | Semin Arthritis Rheum
Aim: To present a detailed analysis of COVID-19 associated pediatric vasculitis.
CLINICAL CHARACTERISTICS
6/21/22
Idehen JB, Kazi U, Quainoo-Acquah JA, et al. | Cureus
Aim: To determine the patterns of neuropsychiatric manifestations of COVID-19, discussing the frequency and its impact on pre-existing psychiatric disorders.
CLINICAL CHARACTERISTICS
6/21/22
Almas T, Malik J, Alsubai AK, et al.  | Ann Med Surg
Aim: To estimate the prevalence of persisting COVID-19 signs and symptoms after recovery.
CLINICAL CHARACTERISTICS
6/21/22
Lee JX, Chieng WK, Abdul Jalal MI, et al. | Front Med
Aim: To determine the role of serum ferritin in predicting outcomes of COVID-19 infection among patients with SCD.
UPDATED
CLINICAL CHARACTERISTICS
6/21/22
Ishak A, Mehendale M, Mahmoud AlRawashdeh M, et al. | Gene
Aim: To evaluate the correlation between variability in the host genetics and the severity and susceptibility towards COVID-19.
CLINICAL CHARACTERISTICS
6/21/22
Sanders I, Stather P, Sivagangan P, et al. | Cureus
Aim: To review our understanding of the incidence, management, and outcomes of patients with COVID-19 who develop thrombotic complications, to reduce direct mortality.
CLINICAL CHARACTERISTICS
6/16/22
Seid AA, Woday Tadesse A, Hasen AA | BMJ Open
Aim: To determine the severity and mortality of COVID-19 among people with different types of disabilities.
UPDATED
CLINICAL CHARACTERISTICS
6/15/22
Cremades-Martínez P, Parker LA, Chilet-Rosell E, et al. | Microbiol Spectr
Aim: To review strategies for identifying SARS-CoV-2 infection before the availability of molecular test results, and to assess the reporting quality of the studies identified through the application of the STARD guideline.
CLINICAL CHARACTERISTICS
6/15/22
Shafiee A, Teymouri Athar MM, Kohandel Gargari O, et al. | Virol J
Aim: To evaluate the efficacy of ivermectin for COVID-19 patients based on current peer-reviewed RCTs and to address disputes over the existing evidence.
CLINICAL CHARACTERISTICS
6/14/22
Meng X, Zhu K, Wang J, et al. | Am J Otolaryngol
Aim: To outline the current knowledge regarding the effects of maternal SARS-CoV-2 infection during pregnancy on newborn hearing.
CLINICAL CHARACTERISTICS
6/14/22
Shobhana SS, Raviraj KG | Egypt J Forensic Sci
Aim: To note the global trends of suicidal ideation, self-harm, and suicidal thoughts amidst the pandemic.
CLINICAL CHARACTERISTICS
6/14/22
Watanabe A, So M, Iwagami M, et al.  | Respirol
Aim: To investigate the characteristics and time-course of pulmonary sequelae after recovery from COVID-19 through 1-year follow-up.
CLINICAL CHARACTERISTICS
6/14/22
Drumheller K, Fan CW | Sleep Epidemiol
Aim: To determine if screen time affected sleep during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
6/13/22
Ma Y, Deng J, Liu Q, et al. | Int J Environ Res Public Health
Aim: To evaluate the long-term consequences of coronavirus disease 2019 (COVID-19) at 6 months and above.
UPDATED
CLINICAL CHARACTERISTICS
6/13/22
D'Onofrio G, Trotta N, Severo M, et al. | J Clin Med
Aim: To review the evidence and effectiveness of psychological interventions applied during Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic.
CLINICAL CHARACTERISTICS
6/13/22
Krumbein H, Kümmel LS, Fragkou PC, et al. | Rev Med Virol
Aim: To critically assess the published literature related to community-acquired viral co-infections and COVID-19 and to evaluate the prevalence, most identified co-pathogens, and relevant risk factors.
UPDATED
CLINICAL CHARACTERISTICS
6/13/22
Banchelli F, Negro P, Guido M, et al. | J Clin Med
Aim: To investigate the role that ABO blood groups play in susceptibility to SARS-CoV-2 infection.
UPDATED
CLINICAL CHARACTERISTICS
6/10/22
Bhattarai A, Dhakal G, Shah S, et al. | Interdiscip Perspect Infect Dis
Aim: To review the evidence on the effect of preexisting asthma on the risk of ICU admission, intubation, and death from COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
6/10/22
Aamir Waheed M, Rashid K, Rajab T, et al.  | Saudi Med J
Aim: To compare the mortality associated with the intensity of anticoagulation in patients admitted with covid-19.
UPDATED
CLINICAL CHARACTERISTICS
6/8/22
Zeng N, Zhao YM, Yan W, et al.  | Mol Psychiatry
Aim: To review the evidence on COVID-19 survivors’ health consequences and sequelae for COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
6/7/22
Shafiee A, Teymouri Athar MM, Nassar M, et al. | Diabetes Metab Syndr
Aim: To evaluate the current evidence available to investigate clinical outcomes between patients with type 1 and type 2 diabetes.
UPDATED
CLINICAL CHARACTERISTICS
6/7/22
Zhi H, Ji X, Zhao Z, et al. | EClinicalMedicine
Aim: To review the evidence on the potential risk factors for impaired diffusing capacity for carbon monoxide (DLCO) in convalescent COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
6/6/22
Banerjee M, Pal R, Dutta S | Prim Care Diabetes
Aim: To provide a pooled estimate of the risk of developing incident diabetes following hospital discharge or at least 28 days after the COVID-19 diagnosis compared to matched controls or severity matched influenza/ non-COVID-19 acute upper respiratory tract infections (AURI).
CLINICAL CHARACTERISTICS
6/2/22
Shin JI, Kim SE, Lee MH, et al. | Eur Rev Med Pharmacol Sci
Aim: To assess the susceptibility to and clinical outcomes of COVID-19 in autoimmune inflammatory rheumatic disease (AIRD) and following AIRD drug use.
UPDATED
CLINICAL CHARACTERISTICS
6/2/22
Okita Y, Morita T, Kumanogoh A | Inflamm Regen
Aim: To review the evidence on the duration of SARS-CoV-2 RNA positivity from several parts of the obdy and clinical characteristics affecting it.
UPDATED
CLINICAL CHARACTERISTICS
6/2/22
Fragkou PC, Palaiodimou L, Stefanou MI, et al. | Ther Adv Neurol Disord
Aim: To review the effects of different dosing regimens of low molecular weight heparin and/or fondaparinux (LMWH/F) on mortality risk as well as the risk of arterial/venous thrombotic events and hemorrhagic complications in confirmed COVID-19 cases.
UPDATED
CLINICAL CHARACTERISTICS
6/2/22
Fakhruddin KS, Samaranayake LP, Buranawat B, et al. | PLoS One
Aim: To review the prevalence, the likely aetiopathogenesis, and the management of oro-facial mucocutaneous manifestations of Coronavirus Disease-2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2).
UPDATED
CLINICAL CHARACTERISTICS
6/2/22
Leazer S, Collen J, Alcover K, et al. | Mil Med
Aim: To determine critical care and organ support outcomes of intensive care unit (ICU) COVID-19 patients and whether they varied depending on the completeness of study follow-up or admission time period.
CLINICAL CHARACTERISTICS
6/2/22
Zhou Y, Ge YT, Yang XX, et al. | Front Public Health
Aim: To determine the prevalence of PE elevation, and the relationship between elevated PE and prognosis in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
6/2/22
Huntley CC, Patel K, Bil Bushra SE, et al. | ERJ Open Res
Aim: To describe and compare the longitudinal pulmonary function and computed tomography (CT) features of patients recovering from SARS, MERS and COVID-19 during follow-up.
UPDATED
CLINICAL CHARACTERISTICS
6/2/22
Hawco S, Rolnik DL, Woolner A, et al. | Eur J Obstet Gynecol Reprod Biol
Aim: To review the evidence on the relationship between SARS-CoV-2 mitigation measures and perinatal outcomes, with extensive subgroup analysis. 
UPDATED
CLINICAL CHARACTERISTICS
6/1/22
Allotey J, Stallings E, Bonet M, et al. | BMJ
Aim: To determine the clinical manifestations, risk factors, and maternal and perinatal outcomes in pregnant and recently pregnant women with suspected or confirmed coronavirus disease 2019 (covid-19).
UPDATED
CLINICAL CHARACTERISTICS
6/1/22
Sheerin D, Abhimanyu, Peton N, et al. | iScience
Aim: To identify mechanisms of immunopathogenic interaction between COVID-19 and TB.
CLINICAL CHARACTERISTICS
5/31/22
Lemes IR, Smaira FI, Ribeiro WJD, et al. | Br J Sports Med
Aim: To describe acute/postacute COVID-19 presentations in athletes.
UPDATED
CLINICAL CHARACTERISTICS
5/31/22
Levin AT, Owusu-Boaitey N, Pugh S, et al. | BMJ Glob Health
Aim: To review the evidence on age-specific seroprevalence or IFR for developing countries.
CLINICAL CHARACTERISTICS
5/31/22
Buitrago-Garcia D, Ipekci AM, Heron L, et al. | PLoS Med
Aim: To review the evidence on asymptomatic SARS-CoV-2 transmission.
UPDATED
CLINICAL CHARACTERISTICS
5/31/22
Anghelescu A, Onose G, Popescu C, et al. | Biomedicines
Aim: To review the evidence on post-SARS-CoV-2 immune-mediated reactions responsible for promoting neurodegeneration.
CLINICAL CHARACTERISTICS
5/31/22
Dzinamarira T, Murewanhema G, Chitungo I, et al.  | J Infect Public Health
Aim: To determine the association of HIV/AIDS comorbidity with COVID-19 mortality.
UPDATED
CLINICAL CHARACTERISTICS
5/31/22
Wang Y, Xie Y, Hu S, et al. | Front Immunol
Aim: To compare the risk of SARS-CoV-2 infection, severe COVID-19 symptoms, and death of PLWH with those without HIV.
CLINICAL CHARACTERISTICS
5/31/22
Oliveira da Silva Kist ML, Hanzen Andrades GR, Drumond Costa CA, et al. | Clin Nutr ESPEN
Aim: To systematically review the literature on the relation between weight excess and the severity of COVID-19 in children and adolescents.
UPDATED
CLINICAL CHARACTERISTICS
5/26/22
Hariyanto TI, Jodhinata C, Halim DA, et al. | Gastroenterol Hepatol Bed Bench
Aim: To provide evidence of the association between viral hepatitis and severe outcomes of COVID-19.
CLINICAL CHARACTERISTICS
5/26/22
Samimisedeh P, Jafari Afshar E, Shafiabadi Hassani N, et al. | J Magn Reson Imaging
Aim: To summarize cardiac MRI findings in COVID-19 vaccine-related myocarditis.
CLINICAL CHARACTERISTICS
5/26/22
de Sire A, Andrenelli E, Negrini F, et al. | Eur J Phys Rehabil Med
Aim: To investigate the literature on rehabilitation services for COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
5/25/22
Ulloque-Badaracco JR, Mosquera-Rojas MD, Hernandez-Bustamante EA, et al. | Heliyon
Aim: To evaluate the prognostic value of the AGR in COVID-19 patients.
CLINICAL CHARACTERISTICS
5/25/22
Dadashi M, Dadashi A, Sameni F, et al. | Gene Rep
Aim: To assess the status of patients co-infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and HIV.
CLINICAL CHARACTERISTICS
5/24/22
Liana P, Liberty IA, Murti K, et al. | Immunol Res
Aim: To summarize studies on the role of NETs in determining the prognosis of COVID-19 patients.
CLINICAL CHARACTERISTICS
5/24/22
Panagouli ED, Thirios AC, Psaltopoulou T, et al. | EMBnet
Aim: To evaluate special features and probable correlations between symptoms, laboratory findings, treatment, and outcomes of COVID-19 in children and adolescents.
CLINICAL CHARACTERISTICS
5/24/22
Ulloque-Badaracco JR, Mosquera-Rojas MD, Hernandez-Bustamante EA, et al. | Heliyon
Aim: To evaluate the prognostic value of the AGR in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
5/24/22
Michailidou D, Stavridou A, Panagouli ED, et al. | EMBnet
Aim: To summarize current evidence on vertical transmission rates, maternal, perinatal and neonatal outcomes and mode of delivery in pregnancies affected by COVID-19.
CLINICAL CHARACTERISTICS
5/23/22
Talukder A, Razu SR, Alif SM, et al. | J Multidiscip Healthc
Aim: To evaluate the association between symptoms and severity of disease in adult patients with confirmed COVID-19.
CLINICAL CHARACTERISTICS
5/23/22
Lee CJ, Woo W, Kim AY, et al. | J Med Virol
Aim: To provide a comparative meta-analysis and systematic review of the risk and clinical outcomes of COVID-19 infection between fully vaccinated and unvaccinated groups.
CLINICAL CHARACTERISTICS
5/23/22
Zuin M, Rigatelli G, Bilato MJ, et al. | Vascular
Aim: To assess prevalence and prognostic implications of pre-existing peripheral artery disease (PAD) in patients infected by the SARS-CoV-2.
CLINICAL CHARACTERISTICS
5/20/22
Lee KH, Li H, Lee MH, et al. | Eur Rev Med Pharmacol Sci
Aim: To describe the clinical and laboratory characteristics of MIS-C.
CLINICAL CHARACTERISTICS
5/20/22
Alvares MA, Ribas BHB, Miranda GB, et al. | Rev Assoc Med Bras
Aim: To correlate 25(OH)D levels with the clinical prognosis of pediatric patients diagnosed with COVID-19.
CLINICAL CHARACTERISTICS
5/20/22
Alahyari S, Moradi M, Rajaeinejad M, et al. | Expert Rev Hematol
Aim: To comprehensively assess the post-COVID hematologic complications in patients.
CLINICAL CHARACTERISTICS
5/19/22
Pandey R, Rai D, Tahir MW, et al.  | Arch Med Sci Atheroscler Dis
Aim: To review the evidence on the comorbidities and symptoms of adult patients with coronavirus disease 2019 (COVID-19) to evaluate comorbidities, symptoms, and severity.
CLINICAL CHARACTERISTICS
5/17/22
Sofizan NMFBN, Rahman AFBA, Soon LP, et al. | Egypt J Forensic Sci
Aim: To summarize the autopsy findings related to COVID-19 death.
CLINICAL CHARACTERISTICS
5/17/22
Péterfi A, Mészáros Á, Szarvas Z, et al. | Physiol Int
Aim: To review the evidence on the relationship of comorbidities and mortality due to Coronavirus Disease 2019 (COVID-19) among the elderly population.
CLINICAL CHARACTERISTICS
5/17/22
Meng X, Wang J, Sun J, et al. | Front Neurol
Aim: To examine whether COVID-19 causes an increased incidence of SSNHL and the clinical characteristics of patients with COVID-19-related SSNHL.
CLINICAL CHARACTERISTICS
5/17/22
Alshammary AF, Alsughayyir JM, Alharbi KK, et al. | Front Med
Aim: To analyze T-cell subsets (CD4/CD8) and IL-10 in severe and fatal cases of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
5/16/22
Afzal S, Nasir M | J Coll Physicians Surg Pak
Aim: To assess risk factors and case fatality in COVID-19 cases with aspergillosis or mucormycosis.
CLINICAL CHARACTERISTICS
5/16/22
Lee B, Ashcroft T, Agyei-Manu E, et al.  | J Glob Health
Aim: To assess whether the common clinical features of COVID-19 have changed to the point that the criteria used to identify both COVID-19 and influenza in surveillance programs needs to be altered.
CLINICAL CHARACTERISTICS
5/16/22
Mastan S, Hodhody G, Sajid M, et al. | Geriatr Orthop Surg Rehabil
Aim: To assess the early mortality rate of hip fracture patients in the UK, with and without COVID-19 infection.
CLINICAL CHARACTERISTICS
5/16/22
Vaseghi N, Sharifisooraki J, Khodadadi H, et al.  | Mycoses
Aim: To evaluate and estimate the global prevalence of coronavirus-associated C. auris infection (CACa).
UPDATED
CLINICAL CHARACTERISTICS
5/16/22
Altobelli E, Angeletti PM, Marzi F, et al. | J Clin Med
Aim: To robustly quantify admission trends of patients with ST-segment elevation MI (STEMI) and non-ST-segment elevation MI (NSTEMI) during the first wave of the pandemic and to characterize on a large basis the risk profile and early prognosis.
CLINICAL CHARACTERISTICS
5/16/22
Nappi F, Bellomo F, Avtaar Singh SS | J Clin Med
Aim: To investigate the role of inflammatory pathways, highlighting several culprits including neutrophil extracellular traps (NETs) which have since been extensively investigated.
CLINICAL CHARACTERISTICS
5/16/22
Ruvinsky S, Voto C, Roel M, et al. | Front Pediatr
Aim: To describe the clinical course, laboratory findings, epidemiology, treatment, and use of resources of MIS-C in children from LAC.
UPDATED
CLINICAL CHARACTERISTICS
5/16/22
Santana LADM, Vieira WA, Gonçalo RIC, et al. | J Stomatol Oral Maxillofac Surg
Aim: To better understand the relationship between COVID-19 infection and oral lesions.
UPDATED
CLINICAL CHARACTERISTICS
5/16/22
Carmassi C, Pacciardi B, Gravina D, et al. | Int J Environ Res Public Health
Aim: To evaluate and gather the scientific evidence on pharmacologic handling during delirium in COVID-19 patients to provide practical recommendations on the optimal management of psychotropic medication in these kinds of patients. 
CLINICAL CHARACTERISTICS
5/12/22
Tavares-Júnior JWL, de Souza ACC, Borges JWP, et al. | Cortex
Aim: To determine any relationship between COVID-19 and cognitive complaints, such as dementia, mild cognitive impairment (MCI), or subjective cognitive decline (SCD).
UPDATED
CLINICAL CHARACTERISTICS
5/11/22
Chang Y, Bai M, You Q | Biomed Res Int
Aim: To investigate the association between interleukins (IL-1beta, IL-2, IL-4, IL-6, IL-8, and IL-10) and the disease severity of coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
5/11/22
Jiang L, Tang K, Irfan O, et al. | Curr Pediatr Rep
Aim: To investigate and synthesize evolving evidence on its clinical characteristics, management, and outcomes in pediatric patients.
CLINICAL CHARACTERISTICS
5/10/22
Weng Y, Yi GY | J Med Virol
Aim: To provide sensible estimates of the mean incubation time of COVID-19 by capitalizing on available estimates reported in the literature and exploring different ways to accommodate heterogeneity involved in the reported studies.
CLINICAL CHARACTERISTICS
5/2/22
Doceda MV, Gavriiloglou M, Petit C, et al. | Oral Health Prev Dent
Aim: To evaluate the potential association of COVID-19 infection with oral health.
CLINICAL CHARACTERISTICS
5/2/22
Shahsavarinia K, Rahvar G, Soleimanpour H, et al. | Pak J Med Sci
Aim: To investigate the underlying factors causing pneumothorax, pneumomediastinum, and subcutaneous emphysema in COVID-19 patients.
CLINICAL CHARACTERISTICS
5/2/22
Gupta S, Jawanda MK | Eur J Neurol
Aim: To evaluate the number of published cases of Bell's palsy as the only major neurological manifestation in patients with COVID-19 from March 2020 to December 2021 and to investigate the association of SARS-CoV2 and Bell's palsy.
CLINICAL CHARACTERISTICS
5/2/22
Kow CS, Ramachandram DS, Hasan SS | J Cardiovasc Pharmacol
Aim: To perform a systematic review and meta-analysis to determine the effect of preadmission/prediagnosis use of CCBs on the clinical outcomes in patients with COVID-19.
CLINICAL CHARACTERISTICS
4/26/22
Alosaimi B, AlFayyad I, Alshuaibi S, et al. | BMC Sports Sci Med Rehabil
Aim: To measure the prevalence of CV complications suffered by COVID-19 athletic patients, explore the outcomes, optimal approaches to diagnoses, and safe return-to-play considerations.
CLINICAL CHARACTERISTICS
4/26/22
Fabrizi F, Alfieri CM, Cerutti R, et al. | Pathogens
Aim: To evaluate the frequency of AKI and dialysis requirement in patients who underwent hospitalization due to COVID-19.
CLINICAL CHARACTERISTICS
4/22/22
Giannos P, Katsikas Triantafyllidis K, et al. | Front Neurol
Aim: To screen the current literature and provide a summary of the reported cases of SARS-CoV-2 infected patients presenting with persistent hiccups.
CLINICAL CHARACTERISTICS
4/21/22
Kastora S, Patel M, Carter B, et al. | Endocrinol Diabetes Metab
Aim: To analyse the collective and geographically stratified mortality, ICU admission, ventilation requirement, illness severity and discharge rate amongst patients with diabetes.
UPDATED
CLINICAL CHARACTERISTICS
4/19/22
Alahyari S, Rajaeinejad M, Jalaeikhoo H, et al. | Arch Iran Med
Aim: To evaluate the role of regulatory T cells (Tregs) as one of the main cells that maintain immune homeostasis.
CLINICAL CHARACTERISTICS
4/18/22
Sabaghian T, Rommasi F, Omidi F, et al. | Bratisl Lek Listy
Aim: To collate the condition and risk factors of AKI and non-AKI COVID-19 patients and to investigate AKI incidence in high-risk patients.
CLINICAL CHARACTERISTICS
4/14/22
Daniels NF, Burrin C, Chan T, et al. | Curr Dev Nutr
Aim: To explore the indirect effects of the first year of COVID-19 on obesity and its risk factors.
UPDATED
CLINICAL CHARACTERISTICS
4/14/22
Rahmati M, Shamsi MM, Khoramipour K, et al. | Rev Med Virol
Aim: To explore the hospitalisation, intensive care unit (ICU) admissions, and mortality rates of COVID-19 patients with a history of PA participation before the onset of the pandemic, and to evaluate the reliability of the evidence.
CLINICAL CHARACTERISTICS
4/14/22
Yang H, Rigsby M, Zhu X, et al. | HERD
Aim: To identify factors associated with LTCF residents' COVID-19 infections and the impacts of the pandemic and the corresponding preventive measures on residents' mental health and behavioral problems.
CLINICAL CHARACTERISTICS
4/14/22
Umbrello M, Venco R, Antonucci E, et al. | Minerva Anestesiol
Aim: To investigate the incidence, risk factors and clinical outcomes of barotrauma among critically ill COVID-19 patients.
CLINICAL CHARACTERISTICS
4/14/22
Modica G, Bianco M, Sollazzo F, et al. | Int J Environ Res Public Health
Aim: To assess the event rates of myocarditis detected by Cardiac Magnetic Resonance (CMR) in athletes who recovered from COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
4/11/22
Koupaei M, Mohamadi MH, Yashmi I, et al. | J Clin Lab Anal
Aim: To evaluate the features of COVID-19 relapse patients.
CLINICAL CHARACTERISTICS
4/11/22
Huang D, Zunong J, Li M, et al. | Curr HIV/AIDS Rep
Aim: To review the evidence on the epidemiological characteristics and clinical presentation of coinfected patients in China, as well as laboratory indicators, antiretroviral therapy status, and disease outcomes in PLHIV coinfected with CoV.
CLINICAL CHARACTERISTICS
4/11/22
Boden I, Bernabeu MO, Dhillon B, et al. | Diabetes Res Clin Pract
Aim: To test the hypothesis that pre-existing diabetic retinopathy (DR), a microvascular disease, is a prognostic indicator for poor COVID-19 outcome in this heterogeneous population.
CLINICAL CHARACTERISTICS
4/11/22
Chaudhry ZS, Nellessen N, Reis C, et al. | Fam Pract
Aim: To identify and summarize clinical reports of acute inflammatory arthritis associated with COVID-19.
CLINICAL CHARACTERISTICS
4/7/22
Hopefl R, Ben-Eltriki M, Deb S | J Pharm Pharm Sci
Aim: To analyze the association of vitamin D levels with the inflammatory markers in COVID-19 patients.
CLINICAL CHARACTERISTICS
4/7/22
Naimi A, Yashmi I, Jebeleh R, et al. | J Clin Lab Anal
Aim: To review the literature reporting the COVID-19 outcomes in patients with hematological malignancies.
CLINICAL CHARACTERISTICS
4/7/22
Fu XL, Qian Y, Jin XH, et al. | Lupus
Aim: To evaluate the epidemiology of SLE and COVID-19, to identify the clinical characteristics of SLE patients with COVID-19, to clarify the treatment of COVID-19 in SLE patients and to assess the impact of COVID-19 pandemic on SLE patients.
CLINICAL CHARACTERISTICS
4/7/22
Mahdizade Ari M, Mohamadi MH, Shadab Mehr N, et al.  | J Clin Lab Anal
Aim: To evaluate the prevalence of neurological complications arises from SARS-CoV-2 and assess the mortality rate from neurological complications.
CLINICAL CHARACTERISTICS
4/6/22
Gupta AK, Leslie A, Hewitt JN, et al. | ANZ J Surg
Aim: To characterize outcomes of COVID-19 positive patients undergoing cardiac surgery.
UPDATED
CLINICAL CHARACTERISTICS
4/6/22
Liu M, Mei K, Tan Z, et al.  | Can J Gastroenterol Hepatol
Aim: To evaluate the relationship between liver fibrosis scores and adverse outcomes in patients with COVID-19, as well as potential dose-response association.
UPDATED
CLINICAL CHARACTERISTICS
4/6/22
Calvert C, John J, Nzvere FP, et al. | Glob Health Action
Aim: To report the findings of a rapid systematic review of studies on levels of maternal mortality before and during the COVID-19 pandemic.
UPDATED
CLINICAL CHARACTERISTICS
4/4/22
Patanavanich R, Siripoon T, Amponnavarat S, et al. | Nicotine Tob Res
Aim: To explore the association between current smoking and the risk for mortality due to COVID-19.
CLINICAL CHARACTERISTICS
4/4/22
Wang Y, Kang L, Chien CW, et al. | Front Cardiovasc Med
Aim: To compare the characteristics, management, and clinical outcomes between the COVID-19 and non-COVID-19 patients concomitant STEMI.
UPDATED
CLINICAL CHARACTERISTICS
4/4/22
Len P, Iskakova G, Sautbayeva Z, et al. | Front Cardiovasc Med
Aim: To assess the association between early hemostatic parameters and infection severity.
CLINICAL CHARACTERISTICS
4/4/22
Yang F, Xu Y, Dong Y, et al. | Pancreatology
Aim: To determine the pooled prevalence and prognostic significance of increased pancreatic enzymes in adult patients with COVID-19.
CLINICAL CHARACTERISTICS
4/1/22
Khedr A, Al Hennawi H, Rauf I, et al. | Infez Med
Aim: To assess and compare mortality outcomes between LMICs and high-income countries (HICs).
CLINICAL CHARACTERISTICS
4/1/22
El-Qushayri AE, Mahmoud MA, Salman S, et al. | Dermatol Ther
Aim: To evaluate the safety of dupilumab use in the management of atopic dermatitis (AD) during the current pandemic regarding the risk and the hazards of COVID-19 infection.
CLINICAL CHARACTERISTICS
4/1/22
Wang F, Ma Y, Xu S, et al. | Clin Rheumatol
Aim: To assess the risk of COVID-19 in patients with rheumatic diseases.
CLINICAL CHARACTERISTICS
4/1/22
Figueiredo EAB, Silva WT, Tsopanoglou SP, et al. | Rev Soc Bras Med Trop
Aim: To discuss the main findings regarding HRQoL in post-COVID-19 patients who required hospitalization.
CLINICAL CHARACTERISTICS
3/31/22
de Oliveira YLM, de Sa Resende A, Martins-Filho PR, et al. | Inflammopharmacology
Aim: To evaluate the expression of TREM-1 in patients with COVID-19 and other viral pneumonias compared to healthy individuals.
CLINICAL CHARACTERISTICS
3/30/22
Almamlouk R, Kashour T, Obeidat S, et al. | Clin Microbiol Infect
Aim: To better understand the pathologic cardiac findings in COVID-19 patients at the time of postmortem evaluation.
CLINICAL CHARACTERISTICS
3/30/22
Zuin M, Bilato C, Quadretti L, et al. | G Ital Cardiol
Aim: To determine the in-hospital incidence of acute PE, based on Italian studies published on this issue.
CLINICAL CHARACTERISTICS
3/28/22
Asiimwe IG, Pushpakom SP, Turner RM, et al. | Br J Clin Pharmacol
Aim: To review the evidence on cardiovascular drug exposure and COVID-19 clinical outcomes.
CLINICAL CHARACTERISTICS
3/28/22
García H, Allende-López A, Morales-Ruíz P, et al. | Arch Med Res
Aim: To conduct a systematic review of the literature on published studies of COVID-19 in newborns with a positive RT–PCR test.
CLINICAL CHARACTERISTICS
3/28/22
Fabbri L, Moss S, Khan FA, et al. | Thorax
Aim: To assess the proportion of chest CT scans and pulmonary function tests consistent with parenchymal lung disease in the follow-up of people hospitalised with COVID-19 and viral pneumonitis.
CLINICAL CHARACTERISTICS
3/28/22
Maglietta G, Diodati F, Puntoni M, et al. | J Clin Med
Aim: To identify, in patients who had been hospitalized for COVID-19, which factors already present or emerging during hospitalization, were associated with an increased risk of exhibiting new or persisting symptoms.
UPDATED
CLINICAL CHARACTERISTICS
3/28/22
Gentile F, Bocci T, Coppola S, et al. | Biomedicines
Aim: To discuss current clinical and pre-clinical data on the relationship between the lung and brain during COVID-19.
CLINICAL CHARACTERISTICS
3/28/22
Riccò M, Ferraro P, Peruzzi S, et al. | Microorganisms
Aim: To summarize the available data about the risk of co-infections SARS-CoV-2–Legionella, specifically focusing on their prevalence, risk factors, and two main outcomes—ICU admission and case fatality ratio (CFR).
CLINICAL CHARACTERISTICS
3/28/22
Li S, Ren J, Hou H, et al. | Neurol Sci
Aim: To investigate the association between stroke and the risk for mortality among coronavirus disease 2019 (COVID-19) patients.
CLINICAL CHARACTERISTICS
3/28/22
Furnica C, Chistol RO, Chiran DA, et al. | Diagnostics
Aim: To evaluate the impact of the early COVID-19 pandemic on the presentation, management, and prognosis of STEMI patients.
UPDATED
CLINICAL CHARACTERISTICS
3/28/22
Decyk A, Kobylinska M, Antosik K, et al. | Rocz Panstw Zakl Hig
Aim: To review the current literature on the influence and importance of vitamin D levels on the course of SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
3/25/22
Muthuka JK, Kiptoo M, Oluoch K, et al. | JMIR Pediatr Parent
Aim: To examine the relationship between pregnancy status and the clinical COVID -19 severity characterized by cytokine storm.
UPDATED
CLINICAL CHARACTERISTICS
3/25/22
Tan CJ, Tan BKJ, Tan XY, et al. | Laryngoscope
Aim: To review the evidence on the pathogenesis of COVID-19 olfactory dysfunction.
CLINICAL CHARACTERISTICS
3/24/22
Bhakta S, Erben Y, Sanghavi D, et al. | J Vasc Surg Venous Lymphat Disord
Aim: To assess the association between race and VTE in hospitalized COVID-19 patients.
CLINICAL CHARACTERISTICS
3/24/22
Farsi Y, Tahvildari A, Arbabi M, et al. | Front Cell Infect Microbiol
Aim: To evaluate the composition of gut microbiota in COVID-19 patients compared with healthy individuals.
CLINICAL CHARACTERISTICS
3/24/22
Tutal E, Ozaras R, Leblebicioglu H | Travel Med Infect Dis
Aim: To assess the prevalence, clinical features and outcome of autoimmune thyroid disorders triggered by COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
3/21/22
Allotey J, Chatterjee S, Kew T, et al.  | BMJ
Aim: To assess the rates of SARS-CoV-2 positivity in babies born to mothers with SARS-CoV-2 infection, the timing of mother-to-child transmission and perinatal outcomes, and factors associated with SARS-CoV-2 status in offspring.
CLINICAL CHARACTERISTICS
3/18/22
Kumar R, Rai AK, Phukan MM, et al. | Curr Genomics
Aim: To assess the cumulative risk assessment of multiple co-morbid conditions associated with severe COVID-19. 
CLINICAL CHARACTERISTICS
3/18/22
Ashktorab H, Russo T, Oskrochi G, et al. | Gastro Hep Adv
Aim: To analyze data from studies reporting Gastrointestinal bleeding (GIB) and/or endoscopic findings in COVID-19 patients in Western countries.
CLINICAL CHARACTERISTICS
3/18/22
Gatti M, Rinaldi M, Bussini L, et al. | Clin Microbiol Infect
Aim: To assess the clinical outcome in SOT recipients with COVID-19 compared to general population.
CLINICAL CHARACTERISTICS
3/18/22
Fatima M, Ahmad Cheema H, Ahmed Khan MH, et al.  | Ann Med Surg
Aim: To provide a detailed account of the development of myocarditis and pericarditis following the COVID-19 vaccination
UPDATED
CLINICAL CHARACTERISTICS
3/18/22
Hartwell M, Lin V, Gatewood A, et al.  | J Matern Fetal Neonatal Med
Aim: To examine the inclusion of the equity reporting in SRMAs focused on pregnancy outcomes and COVID-19 using PROGRESS-Plus equity framework.
CLINICAL CHARACTERISTICS
3/18/22
Gong X, Yuan B, Yuan Y | PLoS One
Aim: To assess the pooled incidence of pulmonary embolic events and the prognostic value of such events in intensive care unit (ICU) admissions of patients with COVID-19.
CLINICAL CHARACTERISTICS
3/18/22
Perez-Lopez FR, Saviron-Cornudella R, Chedraui P, et al. | J Matern Fetal Neonatal Med
Aim: To compare obstetric and perinatal outcomes in laboratory-tested pregnant women for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection before delivering.
CLINICAL CHARACTERISTICS
3/18/22
Qi X, Northridge ME, et al. | Aging Health Res
Aim: To determine the prevalence of oral health conditions in participants with COVID-19 infection and identify the associations of oral health conditions with COVID-19 related outcomes.
UPDATED
CLINICAL CHARACTERISTICS
3/18/22
Zou Y, Han M, Wang J, et al. | Ann Transl Med
Aim: To compare the mortality risk of frail vs. non-frail hospitalized patients with COVID-19.
CLINICAL CHARACTERISTICS
3/18/22
Jaiswal V, Almas T, Peng Ang S, et al. | Ann Med Surg
Aim: To find the symptoms, risk factors, clinical findings, and outcomes in patient of COVID-19 having STEMI.
UPDATED
CLINICAL CHARACTERISTICS
3/14/22
Kaya T, Dilek A, Ozaras R, et al. | Travel Med Infect Dis
Aim: To evaluate COVID-19 cases presented with febrile neutropenia and provide information regarding incidence, clinical course and prognosis.
UPDATED
CLINICAL CHARACTERISTICS
3/14/22
Chen W, Yin C, Zhong M, et al. | Ann Palliat Med
Aim: To identify studies systematically that describe the incidence and outcome of COVID-19-related pulmonary aspergillosis (CAPA).
CLINICAL CHARACTERISTICS
3/14/22
Sharma P, Malik S, Wadhwan V, et al. | Rev Med Virol
Aim: To assess the prevalence of oral manifestations in COVID-19 confirmed individuals.
UPDATED
CLINICAL CHARACTERISTICS
3/11/22
Chen H, Shi H, Liu X, et al. | Front Med
Aim: To evaluate the effect of PR on lung impairment for patients with post-COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
3/10/22
Dao TL, Hoang VT, Colson P, et al. | J Clin Virol Plus
Aim: To determine the proportion of co-infection with influenza viruses in SARS-CoV-2 positive patients and to investigate the severity of COVID-19 in these patients.
CLINICAL CHARACTERISTICS
3/9/22
Wang Y, Li Y, Zhang Y, et al. | BMC Gastroenterol
Aim: To investigate the relationship between gastrointestinal symptoms and COVID-19 mortality.
CLINICAL CHARACTERISTICS
3/9/22
Alzoughool F, Abumweis S, Alanagreh L, et al. | Osong Public Health Res Perspect
Aim: To evaluate the association of pre-existing cardiovascular comorbidities, including hypertension and coronary heart disease, with coronavirus disease 2019 (COVID-19) severity and mortality.
CLINICAL CHARACTERISTICS
3/9/22
Balawender K, Pliszka A, Krowiak A, et al. | Curr Pharm Biotechnol
Aim: To present the current understanding of the effects of Covid-19 infection on the male genitourinary system.
CLINICAL CHARACTERISTICS
3/9/22
Wafa IA, Pratama NR, Sofia NF, et al. | Diabetes Metab J
Aim: To investigate the differences in metabolic control parameters in diabetic patients before and during the lockdown.
UPDATED
CLINICAL CHARACTERISTICS
3/9/22
Beigi-Khoozani A, Merajikhah A, Soleimani M | Chin Med Sci J
Aim: To review the evidence on magnetic resonance imaging findings of olfactory bulb in anosmic patients with COVID-19.
CLINICAL CHARACTERISTICS
3/9/22
Soltani S, Zandi M, Faramarzi S, et al.  | Osong Public Health Res Perspect
Aim: To determine the pooled prevalence of fungal coinfections in coronavirus disease 2019 (COVID-19) patients. 
CLINICAL CHARACTERISTICS
3/8/22
Martin-Martin J, Martin-Cazorla F, Suarez J, et al. | Curr Med Res Opin
Aim: To review complete autopsy cases and their postmortem findings and comorbidities associated with death caused by COVID-19.
CLINICAL CHARACTERISTICS
3/8/22
SeyedAlinaghi S, Karimi A, Barzegary A, et al. | Health Sci Rep
Aim: To review the evidence on mucormycosis co?infection in patients with COVID?19.
CLINICAL CHARACTERISTICS
3/7/22
Domingues RB, Leite FBVM, Senne C | Arq Neuropsiquiatr
Aim: To review the evidence on CSF findings relating to COVID-19.
CLINICAL CHARACTERISTICS
3/7/22
Hessami K, Aagaard K, Castro EC, et al. | Am J Perinatol
Aim: To review the evidence on histopathologic findings in the placentas of women with SARS-CoV-2 infection during pregnancy.
CLINICAL CHARACTERISTICS
3/4/22
Satpathy S, Wundaville LT, Satapathy S, et al. | J Patient Exp
Aim: To review the existing scales on patients’ satisfaction used for hospitalized patients and their application in COVID-19 situation. 
CLINICAL CHARACTERISTICS
3/4/22
Hu H, Pan H, Li R, et al. | Front Pharmacol
Aim: To identify the key factors associated to COVID-19 severity and death, especially in terms of the sex and race bias detected in severe COVID-19 patients.
CLINICAL CHARACTERISTICS
3/4/22
Krzych LJ, Putowski Z, Gruca K, et al. | Pol Arch Intern Med
Aim: To review the evidence on mortality in critically ill COVID-19 patients with fungal infections.
CLINICAL CHARACTERISTICS
3/4/22
Goyal M, Ray I, Mascarenhas D, et al. | QJM
Aim: To elucidate the clinical findings, laboratory parameters, treatment and outcomes of individuals with Myocarditis after COVID-19 vaccination.
UPDATED
CLINICAL CHARACTERISTICS
3/4/22
Quintero-Martinez JA, Hindy JR, Mahmood M, et al. | Am J Med Sci
Aim: To provide a descriptive analysis of the clinical features and outcomes of patients with IE and recent COVID-19.
CLINICAL CHARACTERISTICS
3/2/22
Nguyen B, Tosti A | JAAD Int
Aim: To characterize the types, incidence, timing, and clinical outcomes of COVID-19-associated alopecia.
CLINICAL CHARACTERISTICS
3/2/22
Notarte KI, Ver AT, Velasco JV, et al.  | Crit Rev Clin Lab Sci
Aim: To review the evidence on the possible effects of age, sex, serostatus, and comorbidities on humoral response (i.e. total antibodies, IgG, and/or IgA) of different populations post-mRNA-based Pfizer-BioNTech vaccination.
CLINICAL CHARACTERISTICS
3/2/22
Ben-Aicha S, Buchanan J, Punjabi P, et al. | Perfusion
Aim: To estimate the rate of in-hospital mortality following different treatments on COVID-19 in patients with CVD.
UPDATED
CLINICAL CHARACTERISTICS
3/2/22
Damara FA, Muchamad GR, Anton, et al. | World Neurosurg
Aim: To evaluate the epidemiological characteristics of TBI patients before and during the COVID-19 pandemic.
UPDATED
CLINICAL CHARACTERISTICS
3/2/22
Tayyebi H, Hasanikhah M, Heidarikhoo M, et al. | Curr Orthop Pract
Aim: To assess the in-hospital and 30-day mortality rates as well as the length of hospital stay in patients with COVID-19 infection who had hip fracture surgery.
CLINICAL CHARACTERISTICS
3/2/22
Pashaei Z, SeyedAlinaghi S, Qaderi K, et al. | Health Sci Rep
Aim: The possible complications of COVID?19 infection in the fetus and newborn babies including the possibility and evidence of vertical transmission.
CLINICAL CHARACTERISTICS
3/2/22
Hannah JR, Ali SS, Nagra D, et al.  | Clin Exp Rheumatol
Aim: To review the evidence on skeletal muscle involvement in COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/28/22
Pathirathna ML, Samarasekara BPP, Dasanayake TS, et al. | Healthcare
Aim: To evaluate the maternal, fetal and neonatal effects associated with COVID-19 in pregnancy.
UPDATED
CLINICAL CHARACTERISTICS
2/28/22
El-Qushayri AE, Kamel AMA, Reda A, et al. | Rev Med Virol
Aim: To give a summary of the available literature regarding the outcomes of dengue and COVID-19 co-infection.
CLINICAL CHARACTERISTICS
2/28/22
Szarpak L, Mierzejewska M, Jurek J, et al. | Biology
Aim: To determine the association between CAD and COVID-19 outcomes. 
CLINICAL CHARACTERISTICS
2/28/22
Oyelade T, Alqahtani JS, Hjazi AM, et al. | Trop Med Infect Dis
Aim: To assess the prevalence of people living with HIV (PLWH) among COVID-19 cases and whether HIV infection affects the risk of severe COVID-19 or related death at the global and continental level. 
CLINICAL CHARACTERISTICS
2/28/22
Kariyawasam JC, Jayarajah U, Abeysuriya V, et al. | Am J Trop Med Hyg
Aim: To outline the important liver manifestations of COVID-19 and discussed the possible underlying pathophysiological mechanisms and their diagnosis and management.
CLINICAL CHARACTERISTICS
2/28/22
Han Q, Zheng B, Daines L, et al. | Pathogens
Aim: To systematically synthesise existing evidence on long-term post-COVID symptoms.
CLINICAL CHARACTERISTICS
2/28/22
Tian Y, Lu H, Liu X, et al. | Medicine
Aim: To assess whether tricuspid annular plane systolic excursion (TAPSE) could be used as a prognostic tool in patients with coronavirus disease 19 (COVID-19).
UPDATED
CLINICAL CHARACTERISTICS
2/28/22
Ng JW, Chong ETJ, Tan YA, et al. | Int J Environ Res Public Health
Aim: To provide insight into the prevalence of COVID-19 in 5 different clinical stages during the outset of the COVID-19 pandemic in Malaysia.
CLINICAL CHARACTERISTICS
2/28/22
Mendiola-Pastrana IR, López-Ortiz E, Río de la Loza-Zamora JG, et al. | Life
Aim: To analyze the impact of different SARS-CoV-2 variants on clinical outcomes.
CLINICAL CHARACTERISTICS
2/28/22
Halim C, Mirza AF, Sari MI | Pathogens
Aim: To determine the relationship, if any, between TNF-alpha, IL-6, vitamin D, and COVID-19 severity and mortality.
CLINICAL CHARACTERISTICS
2/24/22
An W, Wang Q, Kim TE, et al. | J Infect Public Health
Aim: To investigate the clinical characteristics, morbidity, severity, and mortality of COVID-19 infection among solid organ transplant (SOT) recipients by meta-analysis.
CLINICAL CHARACTERISTICS
2/24/22
Li J, Wang Y, Liu Y, et al.  | Eur J Med Res
Aim: To determine the effect of polymorphisms and mutations in angiotensin-converting enzyme 2 (ACE2) and Type 2 transmembrane serine proteases (TMPRSS2) genes on susceptibility to corona virus disease 2019 (COVID-19) and patient prognosis.
UPDATED
CLINICAL CHARACTERISTICS
2/24/22
Isla A, Landy D, Teasdall R, et al. | Eur J Orthop Surg Traumatol
Aim: To explore the association of COVID-19 with short-term mortality in hip fracture patients.
CLINICAL CHARACTERISTICS
2/24/22
Fabião J, Sassi B, Pedrollo EF, et al. | Braz J Med Biol Res
Aim: To study the mechanism behind worse coronavirus disease-19 (COVID-19) outcomes in men and whether the differences between sexes regarding mortality as well as disease severity are influenced by sex hormones.
UPDATED
CLINICAL CHARACTERISTICS
2/22/22
Heidary M, Asadi A, Noorbakhsh N, et al. | J Clin Lab Anal
Aim: To discuss the characteristics of COVID-19 in HIV-positive patients.
CLINICAL CHARACTERISTICS
2/22/22
Kamat M, Datar U, Byakodi S, et al. | J Clin Transl Res
Aim: To report and analyze CAM regarding risk factors, clinical characteristics and to understand the associated pathogenesis.
CLINICAL CHARACTERISTICS
2/22/22
Pandey SR, Adhikari Yadav S, Gautam S, et al. | F1000Res
Aim: To evaluate the clinical and radiological effects of LDRT in patients with severe acute respiratory syndrome (SARS) due to COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/21/22
Silveira FM, Mello ALR, da Silva Fonseca L, et al. | Arch Oral Biol
Aim: To integrate the morphological and tissue-based molecular characterization of oral lesions occurring in individuals infected by COVID-19 (OLICs).
UPDATED
CLINICAL CHARACTERISTICS
2/18/22
Yadav M, Singh A, Meena J, et al. | J Laryngol Otol
Aim: To review the evidence on the otorhinolaryngologic manifestations of COVID-19 in paediatric patients.
CLINICAL CHARACTERISTICS
2/18/22
Kazemi S, Pourgholaminejad A, Saberi A | Basic Clin Neurosci
Aim: To review the change of stroke incidence during the COVID-19 pandemic period and the proposed mechanisms of the relationship between SARS-CoV-2 and stroke.
CLINICAL CHARACTERISTICS
2/18/22
Hannum ME, Koch RJ, Ramirez VA, et al.  | Chem Senses
Aim: To establish the predicted prevalence rate of taste loss in COVID-19 patients.
CLINICAL CHARACTERISTICS
2/17/22
Di Felice G, Visci G, Teglia F, et al. | Elife
Aim: To compare the outcomes of unvaccinated COVID-19 patients with and without cancer.
CLINICAL CHARACTERISTICS
2/17/22
Harwood R, Yan H, Talawila Da Camara N, et al.  | EClinicalMedicine
Aim: To identify which CYP were at increased risk of severe disease or death in CYP admitted to hospital with SARS-CoV-2 infection or PIMS-TS / MIS-C.
CLINICAL CHARACTERISTICS
2/16/22
Barzegar M, Mirmosayyeb O, Ebrahimi N, et al. | Mult Scler Relat Disord
Aim: To assess the risk of coronavirus disease (COVID-19), clinical features and outcome among patients with neuromyelitis optica spectrum disorder (NMOSD).
CLINICAL CHARACTERISTICS
2/16/22
Shah K, Varna VP, Sharma U, et al. | QJM
Aim: To study the effect of vitamin D supplementation on morbidity and mortality in hospitalized COVID-19 patients.
CLINICAL CHARACTERISTICS
2/15/22
Elberry MH, Abdelgawad HAH, Hamdallah A, et al. | J Thromb Thrombolysis
Aim: To report susceptible demographics outcomes, commonalities, and prognosis of reporting cases. 
CLINICAL CHARACTERISTICS
2/15/22
Uaprasert N, Tangcheewinsirikul N, Rojnuckarin P, et al. | Blood Adv
Aim: To systematically review the clinical features and outcomes of patients with COVID-19 with confirmed HIT.
UPDATED
CLINICAL CHARACTERISTICS
2/14/22
Xiao D, Tang F, Chen L, et al. | Front Cardiovasc Med
Aim: To evaluate the association between thrombosis and the prognosis of COVID-19.
CLINICAL CHARACTERISTICS
2/14/22
Kariyawasam RM, Dingle TC, Kula BE, et al. | Clin Microbiol Infect
Aim: To review the prevalence, diagnosis, treatment, and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA) and compare research definitions.
CLINICAL CHARACTERISTICS
2/14/22
Bachour Y, Bekkenk MW, Rustemeyer T, et al. | J Cosmet Dermatol
Aim: To review the evidence on late inflammatory reactions in patients with soft tissue fillers after infection with SARS-CoV-2 and vaccination.
CLINICAL CHARACTERISTICS
2/14/22
Nagalli S, Kikkeri NS | Infez Med
Aim: To study the patient’s characteristics, risk factors, complications, and outcomes of COVID-19 patients diagnosed with mucormycosis.
CLINICAL CHARACTERISTICS
2/14/22
Alali AH, Smaisem MS, Alsheikh AM, et al. | Infez Med
Aim: To explore myocardial injury in coronavirus disease-19 (COVID-19) patients who were hospitalized with severe complicated infections.
CLINICAL CHARACTERISTICS
2/11/22
Quintanilla-Sánchez C, Salcido-Montenegro A, González-González JG, et al. | Rev Neurosci
Aim: To describe the prevalence and risk of ACVE in patients with severe and nonsevere COVID-19. 
UPDATED
CLINICAL CHARACTERISTICS
2/11/22
da Silva CGL, Santana JRP, Pinheiro LFG, et al. | Adv Exp Med Biol
Aim: To analyze the main morphofunctional changes in the involvement of multiple organs in patients infected with SARS-CoV-2, correlating anatomopathological findings with the clinical picture.
CLINICAL CHARACTERISTICS
2/11/22
Ramandi A, Akbarzadeh MA, Khaheshi I, et al. | Curr Probl Cardiol
Aim: To review articles inclusive of aortic dissection concurrent with Covid-19 infection.
CLINICAL CHARACTERISTICS
2/11/22
Jaiswal V, Nepal G, Dijamco P, et al. | J Prim Care Community Health
Aim: To systematically review the baseline features, clinical characteristics, treatment, and outcomes in patients developing CVST post-COVID-19 vaccination.
CLINICAL CHARACTERISTICS
2/11/22
Liu N, Yang D, Zhang T, et al. | Int J Infect Dis
Aim: To assess the risk factors for olfactory and gustatory dysfunction in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/11/22
Al Kiyumi MH, Kalra S, Davies JS, Kalhan A | Indian J Endocrinol Metab
Aim: To ascertain the prevalence of VDD in patients with COVID-19. 
UPDATED
CLINICAL CHARACTERISTICS
2/9/22
Audrey J, Wisnu W, Tahapary DL | Curr Diabetes Rev
Aim: To investigate the association between statin use and poor outcomes in COVID-19 patients with diabetes.
CLINICAL CHARACTERISTICS
2/9/22
Han S, Zhuang Q, Chiang J, et al. | BMJ Open
Aim: To determine the proportion of COVID-19 patients with cancer, their severity and mortality outcomes through a systematic review and meta-analysis (MA).
CLINICAL CHARACTERISTICS
2/9/22
Al-Maiahy TJ, Al-Kuraishy HM, Al-Gareeb AI | J Pak Med Assoc
Aim: To illustrate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections during pregnancy and to explore pregnancy outcomes, vertical and perinatal transmission as well as management of coronavirus disease-2019 (Covid-19) during pregnancy.
CLINICAL CHARACTERISTICS
2/9/22
Risk Factors for Severe COVID-19 in Children: A Systematic Review and Meta-Analysis | J Korean Med Sci
Aim: To identify children at high risk of severe COVID-19, with a focus on comorbidities and age.
CLINICAL CHARACTERISTICS
2/8/22
Alkodaymi MS, Omrani OA, Fawzy NA, et al. | Clin Microbiol Infect
Aim: To estimate the prevalence of persistent symptoms and signs at least 12 weeks after acute COVID-19 at different follow-up periods.
CLINICAL CHARACTERISTICS
2/8/22
Baker J, Krishnan N, Abroms LC, et al. | J Smok Cessat
Aim: To determine whether a history of tobacco use increases risks for adverse outcomes among COVID-19 patients.
CLINICAL CHARACTERISTICS
2/8/22
Tan Z, Huang S, Mei K, et al.  | Front Cardiovasc Med
Aim: To determine the prevalence and associated death of ventricular arrhythmia and sudden cardiac death (SCD) in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/7/22
Premraj L, Kannapadi NV, Briggs J, et al. | J Neruol Sci
Aim: To determine the prevalence of neurological and neuropsychiatric symptoms reported 12 weeks (3 months) or more after acute COVID-19 onset in adults.
CLINICAL CHARACTERISTICS
2/7/22
Duarsa MDVI, Kandarini Y, Yogiswara N, et al. | Truk J Urol
Aim: To systematically review the current findings regarding survival and clinical outcomes of KT recipients with COVID-19 infection.
CLINICAL CHARACTERISTICS
2/4/22
Manzano GS, McEntire CRS, Martinez-Lage M, et al. | Neurol Neuroimmunol Neuroinflamm
Aim: To synthesize their clinical features, response to treatments, and clinical outcomes to better understand the nature of this neurologic consequence of COVID-19 infection.
CLINICAL CHARACTERISTICS
2/4/22
Malik J, Zaidi SMJ, Waqar AU, et al. | Expert Rev Endocrinol Metab
Aim: To assess the prevalence of hypothyroidism in patients with COVID-19.
CLINICAL CHARACTERISTICS
2/4/22
Mir T, Attique HB, Sattar Y, et al.  | Cardiovasc Revasc Med
Aim: To evaluate the mortality outcomes of critically ill patients with and without PE (WPE).
CLINICAL CHARACTERISTICS
2/4/22
Malik P, Patel K, Pinto C, et al. | J Med Virol
Aim: To evaluate the pooled prevalence of poor quality of life in post-acute COVID-19 syndrome (PCS).
CLINICAL CHARACTERISTICS
2/4/22
Ouyang L, Gong J, Yu M | Int Immunopharmacol
Aim: To investigate the prevalence of ILD among patients with COVID-19 and figure out the relationship between ILD and the poor clinical outcomes of COVID-19.
CLINICAL CHARACTERISTICS
2/4/22
Prada L, D Santos C, Baião RA, et al. | J Clin Pharmacol
Aim: To systematically evaluate the risk of SARS-CoV-2 infection and mortality and the risk of severe coronavirus disease 2019 (COVID-19) associated with previous exposure to NSAIDs. 
CLINICAL CHARACTERISTICS
2/2/22
Sharma A, D Goel A, Bhardwaj P, et al. | Anaesthesiol Intensive Ther
Aim: To review the outcomes of coronavirus disease 2019 (COVID-19) patients who underwent tracheostomy.
CLINICAL CHARACTERISTICS
2/1/22
De Hert M, Mazereel V, Stroobants M, et al. | Front Psychiatry
Aim: To assess the risk of death associated with COVID-19 infection in people with SMI (schizophrenia spectrum disorders, BD, and MDD), compared with patients without SMI, or without any psychiatric disorder.
CLINICAL CHARACTERISTICS
2/1/22
Tian Y, Wu Q, Li H, et al. | Can Respir J
Aim: To review the evidence on the clinical characteristics of COVID-19 in patients based on geographical regions.
UPDATED
CLINICAL CHARACTERISTICS
2/1/22
Mohammed SA, Eid KM, Anyiam FE, et al.  | Egypt Liver J
Aim: To confirm the correlation of liver involvement in SARS-CoV-2 infection patients and detect the prognosis relationship with COVID-19 patients.
CLINICAL CHARACTERISTICS
2/1/22
Chivese T, Matizanadzo M, Musa O, et al. | Pathog Glob Health
Aim: To estimate the prevalence and longevity of detectable SARS-CoV-2 antibodies and T and B memory cells after recovery.
UPDATED
CLINICAL CHARACTERISTICS
1/31/22
Abbas AS, Hardy N, Ghozy S, et al. | Clin Neurol Neursurg
Aim: To assess the outcomes of invasive ventilation, mortality, and hospital length of stay (HLoS) for patients presenting with MG and COVID-19.
CLINICAL CHARACTERISTICS
1/31/22
Yang J, D'Souza R, Kharrat A, et al. | Acta Obstet Gynecol Scand
Aim: To review the evidence on pregnancy and neonatal outcomes by comparing the pandemic and pre-pandemic periods.
UPDATED
CLINICAL CHARACTERISTICS
1/31/22
Pepera G, Tribali MS, Batalik L, et al. | Rev Cardiovasc Med
Aim: To assess the link between COVID-19 and cardiovascular risk factors, and investigate the prognosis in the case of myocardial injury.
UPDATED
CLINICAL CHARACTERISTICS
1/31/22
Haase KR, Verma R, Kilgour HM | Curr Opin Support Palliat Care
Aim: To summarize the literature on the impact of COVID-19 on older adults with cancer, including both the impacts of COVID-19 diagnosis on older adults with cancer and the implications of the pandemic on cancer care.
CLINICAL CHARACTERISTICS
1/28/22
Dar-Odeh N, Bobamuratova DT, Alnazzawi A, et al. | Cranio
Aim: To highlight jaw-related complications in COVID-19 manifestations, their etiology, and prevention methods.
CLINICAL CHARACTERISTICS
1/28/22
Singh R, Rathore SS, Khan H, et al. | Front Med
Aim: To investigate the association of ACEIs and ARBs used in COVID-19 and its effect on the mortality rate and severity of COVID-19.
CLINICAL CHARACTERISTICS
1/28/22
Bepouka B, Situakibanza H, Sangare M, et al. | J Clin Hypertens
Aim: To evaluate the magnitude of COVID-19 mortality in patients with hypertension in SSA.
CLINICAL CHARACTERISTICS
1/27/22
Díaz LA, García-Salum T, Fuentes-López E, et al. | Gastroenterol Hepatol
Aim: To assess the clearance time in stools of SARS-CoV-2.
UPDATED
CLINICAL CHARACTERISTICS
1/27/22
Gil-Rodríguez J, Pérez de Rojas J, Aranda-Laserna P, et al. | Eur J Radiol
Aim: To identify the defining LUS findings of COVID-19, and to establish its association to the initial severity of the disease and prognostic outcomes.
UPDATED
CLINICAL CHARACTERISTICS
1/26/22
 | IRIS PAHO
Aim: To review the evidence on potential therapeutic options for COVID-19.
CLINICAL CHARACTERISTICS
1/25/22
Gupta P, Gupta M, KAtoch N, et al. | Int J Endocrinol Metab
Aim: To determine the overall mortality and diabetes-associated mortality in COVID-19 patients.
CLINICAL CHARACTERISTICS
1/25/22
Deb P, Zannat KE, Talukder S, et al. | HLA
Aim: To identify significant HLAs for their association with COVID 19. 
CLINICAL CHARACTERISTICS
1/25/22
Sathian B, Banerjee I, Mekkodathil AA, et al. | Nepal J Epidemiol
Aim: To review the evidence on the epidemiologic and clinical characteristics of COVID-19 in pregnant women.
CLINICAL CHARACTERISTICS
1/25/22
Subramaniam A, Shekar K, Afroz A, et al.  | Intern Med J
Aim: To examine associations between frailty and short-term mortality in patients hospitalised with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
1/25/22
Esmaeili M, Abdi F, Shafiee G, et al. | Int J Prev Med
Aim: To systematically review and pool all available evidence on the olfactory and gustatory dysfunction in COVID-19 patients. 
UPDATED
CLINICAL CHARACTERISTICS
1/24/22
Wu HHL, Shenoy M, Kalra PA, et al. | Children
Aim: To delineate the range of intrinsic kidney pathologies that have manifested following acute COVID-19 infection in children.
CLINICAL CHARACTERISTICS
1/24/22
Miller JL, Tada M, Goto M, et al.  | Acad Emerg Med
Aim: To evaluate published reports of prediction models for severe illnesses caused COVID-19.
CLINICAL CHARACTERISTICS
1/24/22
Ledda C, Costantino C, Motta G, et al. | Trop Med Infect Dis
Aim: To provide evidence on mRNA reported vaccine breakthrough infections among HCP.
CLINICAL CHARACTERISTICS
1/24/22
Amiri-Dashatan N, Koushki M, Parsamanesh N, et al. | J Investig Med
Aim: To reassess the available findings on the association between cortisol level and severity of COVID-19 infection.
CLINICAL CHARACTERISTICS
1/24/22
Chen Y, Li X, Dai Y, et al. | Front Endocrinol
Aim: To evaluate the effect of the severity of COVID-19 on thyroid-related hormones and the effect of thyroid-related hormones on the outcome of COVID-19.
CLINICAL CHARACTERISTICS
1/21/22
Bailey AJM, Kirkham AM, Monaghan M, et al. | Curr Oncol
Aim: To review the evidence on the clinical manifestations and outcomes of HCT recipients contracting COVID-19 at all stages following transplant, including both pediatric and adult recipients.
UPDATED
CLINICAL CHARACTERISTICS
1/21/22
Pranata R, Yonas E, Huang I, et al. | Eur J Gastroenterol Hepatol
Aim: To explore the association between the FIB-4 index and the risk of mortality among COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
1/21/22
De Lorenzo A, Cenname G, Marchetti M, et al. | Eur Rev Med Pharmacol Sci
Aim: To highlight the relationship between nutritional quality and social inequalities related to CDNCD, obesity and SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
1/19/22
Wong K, Farooq Alam Shah MU, Khurshid M, et al. | Ann Med Surg
Aim: To analyze the association of COVID-19 with vasculitis.
UPDATED
CLINICAL CHARACTERISTICS
1/19/22
George TP, Joy SS, Rafiullah M, et al. | Curr Diabetes Rev
Aim: To look into cytokine levels, prevalence of risk factors, and other comorbidities in COVID-19 patients with and without diabetes mellitus during the early COVID-19 outbreak.
CLINICAL CHARACTERISTICS
1/19/22
Qin R, He L, Yang Z, et al.  | Clin Rev Allergy Immunol
Aim: To provide an updated synthesis of the association between immune-related indicators and COVID-19 prognosis.
UPDATED
CLINICAL CHARACTERISTICS
1/18/22
Espinoza-Espinoza DAK, Dulanto-Vargas JA, Cáceres-LaTorre OA, et al. | J Int Soc Prev Community Dent
Aim: To evaluate the available evidence about a potential association between PD and the risk of COVID-19 complications.
UPDATED
CLINICAL CHARACTERISTICS
1/18/22
Ao G, Wang Y, Liu F, et al. | Exp Clin Transplant
Aim: To compare the clinical outcomes between kidney transplant recipients and patients on dialysis with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
1/17/22
Alharbi MG | Expert Rev Hematol
Aim: To review the evidence on COVID-19 infection associated with ITP.
CLINICAL CHARACTERISTICS
1/17/22
Hermansyah TA, Ginanjar E, Putri VH | Acta Med Indones
Aim: To summarize the prognosis of Corona Virus Disease 2019 (COVID-19) patients with elevated troponin and N-terminal pro brain natriuretic peptide (NT-proBNP) levels and demonstrate the involvement of myocardial injury as a complication in COVID-19.
CLINICAL CHARACTERISTICS
1/17/22
Shahzad M, Chaudhary SG, Zafar MU, et al. | Transpl Infect Dis
Aim: To investigate the impactof COVID-19 in HSCT recipients, including the severity of symptoms, treatment modalities used, and prognosis.
CLINICAL CHARACTERISTICS
1/17/22
Danwang C, Noubiap JJ, Robert A, et al. | AIDS Res Ther
Aim: To summarize the available information on the risk of hospitalization, severe disease, and death attributable to HIV in patients with COVID-19 and to determine the proportion of patients co-infected with HIV among patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
1/17/22
Singh A, Singh Y, Pangasa N, et al. | Indian J Crit Care Med
Aim: To highlight the risk factors, types, and outcomes of air leak in COVID-19.
CLINICAL CHARACTERISTICS
1/14/22
Rosário Ferreira ME, Santos de Andrade AV, Ferreira Queiroz AA, et al.  | EXCLI J
Aim: To review the evidence on the clinical and laboratory characteristics, associated comorbidities, and outcomes of obese patients with COVID-19.
CLINICAL CHARACTERISTICS
1/13/22
Jdiaa SS, Mansour R, El Alayli A, et al. | J Nephrol
Aim: To summarize the effect of CKD on different outcomes among patients with COVID–19. 
CLINICAL CHARACTERISTICS
1/13/22
Reddy SGK, Mantena M, Garlapati SKP, et al. | J Pharm Bioallied Sci
Aim: To determine the pooled estimations in the clinical features and prognosis along with the subgroups based on the severity of the disease in various regions of the world.
CLINICAL CHARACTERISTICS
1/13/22
Soltani S, Zandi M, Ahmadi SE, et al. | Iran J Med Sci
Aim: To identify ophthalmic symptoms of COVID-19 patients and establish an association between these symptoms and SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
1/12/22
Dzinamarira T, Murewanhema G, Mhango M, et al. | Int J Environ Res Public Health
Aim: To map and analayse the available global evidence on the prevalence of SARS-CoV-2 infections among healthcare workers. 
CLINICAL CHARACTERISTICS
1/12/22
Jdiaa SS, Mansour R, El Alayli A, et al. | J Nephrol
Aim: To summarize the effect of CKD on different outcomes among patients with COVID–19. 
UPDATED
CLINICAL CHARACTERISTICS
1/12/22
Zuin M, Roncon L, Zuliani G. | J Cardiovasc Med
Aim: To compare the echocardiographic systolic pulmonary arterial pressure (sPAP) difference between COVID-19 survivors (S) and nonsurvivors (NS).
CLINICAL CHARACTERISTICS
1/11/22
Salman MA, Mallah SI, Khalid W, et al. | Int J Gen Med
Aim: To investigate the clinical characteristics of patients whose cerebrospinal fluid (CSF) tested positive for SARS-CoV-2.
CLINICAL CHARACTERISTICS
1/11/22
Pranata R, Huang I, Lim MA, et al. | Front Med
Aim: To assess whether elevated De Ritis ratio is associated with poor prognosis in patients with coronavirus 2019 (COVID-19).
UPDATED
CLINICAL CHARACTERISTICS
1/11/22
Shrestha DB, Sedhai YR, Budhathoki P, et al. | Ann Med Surg
Aim: To assess the value and significance of spontaneous pulmonary barotrauma such as pneumothorax, pneumomediastinum, and subcutaneous emphysema in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
1/11/22
Schlage S, Lehrnbecher T, Berner R, et al. | Eur J Pediatr
Aim: To update the available information on SARS-CoV-2 infections in pediatric cancer patients.
CLINICAL CHARACTERISTICS
1/11/22
Hernández-Vásquez A, Chavez-Ecos F, Barrenechea-Pulache A, et al. | PeerJ
Aim: To estimate the seroprevalence and lethality attributable to SARS-CoV-2 in the indigenous population of LAC.
UPDATED
CLINICAL CHARACTERISTICS
1/11/22
Ogungbe O, Kumbe B, Fadodun O, et al. | Int J Cardiol Heart Vasc
Aim: To quantify the association between biomarkers of myocardial injury (troponin), myocardial stretch (NT-proBNP, Gal-3), coagulation (D-Dimer), inflammation (CRP, IL-6) and severe COVID-19 or death in hospitalized patients.
UPDATED
CLINICAL CHARACTERISTICS
1/11/22
Marchand G, Patil AS, Masoud AT, et al. | AJOB Glob Rep
Aim: To review the evidence on the maternal and neonatal outcomes in pregnant women infected with the Coronavirus Disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
1/11/22
Hada M, Mosholder AD, Leishear K, et al. | Neurol Sci
Aim: To examine the available data on U.S. therapies approved to treat MS and the risk of SARS-CoV-2 infection or severe COVID-19 outcomes. 
CLINICAL CHARACTERISTICS
1/11/22
Mahmoudi E, Mollazadeh R, Mansouri P, et al. | Clin Cardiol
Aim: To evaluate electrocardiogram (ECG) markers of repolarization heterogeneity in patients hospitalized with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
1/11/22
Chiodini I, Gatti D, Soranna D, et al. | Front Public Health
Aim: To investigate whether vitamin D status is associated with the COVID-19 severity, defined as ARDS requiring admission to intensive care unit (ICU) or mortality (primary endpoints) and with the susceptibility to SARS-CoV-2 and COVID-19-related hospitalization (secondary endpoints).
CLINICAL CHARACTERISTICS
1/10/22
Omar M, Youssef MR, Trinh LN, et al. | Birth
Aim: To evaluate variations in clinical presentation, laboratory findings, and maternal/neonatal outcomes in COVID-19 patients who delivered vaginally versus via cesarean.
CLINICAL CHARACTERISTICS
1/6/22
Amirian A, Pakzad R, Hasanpour V, et al. | J Matern Fetal Neonatal Med
Aim: To investigate neonatal outcomes among pregnant women with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
1/5/22
Molaee H, Emadi SN, M'Imunya JMN, et al. | Dermatol Ther
Aim: To investigate chilblain-like lesions in children during the COVID-19 pandemic, any predisposition, location, clinical course, and prognosis.
CLINICAL CHARACTERISTICS
1/5/22
Cui Y, Zhao B, Li T, et al. | Brain Res Bull
Aim: To evaluate the association between the risk of ischemic stroke and COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
1/4/22
Bhattacharyya A, Sarma P, Kaur H, et al. | Indian J Pharmacol
Aim: To review the evidence on the demographic and clinical profile, risk factors, impact of different interventions, and outcomes among C-ROCM cases.
CLINICAL CHARACTERISTICS
1/3/22
Ceban F, Ling S, Lui LMW, et al. | Brain Behav Immun
Aim: To quantify the proportion of individuals experiencing fatigue and cognitive impairment 12 or more weeks following COVID-19 diagnosis, and to characterize the inflammatory correlates and functional consequences of post-COVID-19 syndrome.
UPDATED
CLINICAL CHARACTERISTICS
1/3/22
Changal K, Veria S, Mack S, et al. | BMC Cardiovasc Disord
Aim: To review the evidence on the effect of myocardial injury on the clinical outcome of patients hospitalized with COVID-19. 
CLINICAL CHARACTERISTICS
1/3/22
Kheyrandish S, Rastgar A, Arab-Zozani M, et al. | Front Med
Aim: To review the evidence on portal vein thrombosis development through COVID-19 infection or vaccination.
CLINICAL CHARACTERISTICS
1/3/22
Jahan N, Brahma A, Kumar MS, et al. | Int J Infect Dis
Aim: To summarize the seroprevalence of SARS-CoV-2 and quantitatively estimate the pooled seroprevalence of SARS-CoV-2 among the Indian population.
UPDATED
CLINICAL CHARACTERISTICS
12/31/21
Zulkarnain Z, Nuryati A, Upix D, et al. | Journal of Health Policy and Management
Aim: To examine the association between gender and anxiety among COVID-19 patients.
CLINICAL CHARACTERISTICS
12/31/21
Jaiswal V, Alquraish D, Sarfraz Z, et al. | J Prim Care Community Health
Aim: To provide thorough analyses of associations between COVID-19 and neurological outcomes for patients with PD.
CLINICAL CHARACTERISTICS
12/30/21
Wang F, Boros S | Baltic Journal of Health and Physical Activity
Aim: To review the evidence of mental and physical health consequences during COVID-19 pandemic.
CLINICAL CHARACTERISTICS
12/30/21
Ali NA, Khoja A, Kazim F | Turk Psikiyatri Derg
Aim: To highlight the role of telemental health services during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
12/29/21
Guan Z, Chen C, Li Y, et al. | Front Public Health
Aim: To evaluate the impact of coinfection with SARS-CoV-2 and influenza on mortality, critical outcomes involving shock, being admitted to ICU or requiring ventilatory support, as well as relevant clinical symptoms and laboratory index compared with mono-infections of SARS-CoV-2.
CLINICAL CHARACTERISTICS
12/29/21
Dashti S, Bolghanabadi N, Ghavami V, et al.  | J Sex Marital Ther
Aim: To review the evidence on the impact of the COVID-19 pandemic on female sexual function.
CLINICAL CHARACTERISTICS
12/29/21
Viner R, Waddington C, Mytton O, et al. | J Infect
Aim: To review the evidence on the extent that children and young people (CYP) under 20 years of age transmit SARS-CoV-2 to other CYP and to adults in household and child-specific (e.g. educational) settings.
UPDATED
CLINICAL CHARACTERISTICS
12/29/21
Amanollahi A, Sotoodeh Ghorbani S, Basir Ghafouri H, et al. | Med J Islam Repub Iran
Aim: To systematically assess and estimate the clinical, laboratory, and imaging features related to COVID-19.
CLINICAL CHARACTERISTICS
12/27/21
Jennings G, Monaghan A, Xue F, et al. | J Clin Med
Aim: To compare the two phases of long COVID, namely ongoing symptomatic COVID-19 and post-COVID-19 syndrome with respect to symptomatology, abnormal functioning, psychological burden, and quality of life.
UPDATED
CLINICAL CHARACTERISTICS
12/27/21
Cuevas-Gonzalez MV, Espinosa-Cristóbal LF, Donohue-Cornejo A, et al. | Medicine
Aim: To identify the main signs and symptoms of COVID-19 in the oral cavity.
UPDATED
CLINICAL CHARACTERISTICS
12/27/21
Moreno-Sánchez E, Castillo-Viera E, Vélez-Moreno E, et al. | Medicina
Aim: To analyse the factors that affect the probability of the paediatric asthma population suffering from COVID-19 or SARS-CoV-2.
CLINICAL CHARACTERISTICS
12/27/21
Gracia-Ramos AE, Martin-Nares E, Hernández-Molina G | Cells
Aim: To analyze the current data regarding the new-onset systemic and rheumatic autoimmune diseases in COVID-19 patients.
CLINICAL CHARACTERISTICS
12/27/21
Menezes RG, Rizwan T, Saad Ali S, et al. | Leg Med
Aim: To identify studies reporting gross, histological, microscopic, and immunohistochemical findings on postmortem examination of COVID-19 patients. 
CLINICAL CHARACTERISTICS
12/24/21
Chen H, Yang G, Long Y, et al. | Evid Based Complement Alternat Med
Aim: To determine the role of lymphocyte and platelet counts as well as interleukin-6 levels as predictors of death in patients with COVID-19.
CLINICAL CHARACTERISTICS
12/24/21
Rico-Martin S, Calderon-Garcia JF, Basilio-Fernandez B, et al. | J Cardiovasc Dev Dis
Aim: To investigate the relationship between metabolic syndrome (MetS) and its components with SARS and mortality in COVID-19 patients.
CLINICAL CHARACTERISTICS
12/24/21
Bradley SA, Banach M, Alvarado N, et al. | J Diabetes
Aim: To determine the prevalence of diabetes in hospitalized COVID-19 patients and investigate the association of diabetes severe COVID-19, rate of acute respiratory distress syndrome (ARDS), mortality, and need for mechanical ventilation.
CLINICAL CHARACTERISTICS
12/24/21
Cai X, Wu G, Zhang J, et al. | Front Med
Aim: To analyse the risk factors for AKI in adult patients with COVID-19.
CLINICAL CHARACTERISTICS
12/24/21
McIntyre KM, Favre NM, Kuo CC, et al. | Cureus
Aim: To identify novel coronavirus disease 2019 (COVID-19) patients with a diagnosis of sudden sensorineural hearing loss (SSNHL) with an aim to describe possible mechanisms.
CLINICAL CHARACTERISTICS
12/24/21
Tomerak S, Khan S, Almasri M, et al. | Scand J Immunol
Aim: To compile clinical data of COVID-19 patients who developed thrombotic complications to investigate the possible role of hyperinflammation in inducing hypercoagulation. 
CLINICAL CHARACTERISTICS
12/23/21
Szarpak L, Borkowska M, Peacock FW, et al. | Cardiol J
Aim: To review the evidence from interventional outcome studies in patients with in-hospital cardiac arrest before and during the coronavirus disease 2019 (COVID-19) pandemic period.
CLINICAL CHARACTERISTICS
12/23/21
Bastos SNMAN, Barbosa BLF, Cruz LGB, et al. | Rev Bras Ginecol Obstet
Aim: To analyze the clinical and obstetric aspects of pregnant women with COVID-19.
CLINICAL CHARACTERISTICS
12/23/21
Mehrdad R, Zahra K, Mansouritorghabeh H | Clin Appl Thromb Hemost
Aim: To determine the levels of fibrinogen, D-dimer and FDP in COVID-19 patients.
CLINICAL CHARACTERISTICS
12/23/21
Otunla A, Rees K, Dennison P, et al. | BMJ Evid Based Med
Aim: To determine if and to what degree asthma may predispose to worse COVID-19 outcomes in order to inform treatment and prevention decisions, including shielding and vaccine prioritisation.
CLINICAL CHARACTERISTICS
12/22/21
Hussain N, Agarwala P, Iqbal K, et al.  | J Med Virol
Aim: To compile and illustrate the clinical characteristics, physical examination findings, outcomes, and possible pathology behind acute TE occurring in COVID-19 recovered patients.
CLINICAL CHARACTERISTICS
12/22/21
Koupaei M, Naimi A, Moafi N, et al. | Front Med
Aim: To evaluate the various aspects such as symptoms, diagnosis, treatment, and mortality rate.
CLINICAL CHARACTERISTICS
12/22/21
Vidya G, Kalpana M, Roja K, et al. | Maedica
Aim: To examine the evidence on the clinical presentation of COVID-19 in children.
CLINICAL CHARACTERISTICS
12/22/21
Jafari M, Dastgheib SA, Ferdosian F, et al. | Hematol Transfus Cell Ther
Aim: To evaluate the proportion of hematological cancer patients with the SARS-CoV-2 infection during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
12/20/21
Jacobs JW, Booth GS | Am J Clin Pathol
Aim: To summarize the epidemiologic, clinical, and laboratory characteristics of autoimmune hemolytic anemia (AIHA) secondary to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or vaccination.
CLINICAL CHARACTERISTICS
12/20/21
Stainer A, Amati F, Suigo G, et al. | Semin Respir Crit Care Med
Aim: To describe clinical picture, disease severity, proposed treatment regimen, and response to vaccination in patients with different types and severity of immunosuppression.
CLINICAL CHARACTERISTICS
12/20/21
Romero Starke K, Reissig D, Petereit-Haack G, et al. | BMJ Glob Health
Aim: To quantify the isolated effect of age on hospitalisation, admission to intensive care unit (ICU), mechanical ventilation and death.
UPDATED
CLINICAL CHARACTERISTICS
12/17/21
Gagelmann N, Passamonti F, Wolschke C, et al. | Haematologica
Aim: To systematically analyse the outcomes of patients with haematological malignancies who received vaccination and to identify specific groups with differences in outcomes. 
CLINICAL CHARACTERISTICS
12/17/21
Bilotta C, Perrone G, Adelfio V, et al. | Front Immunol
Aim: To analyze published cases of thrombosis after COVID-19 vaccinations to identify patients’ features, potential pathophysiological mechanisms, timing of appearance of the adverse events, and other critical issues.
CLINICAL CHARACTERISTICS
12/17/21
Castillo-Perez M, Jerjes-Sanchez C, Castro-Varela A, et al.  | Thromb J
Aim: To determine the therapeutic trends and outcomes in VTE COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
12/17/21
Dhillon RA, Qamar MA, Gilani JA, et al. | Ann Med Surg
Aim: To assess the determinants and disease spectrum of COVID-19 reinfection.
UPDATED
CLINICAL CHARACTERISTICS
12/16/21
You Y, Niu Y, Sun F, et al. | BMJ Open
Aim: To evaluate the impact of the COVID-19 pandemic on stroke hospitalisations, especially haemorrhagic stroke.
CLINICAL CHARACTERISTICS
12/16/21
Mao YJ, Wang WW, Ma J, et al. | Chin Med J
Aim: To assess the incidence of SARS-CoV-2 reinfection and the protection effect of previous infection against reinfection.
CLINICAL CHARACTERISTICS
12/16/21
Rungjirajittranon T, Owattanapanich W, Leelakanok N, et al. | Clin Appl Thromb Hemost
Aim: To better understand the incidence of thrombosis, bleeding, and mortality rates among patients discharged after COVID-19 hospitalization.
CLINICAL CHARACTERISTICS
12/15/21
van Reekum EA, Rosic T, Sergeant A, et al. | J Med Case Rep
Aim: To synthesize neuropsychiatric outcomes of COVID-19 in people with preexisting psychiatric disorders.
CLINICAL CHARACTERISTICS
12/15/21
Ma Q, Liu J, Liu Q, et al. | JAMA Netw Open
Aim: To evaluate the percentage of asymptomatic infections among individuals undergoing testing (tested population) and those with confirmed COVID-19 (confirmed population).
CLINICAL CHARACTERISTICS
12/15/21
Dadras O, Afsahi AM, Pashaei Z, et al. | Immun Inflamm Dis
Aim: To systematically review the association between SARS-CoV-2 viral load and COVID-19 severity.
CLINICAL CHARACTERISTICS
12/14/21
Abu-Amara J, Szpecht D, Al-Saad SR, et al. | Arch Med Sci
Aim: To assess the relationship of COVID-19 with the early gestational trimesters of pregnancy.
CLINICAL CHARACTERISTICS
12/14/21
Hosseini SF, Behnam-Roudsari S, Alavinia G, et al. | J Res Med Sci
Aim: To determine whether clinicians used these scoring systems while assessing COVID-19 patients and the role of relevant biomarkers in disease severity and outcome.
CLINICAL CHARACTERISTICS
12/14/21
Zuin M, Engelen MM, Barco S, et al. | Thromb Res
Aim: To estimate the incidence of VTE after hospital discharge among COVID-19 patients.
CLINICAL CHARACTERISTICS
12/14/21
Naderi N, Rahimzadeh M | Virology
Aim: To determine whether KL-6 could be used as a prognostic factor for severe COVID-19.
CLINICAL CHARACTERISTICS
12/14/21
Szarpak L, Filipiak KJ, Skwarek A, et al. | Cardiol J
Aim: To determine the impact of AF/atrial flutter (AFL) on mortality, as well as individual complications in patients hospitalized with the coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
12/13/21
Ebrahimzadeh A, Mohseni S, Narimani B, et al. | Crit Rev Food Sci Nutr
Aim: To review the evidence on the association between vitamin D status and risk of COVID-19 in-hospital mortality among observational studies.
CLINICAL CHARACTERISTICS
12/13/21
Damayanthi HDWT, Prabani KIP, Weerasekara I | Gerontol Geriatr Med
Aim: To identify various factors associated with mortality among older people infected with COVID-19.
CLINICAL CHARACTERISTICS
12/13/21
Agolli A, Agolli O, Velazco DFS, et al.  | Avicenna J Med
Aim: To understand the role of COVID-19 infection in causing pregnancy complications specifically fatal outcomes.
CLINICAL CHARACTERISTICS
12/13/21
Alenezi FK, Almeshari MA, Mahida R, et al. | Ren Fail
Aim: To assess the incidence and risk factors of AKI, need for kidney replacement therapy (KRT), and mortality rate among COVID-19 patients with and without ARDS from the first wave of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
12/13/21
Orilisi G, Mascitti M, Togni L, et al. | Int J Environ Res Public Health
Aim: To investigate the frequency of oral manifestations in COVID-19 hospitalized patients.
CLINICAL CHARACTERISTICS
12/13/21
Chen MY, Xiao FP, Kuai L, et al. | Am J Emerg Med
Aim: To provide a comprehensive description of the impact of AF on the prognosis of patients with COVID-19 pneumonia.
CLINICAL CHARACTERISTICS
12/13/21
Sharma D, Bhaskar SMM | APMIS
Aim: To determine a pooled prevalence estimate of PHICs in paediatric and adolescent hospitalised patients admitted for treatment due to COVID-19.
CLINICAL CHARACTERISTICS
12/13/21
Abrokwa SK, Müller SA, Méndez-Brito A, et al. | PLoS One
Aim: To review the evidence on the extent and characteristics of reinfections and re-positive rates of SARS-CoV-2.
CLINICAL CHARACTERISTICS
12/9/21
Chen X, Huang Z, Wang J, et al. | BMJ Open
Aim: To estimate the rate of asymptomatic COVID-19 from published studies and compare this rate among different regions and patient groups.
CLINICAL CHARACTERISTICS
12/9/21
Tiwari S, Kc N, Thapa S, et al. | Middle East Fertil Soc J
Aim: To analyze the overall consequences of COVID-19 on semen parameters and male sex hormones.
UPDATED
CLINICAL CHARACTERISTICS
12/7/21
Al Maqbali M, Al Badi K, Al Sinani M, et al. | Biol Res Nurs
Aim: To identify the prevalence of the clinical symptoms of patient with COVID-19.
CLINICAL CHARACTERISTICS
12/7/21
Jackson WM, Price JC, Eisler L, et al. | J Neurosurg Anesthesiol
Aim: To assess the scope of diagnosis, treatment, and management of COVID-19 in pediatric patients.
CLINICAL CHARACTERISTICS
12/7/21
Santos MO, Gonçalves LC, Silva PAN, et al. | J Pediatr
Aim: To describe the main symptoms of MIS-C and characterize its treatment and possible outcomes.
UPDATED
CLINICAL CHARACTERISTICS
12/7/21
Jeyalan V, Storrar J, Wu HHL, et al. | World J Transplant
Aim: To provide an overview of the current literature on the renal histopathological features and mechanistic insights described in association with coronavirus disease 2019 (COVID-19) infection.
UPDATED
CLINICAL CHARACTERISTICS
12/7/21
Ma C, Tu D, Gu J, et al.  | Front Cardiovasc Med
Aim: To explore the predictive value of elevated Mb for adverse outcomes of patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
12/6/21
Ikeagwulonu RC, Ugwu NI, Ezeonu CT, et al. | West Afr J Med
Aim: To provide evidence that will guide clinical management by reviewing studies that assessed CRP concentration and COVID-19 severity/outcome.
CLINICAL CHARACTERISTICS
12/6/21
McDaniel CG, Commander SJ, DeLaura I, et al. | J Pediatr Hematol Oncol
Aim: To review the evidence on coagulation abnormalities and clinical complications in children With SARS-CoV-2.
CLINICAL CHARACTERISTICS
12/6/21
Yadav DK, Adhikari VP, Ling Q, et al. | Front Med
Aim: To approximate the prognosis of LT recipients with COVID-19 on the standard maintenance IS.
CLINICAL CHARACTERISTICS
12/6/21
Patrucco F, Zeppegno P, Baricich A, et al. | Minerva Med
Aim: To review systematically emerging evidence about clinical and functional consequences of Covid-19 pneumonia months after hospital discharge.
CLINICAL CHARACTERISTICS
12/6/21
Yu T, Wang H, Zheng S, et al. | Infect Drug Resist
Aim: To perform a comprehensive review and identify clinical cases with COVID-19 complicated by CVD to establish possible demographic, clinical, laboratory patterns, and prognostic features of these cases. 
CLINICAL CHARACTERISTICS
12/3/21
Jaiswal V, Sarfraz Z, Sarfraz A, et al. | J Prim Care Community Health
Aim: To collate current evidence about demographics, symptomatology, diagnostic, and clinical outcomes of COVID-19 infected patients with myocarditis.
CLINICAL CHARACTERISTICS
12/3/21
Khan DSA, Hamid LR, Ali A, et al. | BMC Pregnancy Childbirth
Aim: To assess differences in risk factors, management, complications, and pregnancy and perinatal outcomes in symptomatic vs. asymptomatic pregnant women with confirmed SARS-CoV-2 infection.
UPDATED
CLINICAL CHARACTERISTICS
12/2/21
Rindi LV, Moghazi SA, Donno DR, et al. | Int J Infect Dis
Aim: To summarize the literature on predicting rules for PE in hospitalized COVID-19 patients (HCPs).
CLINICAL CHARACTERISTICS
12/2/21
Pakzad R, Malekifar P, Shateri Z, et al. | J Clin Lab Anal
Aim: To evaluate the pathogens' coinfection prevalence among COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
12/1/21
Granata G, Petrosillo N, Al Moghazi S, et al.  | Anaerobe
Aim: To assess the proportion of confirmed COVID-19 patients with Clostridioides difficile infection (CDI) and to describe risk factors and outcome of these patients.
CLINICAL CHARACTERISTICS
11/30/21
Siahaan YMT, Ketaren RJ, Hartoyo V, et al. | Epilepsy Behav
Aim: To analyze whether patients with epilepsy have an increased risk of having poor COVID-19 outcomes.
CLINICAL CHARACTERISTICS
11/30/21
Zuin M, Rigatelli G, Quadretti L, et al. | Infect Dis Rep
Aim: To assess the prevalence and mortality risk in COVID-19 patients with anemia.
CLINICAL CHARACTERISTICS
11/30/21
Iftikhar S, Rehman AU, Ameer MZ, et al. | Ann Med Surg
Aim: To review the evidence on COVID-19-related-PRES from both clinical and pathophysiological standpoint.
CLINICAL CHARACTERISTICS
11/29/21
Yusof W, Irekeola AA, Wada Y, et al. | Life
Aim: To provide a global mutational profile of SARS-CoV-2 from December 2019 to October 2020.
UPDATED
CLINICAL CHARACTERISTICS
11/29/21
Hussain S, Riad A, Singh A, et al.  | J Fungi
Aim: To compute the pooled prevalence of CAM and other associated clinical outcomes.
CLINICAL CHARACTERISTICS
11/29/21
Etemadifar M, Nouri H, Maracy MR, et al. | Rev Neurol
Aim: To gather, synthesize, and meta-analyze data regarding the risk factors associated with a severe course of COVID-19 among patients with multiple sclerosis (pwMS).
CLINICAL CHARACTERISTICS
11/26/21
Khanijahani A, Iezadi S, Gholipour K, et al. | Int J Equity Health
Aim: To systematically review the evidence on the association of racial/ethnic and socioeconomic status (SES) with health outcomes and access to healthcare services during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
11/25/21
Zhang C, Chu H, Pei YV, et al. | Front Glob Womens Health
Aim: To evaluate the effects of COVID-19 among SARS-CoV-2-positive pregnant women in late pregnancy and neonates with SARS-CoV-2-positive pregnant mothers using blood assays to find indicators of maternal and neonatal complications. 
CLINICAL CHARACTERISTICS
11/25/21
Behnood SA, Shafran R, Bennett SD, et al. | J Infect
Aim: To estimate the prevalence of persistent symptoms following SARS-CoV-2 infection compared with uninfected controls and to identify potential risk factors associated with development of post-COVID symptoms in CYP.
CLINICAL CHARACTERISTICS
11/25/21
Senia P, Vella F, Mucci N, et al. | Exp Ther Med
Aim: To analyze the causes of mortality associated with SARS-CoV-2 infection in general, with particular focus on the result of infection in a professional environment.
CLINICAL CHARACTERISTICS
11/23/21
Guven DC, Sahin TK, Kilickap S, et al. | Front Oncol
Aim: To evaluate the antibody responses to COVID-19 in cancer patients.
CLINICAL CHARACTERISTICS
11/23/21
Asif AA, Hussain H, Senthil Kumaran S, et al. | J Community Hosp Intern Med Perspect
Aim: To assess efficacy of subcutaneous IFN-beta in regards to mortality and discharge rate.
CLINICAL CHARACTERISTICS
11/23/21
Ahmad S, Sohail A, Shahid Chishti MA, et al. | J Taibah Univ Med Sci
Aim: To determine whether the prevalence of OGD is sufficiently high in COVID-19 to justify their use as screening tools for this disease.
CLINICAL CHARACTERISTICS
11/23/21
Conway R, Grimshaw AA, Konig MF, et al. | Arthritis Rheumatol
Aim: To quantify the risk for SARS-CoV-2 infection and describe clinical outcomes of COVID-19 in people with RMD.
UPDATED
CLINICAL CHARACTERISTICS
11/22/21
Meng Y, Wang J, Wen K, et al. | Biomed Res Int
Aim: To present systematic reviews and detailed estimates of the major symptoms of COVID-19, determine the prevalence of serious comorbidities, and assess patient progression via comorbidities, major symptoms and laboratory examination to help severe patients and effectively reduce the mortality of COVID-19 under the condition of limited medical resources.
UPDATED
CLINICAL CHARACTERISTICS
11/22/21
Becerril-Gaitan A, Vaca-Cartagena BF, Ferrigno AS, et al. | Eur J Cancer
Aim: To assess seroconversion rates based on anti-S IgG titres after partial and complete COVID-19 immunisation among oncological patients compared with non-cancer participants.
UPDATED
CLINICAL CHARACTERISTICS
11/22/21
Nagarajan R, Krishnamoorthy Y, Basavarachar V, et al. | J Affect Disord
Aim: To estimate the prevalence of PTSD among the severe cases of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
11/22/21
Zinellu A, Paliogiannis P, Carru C, et al. | Clin Exp Med
Aim: To investigate serum concentrations of hydroxybutyrate dehydrogenase (HBDH), a combined marker of myocardial and renal injury, in hospitalized COVID-19 patients with different disease severity and survival status.
UPDATED
CLINICAL CHARACTERISTICS
11/19/21
Nascimento RB, Araujo NS, Silva JC, et al. | Spec Care Dentist
Aim: Evaluate oral manifestations detected in children with MIS-C and KD associated to COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
11/18/21
Khoshnood RJ, Zali A, Tafreshinejad A, et al. | Neurol Sci
Aim: To update the pooled prevalence of COVID-19 infection in patients with PD.
CLINICAL CHARACTERISTICS
11/18/21
Daly SR, V Nguyen A, Zhang Y, et al. | Brain Hemorrhages
Aim: To explore current literature on the association between COVID-19 and intracranial hemorrhage (ICH).
CLINICAL CHARACTERISTICS
11/17/21
Debi H, Itu ZT, Amin MT, et al. | Expert Rev Endocrinol Metab
Aim: To investigate the association of serum CRP and D-dimer concentration with COVID-19 severity in diabetic and non-diabetic patients.
CLINICAL CHARACTERISTICS
11/17/21
Shahsanayi F, Gharibzadeh A, Petrudi NR | Curr Probl Cardiol
Aim: To systematically assess the clinical sequels as well ascardiovascular findings in patients suffering STEMI following Covid-19.
CLINICAL CHARACTERISTICS
11/17/21
Ramzi ZS | Am J Emerg Med
Aim: To perform a systematic review and meta-analysis on the prevalence of one-year hospital readmissions and post-discharge all-cause mortality in recovered COVID-19 patients. 
CLINICAL CHARACTERISTICS
11/17/21
Seligman WH, Fialho L, Sillett N, et al. | BMJ Open
Aim: To develop a standardised minimum set of outcomes for clinical care.
CLINICAL CHARACTERISTICS
11/16/21
Du P, Chen W, Luo X, et al. | Ann Palliat Med
Aim: To compare the time intervals from onset to first medical visit and onset to the hospitalization of COVID-19 patients in different regions and assess the supply and demand status of medical resources.
UPDATED
CLINICAL CHARACTERISTICS
11/16/21
Xie Q, Tang S, Li Y | Ann Palliat Med
Aim: To evaluate the safety and efficacy of administering ACEIs and ARBS to patients with COVID-19.
CLINICAL CHARACTERISTICS
11/15/21
Gutiérrez-Valencia M, Leache L, Librero J, et al. | Transfusion
Aim: To synthesize the evidence on the association between ABO and the risk of COVID-19 infection and prognosis.
CLINICAL CHARACTERISTICS
11/15/21
de Medeiros KS, Sarmento ACA, Costa APF, et al. | Int J Gynaecol Obstet
Aim: To clarify the clinical features of COVID-19 and analyze maternal/fetal morbidity and mortality and the obstetric and neonatal outcomes of pregnant patients.
CLINICAL CHARACTERISTICS
11/15/21
Meyer HJ, Wienke A, Surov A | Acad Radiol
Aim: To elucidate the influence of non-pulmonary findings of thoracic computed tomography (CT) on unfavorable outcomes and in-hospital mortality in COVID-19 patients based on a large patient sample.
CLINICAL CHARACTERISTICS
11/15/21
Roy S, Demmer RT | Transl Res
Aim: To review the evidence on the interplay between impaired glucose regulation, diabetes mellitus and SARS-CoV-2.
CLINICAL CHARACTERISTICS
11/15/21
Chen JJ, Kuo G, Lee TH, et al. | J Clin Med
Aim: To explore the rate of mortality, intensive care unit admission, invasive mechanical ventilation, acute kidney injury, kidney replacement therapy and graft loss in the adult kidney transplant population with COVID-19.
CLINICAL CHARACTERISTICS
11/15/21
Ojha V, Mani A, Mukherjee A, et al. | Abdom Radiol
Aim: To assess the most common CT imaging features of AMI in COVID-19.
CLINICAL CHARACTERISTICS
11/15/21
Tufano A, Rendina D, Abate V, et al.  | J Clin Med
Aim: To evaluate the RD of the occurrence of VTE, pulmonary embolism (PE), and deep venous thrombosis (DVT) between COVID-19 and other pulmonary infection cohorts, in particular H1N1, and in an ICU setting. 
CLINICAL CHARACTERISTICS
11/11/21
Ramasamy C, Mishra AK, John KJ, et al. | World J Clin Cases
Aim: To identify contributors of worse outcomes in patients with malignancy and COVID-19 and to describe the role of critical care.
CLINICAL CHARACTERISTICS
11/11/21
Ahmed F, Abid M, Maniya T, et al. | Eur J Prev Cardiol
Aim: To provide a well-powered comprehensive assessment of the risk and prognosis of COVID-19 in recipients of HT.
CLINICAL CHARACTERISTICS
11/11/21
Jafar A, Lasso A, Shorr R, et al. | PLoS One
Aim: To evaluate the extent and timing of olfactory recovery following loss due to COVID-19 infection.
UPDATED
CLINICAL CHARACTERISTICS
11/11/21
Ulloque-Badaracco JR, Hernandez-Bustamante EA, Herrera-Añazco P, et al. | Travel Med Infect Dis
Aim: To assess the prognosis value of apolipoproteins and ApoB/ApoA1 ratio for COVID-19 severity and mortality.
CLINICAL CHARACTERISTICS
11/11/21
Mahmood MM, Jafarli I, Al-Barazanchi AF, et al. | Zhongguo Dang Dai Er Ke Za Zhi
Aim: To describe clinical features of coronavirus disease 2019 (COVID-19) in children with a focus on the possible reasons why children are less susceptible to COVID-19 and whether their immune response works better than adults.
CLINICAL CHARACTERISTICS
11/8/21
Cau A, Cheng MP, Lee T, et al. | Can J Kidney Health Dis
Aim: To review the evidence on the frequencies of AKI and renal replacement therapy (RRT) in critically ill COVID-19 patients.
CLINICAL CHARACTERISTICS
11/8/21
Ebrahimpour L, Marashi M, Zamanian H, et al. | Quant Imaging Med Surg
Aim: To compile the existing data on the CT characteristics of COVID-19 disease in children.
CLINICAL CHARACTERISTICS
11/8/21
Fakhrolmobasheri M, Mazaheri-Tehrani S, Kieliszek M, et al. | Biol Trace Elem Res
Aim: To summarize the available data surrounding the association of body selenium levels with the outcomes of COVID-19
CLINICAL CHARACTERISTICS
11/8/21
Haussner W, DeRosa AP, Haussner D, et al. | Am J Emerg Med
Aim: To conduct a systematic review of COVID-19-associated myocarditis, including clinical presentation, risk factors, and prognosis.
CLINICAL CHARACTERISTICS
11/8/21
Agyemang C, Richters A, Jolani S, et al. | BMJ Glob Health
Aim: To describe the presence and magnitude of associations between ethnic groups and COVID-19-related outcomes.
CLINICAL CHARACTERISTICS
11/8/21
Rostami M, Mansouritorghabeh H, Parsa-Kondelaji M | Clin Environ Med
Aim: To obtain data on the status of the hemostatic factors of COVID-19.
CLINICAL CHARACTERISTICS
11/8/21
Margarucci LM, Enrico M, GIanfranceschi G, et al.  | Acta Biomed
Aim: To assess whether low serum 25-OHD is associated with susceptibility to COVID 19, their severity, and mortality. 
UPDATED
CLINICAL CHARACTERISTICS
11/5/21
Li Y, Chen B, Hong Z, et al. | Sleep Med
Aim: To review the evidence on the prevalence of insomnia symptoms during the early and late stages of the COVID-19 pandemic in China, and to determine the prevalence of insomnia symptoms in specific populations during the pandemic.
CLINICAL CHARACTERISTICS
11/5/21
Heidarpour M, Abhari AP, Sadeghpour N, et al. | Diabetes Metab Syndr
Aim: To investigate the clinical outcome of COVID-19 in patients with prediabetes
UPDATED
CLINICAL CHARACTERISTICS
11/5/21
Damara FA, Muchamad GR, Ikhsani R, et al. | Diabetes Metab Syndr
Aim: To summarize recent findings on the relationship between thyroid disease and COVID-19 outcome.
UPDATED
CLINICAL CHARACTERISTICS
11/4/21
Nikolopoulos M, Maheshwari MK, Doumouchtsis SK, et al. | Arch Gynecol Obstet
Aim: To evaluate the impact of the COVID-19 pandemic on patients with gynaecological cancer and the impact of cancer on the clinical presentation of COVID-19 infection.
CLINICAL CHARACTERISTICS
11/3/21
Alrashed F, Battat R, Abdullah I, et al. | BMJ Open Gastroenterol
Aim: To evaluate the association between IBD therapies and severe COVID-19 outcomes.
CLINICAL CHARACTERISTICS
11/3/21
Hartling L, Pillay J, Bialy L, et al. | SPOR
Aim: To review the evidence on the incidence and outcomes of myocarditis and pericarditis following COVID-18 vaccination.
CLINICAL CHARACTERISTICS
11/3/21
Hoang MP, Staibano P, McHugh T, et al. | Int Forum Allergy Rhinol
Aim: To assess the sensitivity of self-reporting and psychophysical tests for OGD.
UPDATED
CLINICAL CHARACTERISTICS
11/3/21
Lindsay RK, Wilson JJ, Trott M, et al. | Ann Med
Aim: To synthesise the recommendations for returning athletes who have experienced long COVID symptoms.
UPDATED
CLINICAL CHARACTERISTICS
11/2/21
Thakker RA, Elbadawi A, Chatila KF, et al. | Curr Probl Cardiol
Aim: To review the evidence on the presentation of STEMI patients who have SARS-CoV-2.
CLINICAL CHARACTERISTICS
11/2/21
Lee JX, Chieng WK, Lau SCD, et al. | Front Med
Aim: To provide an overview of the clinical profile, including the clinical presentations, laboratory, and radiological findings, as well as the outcome of COVID-19 infection among patients with hemoglobinopathy.
UPDATED
CLINICAL CHARACTERISTICS
11/2/21
Tripathi K, Godoy Brewer G, Thu Nguyen M, et al. | Inflamm Bowel Dis
Aim: To investigate the epidemiology, clinical characteristics, and outcomes in IBD patients with COVID-19.
CLINICAL CHARACTERISTICS
11/2/21
Funakoshi K, Morita T, Kumanogoh A | Front Med
Aim: To review the clinical course among intubated survivors, non-survivors, and extracorporeal membrane oxygenation (ECMO) patients to reveal the standard clinical course and the difference among critical COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
11/2/21
Li Z, Shao W, Zhang J, et al. | Front Cardiovasc Med
Aim: To clarify the prevalence and clinical impact of AF and new-onset AF in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
11/1/21
Bacon SL, Ribeiro PAB, Stojanovic J, et al. | SPOR
Aim: To review the evidence on how the level of vaccine effectiveness, including effectiveness against asymptomatic and symptomatic infection, and severe outcomes change over time in individuals who have received a complete primary COVID-19 vaccine series.
CLINICAL CHARACTERISTICS
11/1/21
Smith CM, Gilbert EB, Riordan PA, et al. | Gen Hosp Psychiatry
Aim: To describe the comorbidities, presentations, and outcomes of adults with incident psychosis and a history of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
11/1/21
Hvas CL, Larsen JB, Adelborg K, et al. | Semin Thromb Hemost
Aim: To review the evidence on dynamic hemostasis and fibrinolysis assays in intensive care in COVID-19 patients and association with thrombosis and bleeding.
CLINICAL CHARACTERISTICS
11/1/21
Poudel AN, Zhu S, Cooper N, et al. | PLoS One
Aim: To review the evidence on the impacts of COVID-19 on HRQoL of patients with Covid-19 (confirmed or suspected) and explore the risk factors for reduced HRQoL of Covid-19 patients.
CLINICAL CHARACTERISTICS
11/1/21
Vasilevska V, Guest PC, Bernstein HG, et al. | J Neuroinflammation
Aim: To identify published cases of anti-NMDAR encephalitis with concurrent neuropsychiatric symptoms temporally associated with SARS-CoV-2 infections.
CLINICAL CHARACTERISTICS
11/1/21
Hartmann-Boyce J, Rees K, Perring JC, et al. | Diabetes Care
Aim: To review the evidence regarding the extent to which PWD are at increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and/or of suffering its complications, including associated mortality.
WHO COLLABORATIVE
CLINICAL CHARACTERISTICS
11/1/21
Hou H, Xu J, Li Y, et al. | J Allergy Clin Immunol Pract
Aim: To investigate the association between asthma and the risk for mortality among COVID-19 patients.
CLINICAL CHARACTERISTICS
10/29/21
Chen JJ, Lee TH, Tian YC, et al. | JAMA Netw Open
Aim: To assess immunogenicity rates in people with end-stage kidney disease (ESKD) receiving SARS-CoV-2 vaccines, explore postvaccination potential risk factors for nonresponse, and assess whether receiving dialysis is associated with different antibody response rates compared with the nondialysis population.
CLINICAL CHARACTERISTICS
10/28/21
Yeahia R, Schefflein J, Chiarolanzio P, et al.  | Clin Imaging
Aim: To compile and analyze brain MRI findings in patients with COVID-19 disease and PRES.
CLINICAL CHARACTERISTICS
10/28/21
Alhumaid S, Al Mutair A, Al Alawi Z, et al. | Diabetol Metab Syndr
Aim: To re-evaluate the association of SARS-CoV-2 and development of DKA and analyse the demographic and biochemical parameters and the clinical outcomes in COVID-19 patients with DKA.
CLINICAL CHARACTERISTICS
10/28/21
Lampsas S, Tsaplaris P, Pantelidis P, et al. | Curr Med Chem
Aim: To understand the global pattern of endothelial biomarkers related to COVID-19 severity.
CLINICAL CHARACTERISTICS
10/27/21
Yasmin F, Najeeb H, Naeem A, et al. | Diseases
Aim: To report cases of COVID-19 associated mucormycosis (CAM), evaluate characteristics, clinical manifestations, and outcomes of mucormycosis in COVID-19 active or recovered patients.
CLINICAL CHARACTERISTICS
10/27/21
Hafeez MU, Ikram M, Shafiq Z, et al.  | Clin Appl Thromb Hemost
Aim: To extrapolate thrombotic risk factors, clinical manifestations, and outcomes of patients diagnosed with TTS following the COVID-19 vaccine.
CLINICAL CHARACTERISTICS
10/27/21
Mahamat-Saleh Y, Fiolet T, Rebeaud ME, et al.  | BMJ Open
Aim: To investigate the association between diabetes, hypertension, body mass index (BMI) or smoking with the risk of death in patients with COVID-19 and to estimate the proportion of deaths attributable to these conditions.
UPDATED
CLINICAL CHARACTERISTICS
10/27/21
Zuin M, Rigatelli G, Bilato C, et al. | Viruses
Aim: To review the evidence on the prevalence and mortality risk in COVID-19 patients with MetS.
CLINICAL CHARACTERISTICS
10/26/21
Ponsford MJ, Ward TJC, Stoneham SM, et al. | Front Immunol
Aim: To investigate the risk of mortality and critical care admission in hospitalised adults with nosocomial COVID-19, relative to adults requiring hospitalisation due to community-acquired infection.
UPDATED
CLINICAL CHARACTERISTICS
10/26/21
van Hattum JC, Spies JL, Verwijs SM, et al. | BMJ Open Sport Exerc Med
Aim: To provide a comprehensive overview of myocardial and pericardial involvement after SARS-CoV-2 infection, long-term cardiac sequelae after infection and risks of sudden cardiac arrest/sudden cardiac death (SCA/SCD) in athletes.
UPDATED
CLINICAL CHARACTERISTICS
10/26/21
Ho QY, Sultana R, Lee TL, et al. | Singapore Med J
Aim: To examine the presenting features, outcomes and the effect of treatment on outcomes of KTRs with COVID-19. 
CLINICAL CHARACTERISTICS
10/26/21
Li W, Huang Z, Tan B, et al. | J Orthop Translat
Aim: To review the evidence on low-dosage glucocorticoid associated osteonecrosis in COVID-19 patients.
CLINICAL CHARACTERISTICS
10/26/21
Scquizzato T, Landoni G, Scandroglio AM, et al. | Eur J Emerg Med
Aim: To assess outcomes of SARS-CoV-2 patients with out-of-hospital cardiac arrest.
UPDATED
CLINICAL CHARACTERISTICS
10/26/21
Guo T, Jiang F, Liu Y, et al. | Front Mol Biosci
Aim: To determine the respiratory outcomes in patients following COVID-19-related hospitalization.
CLINICAL CHARACTERISTICS
10/26/21
Shi Q, Wang Z, Liu J, et al. | EClinicalMedicine
Aim: To identify the predictors of unfavorable prognosis of COVID-19 in children and adolescents.
CLINICAL CHARACTERISTICS
10/26/21
Fakhruddin KS, Haiat A, Ngo HC, et al. | Acta Odontol Scand
Aim: To review the evidence of SARS-CoV-2 in the saliva of asymptomatic individuals.
CLINICAL CHARACTERISTICS
10/25/21
Ippolito M, Simone B, Filisina C, et al. | Microorganisms
Aim: To estimate the pooled occurrence of BSIs among hospitalized patients with COVID-19 and mortality of this patient population.
CLINICAL CHARACTERISTICS
10/25/21
Middleton P, Hsu C, Lythgoe MP | Hepatology
Aim: To assess the reported clinical outcomes of patients with cirrhosis who develop COVID-19 infection.
CLINICAL CHARACTERISTICS
10/25/21
Morello W, Vianello FA, Proverbio E, et al. | Pediatr Nephrol
Aim: To describe the severity of all SARS-CoV-2 infections reported in children with INS, to evaluate the risk of new onset and relapses associated with SARS-CoV-2 infection, and to draw recommendations on their management and vaccination.
CLINICAL CHARACTERISTICS
10/25/21
Mattey-Mora PP, Begle CA, Owusu CK, et al. | Rev Med Virol
Aim: To systematically assess COVID-19 patient background characteristics and pre-existing comorbidities associated with hospitalisation status. 
UPDATED
CLINICAL CHARACTERISTICS
10/25/21
Sahni S, Gupta G, Sarda R, et al. | Diabetes Metab Syndr
Aim: To highlight the impact of cardio-metabolic comorbidities on COVID-19 severity and mortality.
CLINICAL CHARACTERISTICS
10/25/21
Podury S, Srivastava S, Khan E, et al. | Brain Sci
Aim: To review the data on CNS and PNS inflammatory disorders in COVID-19 with respect to CSF, serum and neuroimaging markers.
UPDATED
CLINICAL CHARACTERISTICS
10/22/21
Yang Z, Wang X, Wan XG, et al.  | Pediatr Pulmonol
Aim: To understand the relationship between the COVID-19 pandemic and asthma outcomes.
UPDATED
CLINICAL CHARACTERISTICS
10/20/21
Ullah I, Sohail A, Shah MUFA, et al.  | Ann Med Surg
Aim: To summarize the evidence on patients diagnosed with central retinal vein occlusion (CRVO) secondary to COVID-19.
CLINICAL CHARACTERISTICS
10/20/21
Mahapure KS, Prabhune AS, Chouvhan AV | Asian J Neurosurg
Aim: To provide an overview of acute disseminating encephalomyelitis, a potential and serious complication of COVID-19.
CLINICAL CHARACTERISTICS
10/20/21
Trimboli P, Cappelli C, Croce L, et al. | Front Endocrinol
Aim: To evaluate the clinical characteristics of SAT.
CLINICAL CHARACTERISTICS
10/20/21
Miniati M, Marzetti F, Palagini L, et al. | Front Psychol
Aim: To summarize current literature studies on COVID pandemic and EDs.
CLINICAL CHARACTERISTICS
10/20/21
Yitbarek GY, Walle Ayehu G, Asnakew S, et al. | SAGE Open Med
Aim: To explore CRP in the context of COVID-19 pathogenesis and assess how its level changes with the severity of the disease.
CLINICAL CHARACTERISTICS
10/18/21
d'Ettorre G, Cacciola EG, Santinelli L, et al. | J Med Virol
Aim: To evaluate the evidence on the working capacity and the relationship life of surviving COVID-19 patients.
CLINICAL CHARACTERISTICS
10/18/21
Luo W, Liu X, Bao K, et al. | J Neurol
Aim: To explore the characteristics of ischemic stroke after SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
10/14/21
Pramana Witarto A, Samarta Witarto B, Er Putra AJ, et al. | Iran Biomed J
Aim: To assess the role of serum KL-6 in reflecting the severity of lung injury in COVID-19 patients.
CLINICAL CHARACTERISTICS
10/14/21
Groff D, Sun A, Ssentongo AE, et al. | JAMA Netw Open
Aim: To estimate organ system-specific frequency and evolution of PASC.
CLINICAL CHARACTERISTICS
10/14/21
Jayant K, Reccia I, Bachul PJ, et al. | J Clin Med
Aim: To better understand the clinical course of COVID-19 in kidney transplant recipients and to identify factors associated with clinical outcomes and mortality.
UPDATED
CLINICAL CHARACTERISTICS
10/14/21
Harapan H, Fajar JK, Supriono S, et al.  | Rev Med Virol
Aim: To determine the prevalence, predictors and outcomes of ALI among patients with COVID-19.
CLINICAL CHARACTERISTICS
10/13/21
Hirschfeld AS | Neurol Neurochir Pol
Aim: To systematically review scientific reports presenting patients with hyperkinetic movement disorders as one of the neurological symptoms.
CLINICAL CHARACTERISTICS
10/13/21
Chong WH, Saha BK, Medarov BI | J Intensive Care Med
Aim: To compare the clinical characteristics between COVID-19 survivors and nonsurvivors requiring ECMO support.
UPDATED
CLINICAL CHARACTERISTICS
10/13/21
Misra S, Kolappa K, Prasad M, et al. | Neurology
Aim: To summarize the frequency of neurological manifestations reported in COVID-19 patients and investigate the association of these manifestations with disease severity and mortality.
CLINICAL CHARACTERISTICS
10/13/21
Lu H, Shi Y, Chen K, et al. | J Zhejiang Univ Sci B
Aim: To provide a comprehensive perspective into the association between anticancer regimens and the outcomes of cancer patients with COVID-19.
CLINICAL CHARACTERISTICS
10/12/21
Mirmoeeni S, Azari Jafari A, Hashemi SZ, et al. | J Cardiovasc Thorac Res
Aim: To determine the rates of CVDs in COVID-19 patients based on the incidence proportion of cardiac manifestations, laboratory findings, and related comorbidities.
CLINICAL CHARACTERISTICS
10/12/21
Jiménez-Ruiz CA, López-Padilla D, Alonso-Arroyo A, et al. | Arch Bronconeumol
Aim: To review the evidence on whether tobacco use in COVID-19 patients associated with a negative progression and adverse outcome of the disease.
CLINICAL CHARACTERISTICS
10/12/21
Agouridis AP, Pagkali A, Zintzaras E, et al. | Atheroscler Plus
Aim: To systematically address all the relevant evidence of the association between high-density lipoprotein cholesterol (HDL-C) and COVID-19 infection.
CLINICAL CHARACTERISTICS
10/12/21
Sinha A, Bhaskar SMM | Int Forum Allergy Rhinol
Aim: To estimate the prevalence of mucormycosis amongst hospitalized COVID-19, and COVID-19 among hospitalized mucormycosis patients.
CLINICAL CHARACTERISTICS
10/12/21
Mahat RK, Rathore V, Singh N, et al. | Clin Nutr ESPEN
Aim: To evaluate the association of lipid parameters (total cholesterol, HDL-cholesterol, LDL-cholesterol, and triacylglycerols) with the severity and mortality in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
10/12/21
Udomkarnjananun S, Kerr SJ, Townamchai N, et al.  | Sci Rep
Aim: To systematically analyze published evidence for risk factors associated with mortality in COVID-19 KTR. 
CLINICAL CHARACTERISTICS
10/12/21
Renaud-Charest O, Lui LMW, Eskander S, et al. | J Psychiatr Res
Aim: To synthesize the extant evidence reporting on the frequency and factors associated with depression in post-COVID-19 syndrome.
UPDATED
CLINICAL CHARACTERISTICS
10/12/21
Jain A, Taneja S | Oral Maxillofac Surg
Aim: To collate and evaluate the data to enable clinicians to understand the disease pattern and types of mycosis and provide meticulous management of these infections in COVID-19 patients.
CLINICAL CHARACTERISTICS
10/12/21
Soetedjo NNM, Iryaningrum MR, Damara FA, et al. | Clin Nutr ESPEN
Aim: To evaluate the prognostic properties of hypoalbuminemia for poor prognosis and factors that may influence the relationship.
UPDATED
CLINICAL CHARACTERISTICS
10/8/21
Sodeifian F, Seyedalhosseini ZS, Kian N, et al. | Front Med
Aim: To examine DILI in COVID-19 patients.
CLINICAL CHARACTERISTICS
10/6/21
Reininghaus EZ, Manchia M, Dalkner N, et al. | Eur Neuropsychopharmacol
Aim: To elucidate the risk and treatment effect of COVID-19 in BD and research on vaccinations in individuals with BD.
CLINICAL CHARACTERISTICS
10/6/21
Farooq H, Aemaz Ur Rehman M, Asmar A, et al. | J Taibah Univ Med Sci
Aim: To recognize the novel association of IgAN and IgAV with COVID-19 and describe its underlying pathogenesis.
CLINICAL CHARACTERISTICS
10/5/21
Rahman MM, Bhattacharjee B, Farhana Z, et al. | J Prev Med Hyg
Aim: To estimate the prevalence of all reported symptoms and comorbidities, and then identified the risk factors associated with age of COVID-19 infected patients.
CLINICAL CHARACTERISTICS
10/5/21
Patel S, Parikh C, Verma D, et al. | Int J Clin Pract
Aim: To provide a holistic review of our current understanding of COVID-19 induced bowel ischemia.
CLINICAL CHARACTERISTICS
10/5/21
Alimohamadi Y, Tola HH, Abbasi-Ghahramanloo A, et al. | J Prev Med Hyg
Aim: To assess the pooled CFR of COVID-19.
CLINICAL CHARACTERISTICS
10/5/21
Kan C, Zhang Y, Han F, et al. | Front Endocrinol
Aim: To assess various antidiabetic agents’ association with mortality in patients with type 2 diabetes (T2DM) who have coronavirus disease 2019 (COVID-19).
UPDATED
CLINICAL CHARACTERISTICS
10/5/21
Yin Y, Rohli KE, Shen P, et al. | Prim Care Diabetes
Aim: To summarize epidemiologic evidence of COVID-19 in patients with Type 2 diabetes, explore pathophysiological mechanisms, and integrate recommendations and guidelines for patient management.
CLINICAL CHARACTERISTICS
10/4/21
Martins-Filho PR, Pereira de Andrade AL, Pereira de Andrade AJ, et al.  | J Clin Neurol
Aim: To describe the clinical features of MFS in patients with COVID-19.
CLINICAL CHARACTERISTICS
10/4/21
Wilairatana P, Masangkay FR, Kotepui KU, et al. | PLoS Negl Trop Dis
Aim: To synthesize, qualitatively and quantitatively, information on the prevalence and characteristics of malaria infection among COVID-19-infected individuals. 
UPDATED
CLINICAL CHARACTERISTICS
10/1/21
Mehraeen E, Oliaei S, SeyedAlinaghi S, et al. | Infect Disord Drug Targets
Aim: To reflect on the current knowledge and practice of COVID-19 among children.
CLINICAL CHARACTERISTICS
10/1/21
Teo KY, Invernizzi A, Staurenghi G, et al. | Am J Ophthalmol
Aim: To evaluate the occurrence of retinal micro-vasculopathy in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and developed coronavirus disease (COVID-19).
CLINICAL CHARACTERISTICS
10/1/21
Sahebi A, Abdi K, Moayedi S, et al. | J Psychosom Res
Aim: To estimate the prevalence of insomnia in healthcare workers.
UPDATED
CLINICAL CHARACTERISTICS
9/30/21
Singh P, Singh SP, Verma AK, et al. | Visc Med
Aim: To evaluate key imaging manifestations of COVID-19 on abdominal imaging.
UPDATED
CLINICAL CHARACTERISTICS
9/30/21
Shah VP, Farah WH, Hill JC, et al.  | Open Forum Infect Dis
Aim: To assess the association between CT values and clinical outcomes, including the risk of hospitalization among patients with COVID-19 and the risk of disease severity and death in such patients.
UPDATED
CLINICAL CHARACTERISTICS
9/30/21
Jain S, Khanna P, Sarkar S | Monaldi Arch Chest Dis
Aim: To identify the overall incidence of VAP, common organisms associated with it, and outcome in COVID-19 patients in comparison to the non-SARS-CoV-2 infected critically ill ventilated COVID-19 patients. 
CLINICAL CHARACTERISTICS
9/30/21
Attisani L, Pucci A, Luoni G, et al.  | J Cardiovasc Surg
Aim: To analyze the outcomes of acute limb ischemia (ALI) in patients suffering from the novel Coronavirus COVID-19 (Sars-Cov-2).
CLINICAL CHARACTERISTICS
9/30/21
Bissacco D, Lomazzi C, Buongiovanni G, et al. | J Cardiovasc Surg
Aim: To present evidence published on COVID-19 and aortic-related issues, highlighting some challenging aspects regarding management, treatment and outcomes.
CLINICAL CHARACTERISTICS
9/30/21
Aggarwal AN, Agarwal R, Dhooria S, et al. | Respir Care
Aim: To evaluate whether asthma increases the risk of severe disease and adverse outcomes among subjects with COVID-19.
CLINICAL CHARACTERISTICS
9/30/21
Zhou C, Zhao Y, Wang X, et al. | Pediatr Pulmonol
Aim: To characterize the laboratory parameters of MIS-C compared with those of KD and Kawasaki disease shock syndrome (KDSS).
UPDATED
CLINICAL CHARACTERISTICS
9/30/21
Maiese A, Frati P, Del Duca F, et al. | Diagnostics
Aim: To evaluate the current knowledge about postmortem cardiac findings in patients who died of COVID-19.
CLINICAL CHARACTERISTICS
9/30/21
Musa SS, Bello UM, Zhao S, et al. | Viruses
Aim: To summarize the evidence from existing systematic reviews about the effects of SARS-CoV-2 infections on maternal perinatal and neonatal outcomes.
CLINICAL CHARACTERISTICS
9/28/21
Chong WH, Saha BK, Neu KP | Infection
Aim: To assess the clinical characteristics and outcomes of patients diagnosed with CAPA compared to those without CAPA.
UPDATED
CLINICAL CHARACTERISTICS
9/28/21
Sakthiswary R, Chuah HY, Chiang KS, et al. | Lupus
Aim: To determine the predictors of severe COVID-19 infection in SLE by comparing the mild to moderate cases with the severe to critical ones.
CLINICAL CHARACTERISTICS
9/28/21
Santos RPD, Lordani TVA, Peres LAB, et al. | Nefrologia
Aim: To determine the AKI incidence in patients hospitalized with COVID-19.
CLINICAL CHARACTERISTICS
9/27/21
Siemieniuk RA, Bartoszko JJ, Díaz Martinez JP, et al. | BMJ
Aim: To evaluate the efficacy and safety of antiviral antibody therapies and blood products for the treatment of novel coronavirus disease 2019 (covid-19).
CLINICAL CHARACTERISTICS
9/27/21
Bahrami R, Schwartz DA, Karimi-Zarchi M, et al.  | Turk J Obstet Gynecol
Aim: To estimate the frequency of intrauterine growth restriction (IUGR) and preterm premature rupture of the membranes (PPROM) in pregnant women with Coronavirus disease-2019 (COVID-19).
CLINICAL CHARACTERISTICS
9/27/21
Pizzol D, Shin JI, Trott M, et al.  | J Endocrinol Invest
Aim: To calculate the pooled prevalence of ED amongst healthcare workers.
CLINICAL CHARACTERISTICS
9/27/21
Fernández-de-Las-Peñas C, Navarro-Santana M, Plaza-Manzano G, et al. | Pain
Aim: To synthesize the prevalence of post-COVID pain symptoms of musculoskeletal origin in hospitalized/non-hospitalized patients recovered from SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
9/24/21
Whear R, Abbott RA, Bethel A, et al. | J Adv Nurs
Aim: To review the evidence on the provision of fundamental nursing care to hospitalized patients with a highly infectious virus and the effectiveness of adaptations to overcome barriers to care.
UPDATED
CLINICAL CHARACTERISTICS
9/24/21
Quante M, Brake L, Tolios A, et al. | Transplant Proc
Aim: To produce a current synoptic assessment of mortality and clinical outcomes subsequent to infection and COVID-19 in SOT recipients.
CLINICAL CHARACTERISTICS
9/24/21
Sengupta P, Leisegang K, Agarwal A | Arab J Urol
Aim: To provide a concise update on the effects of coronavirus disease 2019 (COVID-19) on male reproduction.
CLINICAL CHARACTERISTICS
9/23/21
Keshavarz P, Haseli S, Yazdanpanah F, et al. | Acad Radiol
Aim: To categorize and summarize the imaging data in COVID-19-induced anosmia.
CLINICAL CHARACTERISTICS
9/23/21
Patel P, DeCuir J, Abrams J, et al. | JAMA Netw Open
Aim: To summarize the descriptive epidemiology and clinical characteristics of MIS-A.
CLINICAL CHARACTERISTICS
9/23/21
Erbas GS, Botsali A, Erden N, et al. | Int J Dermatol
Aim: To review the evidence on specific manifestations of COVID-19 in the oral mucosa.
CLINICAL CHARACTERISTICS
9/23/21
Srivastava R, Parveen R, Mishra P, et al. | Int J Clin Pract
Aim: To assess the association of venous thromboembolism with severity of COVID-19 disease.
CLINICAL CHARACTERISTICS
9/22/21
Lashkari A, Ranjbar R | J Neurovirol
Aim: To review the case studies of COVID-19-related acute cerebrovascular diseases such as ischaemic stroke, intracerebral hemorrhage, and cerebral sinus thrombosis. 
CLINICAL CHARACTERISTICS
9/22/21
Sánchez-García V, Hernández-Quiles R, de-Miguel-Balsa E, et al. | J Eur Acad Dermatol Venereol
Aim: To assess the prevalence of COVID-19 (diagnosed using PCR and/or serology) in patients with CLL.
UPDATED
CLINICAL CHARACTERISTICS
9/22/21
Wiedenmann M, Goutaki M, Keiser O, et al. | Swiss Med Wkly
Aim: To review the evidence on the role of children and adolescents in the SARS-CoV-2 pandemic, specifically the severity of SARS-CoV-2 presentation, risk of SARS-CoV-2 infection and risk of transmitting SARS-CoV-2.
CLINICAL CHARACTERISTICS
9/21/21
Hossein Kazemi M, Kuhestani Dehaghi B, et al. | Iran J Med Sci
Aim: To explore the possible association of HScore parameters with severity in COVID-19 patients. 
UPDATED
CLINICAL CHARACTERISTICS
9/21/21
Geng J, Yu X, Bao H, et al. | Front Med
Aim: To determine the predictive value of chronic diseases for the severity and mortality of COVID-19.
CLINICAL CHARACTERISTICS
9/21/21
Long Q, Li J, Hu X, et al. | Front Med
Aim: To determine the adverse effects on multiple systems and differences between severe and non-severe patients in the post-acute phase.
UPDATED
CLINICAL CHARACTERISTICS
9/20/21
Diaz-Arocutipa C, Saucedo-Chinchay J, Argulian A | Clin Cardiol
Aim: To review the evidence on the prognostic utility of right ventricular dysfunction (RVD) in patients with coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
9/20/21
Zamani R, Pouremamali R, Rezaei N | Rev Neurosci
Aim: To determine the profile and possible mechanisms behind CNS inflammatory diseases in the context of Covid-19.
CLINICAL CHARACTERISTICS
9/20/21
von Bartheld CS, Hagen MM, Butowt R | ACS Chem Neurosci
Aim: To review the evidence on the role of COVID-19 and genetics on the presentation of anosmia in COVID-19 patients.
CLINICAL CHARACTERISTICS
9/20/21
Alemzadeh E, Alemzadeh E, Ziaee M, et al. | Immun Inflamm Dis
Aim: To analyze the correlation between admission to ICU and hospital, disease severity, mortality, D-dimer count, lymphocyte count, and serum calcium levels.
CLINICAL CHARACTERISTICS
9/16/21
Ghayda RA, Lee KH, Kim JS, et al. | Int J Med Sci
Aim: To document the chest CT findings in patients with confirmed COVID-19 and their association with the clinical severity.
CLINICAL CHARACTERISTICS
9/16/21
Martins LA, Santos DVD, Marques PF, et al. | Rev Gaucha Enferm
Aim: To identify in the scientific literature the clinical overview of the pediatric population that tested positive for SARS-CoV-2 and care recommendations and recommendations among children who tested positive for SARS-CoV-2. 
CLINICAL CHARACTERISTICS
9/15/21
Mazzaccaro D, Giannetta M, Fancoli F, et al. | J Cardiovasc Surg
Aim: To review the prevalence, the risk factors and the outcomes of venous thrombosis (VT) in patients hospitalized for COronaVirus Disease 19 (COVID-19).
CLINICAL CHARACTERISTICS
9/15/21
Ming W, Zuo J, Han J, et al. | Eur Arch Otorhinolaryngol
Aim: To analyze the impact of AAD on the severity and mortality of COVID-19 patients and compare clinical outcomes between patients with and without AAD.
UPDATED
CLINICAL CHARACTERISTICS
9/14/21
Marasco G, Maida M, Morreale GC, et al. | Can J Gastroenterol Hepatol
Aim: To estimate the rate of gastrointestinal bleeding in COVID-19 patients and its association with mortality.
CLINICAL CHARACTERISTICS
9/14/21
Liu L, Ni SY, Yan W, et al. | EClinicalMedicine
Aim: To assess the overall and type-specific risk of mental and neurological disorders for COVID-19 infection and clinical outcomes. 
UPDATED
CLINICAL CHARACTERISTICS
9/14/21
Aragoneses J, Suárez A, Algar J, et al. | Front Med
Aim: To investigate the types of oral manifestations of COVID-19 and their prevalence.
CLINICAL CHARACTERISTICS
9/13/21
Becchetti C, Gschwend SG, Dufour JF, et al. | J Clin Med
Aim: To analyze and summarize the published literature concerning LT recipients with COVID-19.
CLINICAL CHARACTERISTICS
9/13/21
Prakash J, Bhattacharya PK, Yadav AK, et al. | J Crit Care
Aim: To determine the predictive accuracy of the ROX index for predicting HFNC failure in COVID-19 patients with AHRF.
UPDATED
CLINICAL CHARACTERISTICS
9/13/21
de Freitas RF, Torres SC, Martín-Sánchez FJ, et al. | Auton Neurosci
Aim: To systematically review the recent published literature that describes syncope or presyncope as a symptom of COVID-19, having it been observed in the days before or after the diagnosis.
CLINICAL CHARACTERISTICS
9/10/21
Saniasiaya J, Kulasegarah J, Narayanan P | J Laryngol Otol
Aim: To elucidate olfactory dysfunction amongst children and adolescents with coronavirus disease 2019.
CLINICAL CHARACTERISTICS
9/9/21
Zinellu A, Paliogiannis P, Fois AG, et al. | Front Public Health
Aim: To capture and interpret the available evidence regarding the relationship between COVID-19 and lipid profile.
UPDATED
CLINICAL CHARACTERISTICS
9/9/21
Corica B, Marra AM, Basili S, et al. | Sci Rep
Aim: To evaluate the prevalence of RVD and associated outcomes in patients with COVID-19
UPDATED
CLINICAL CHARACTERISTICS
9/8/21
Subramaniam A, Lim ZJ, Ponnapa Reddy M, et al. | Intern Med J
Aim: To investigate the incidence, characteristics, and outcomes of patients who were readmitted to hospital emergency departments or required re-hospitalization following an index hospitalization with a diagnosis of COVID-19.
CLINICAL CHARACTERISTICS
9/8/21
Nayeri ND, Nadali J, Divani A, et al. | J Res Med Sci
Aim: To systematically review of symptoms, laboratory and radiologic findings, treatment, and outcomes of patients with COVID-19.
CLINICAL CHARACTERISTICS
9/8/21
Shams Vahdati S, Ala A, et al. | Egypt J Neurol Psychiatr Neurosurg
Aim: To systematically review the previous systematic reviews which addressed the neurological manifestations of the COVID-19 infection.
CLINICAL CHARACTERISTICS
9/8/21
Tan X, Guo J, Chen Z, et al. | Therap Adv Gastroenterol
Aim: To report on clinical outcomes of COVID-19 patients who underwent GI endoscopy.
UPDATED
CLINICAL CHARACTERISTICS
9/8/21
Malekifar P, Pakzad R, Shahbahrami R, et al. | Biomed Res Int
Aim: To identify the viral coinfection prevalence among infected people with SARS-CoV-2.
UPDATED
CLINICAL CHARACTERISTICS
9/7/21
Sari Motlagh R, Abufaraj M, Karakiewicz PI, et al.  | World J Urol
Aim: To assess the risk of SARS-CoV-2 infection and the severity of disease in PCa patients treated with ADT. 
UPDATED
CLINICAL CHARACTERISTICS
9/7/21
Minh LHN, Abozaid AA, Ha NX, et al. | Rev Med Virol
Aim: To estimate the frequency of clinical symptoms by comparing different clinical presentations based on the severity and living status of the cases.
CLINICAL CHARACTERISTICS
9/7/21
Kim JY, Han K, Suh YJ | J Cardiovasc Magn Reson
Aim: To investigate the prevalence of abnormal CMR findings in recovered COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
9/3/21
Mutneja HR, Bhurwal A, Arora S, et al. | Scand J Gastroenterol
Aim: To evaluate whether COVID-19 affects the severity and outcomes associated with acute pancreatitis.
CLINICAL CHARACTERISTICS
9/1/21
Spacey A, Porter S, Board M, et al. | Palliat Med
Aim: To describe and evaluate the impact of the COVID-19 pandemic on end of life care delivery in care homes.
CLINICAL CHARACTERISTICS
9/1/21
Malik P, Patel K, Pinto C, et al. | J Med Virol
Aim: To evaluate pooled prevalence of poor quality of life in post-acute COVID-19 syndrome (PCS) and conduct meta-regression to evaluate effects of persistent symptoms and ICU admission on poor quality of life.
CLINICAL CHARACTERISTICS
8/31/21
Wang Y, Wang Y, Huo L, et al. | J Neurol
Aim: To review the evidence on the acute and post-infectious manifestations of SARS-CoV-2-associated ADEM to guide long-term management and health service reorganization.
CLINICAL CHARACTERISTICS
8/30/21
Kornitzer J, Johnson J, Yang M, et al. | Int J Environ Res Public Health
Aim: To assess the spectrum of COVID-19 presentation in children, with special emphasis on characteristics associated with multisystem inflammatory syndrome (MIS-C). 
CLINICAL CHARACTERISTICS
8/30/21
O'Loughlin L, Alvarez Toledo N, Budrie L, et al. | Neurol Int
Aim: To provide an updated review of the current published data on pediatric patients with COVID-19 and coexisting severe neurological manifestations.
CLINICAL CHARACTERISTICS
8/30/21
Manzano GS, McEntire CRS, Martinez-Lage M, et al. | Neurol Neuroimmunol Neuroinflamm
Aim: To synthesize the clinical features of ADEM and AHLE, response to treatments, and clinical outcomes to better understand the nature of this neurologic consequence of COVID-19 infection.
CLINICAL CHARACTERISTICS
8/30/21
Aram K, Patil A, Goldust M, et al. | Dermatol Ther
Aim: To evaluate presentations, post-infection change in the manifestation, diagnosis, and management of flare-ups of underlying dermatologic disease in patients with COVID-19. 
CLINICAL CHARACTERISTICS
8/30/21
Sanchez-Ramirez DC, Normand K, Zhaoyun Y, et al. | Biomedicines
Aim: To explore persistent effects of COVID-19 beyond 3 months follow-up on patient chest computed tomography (CT), lung function, respiratory symptoms, fatigue, functional capacity, quality of life, and the ability to return to work. 
UPDATED
CLINICAL CHARACTERISTICS
8/30/21
Treskova-Schwarzbach M, Haas L, Reda S, et al. | BMC Med
Aim: To summarise the evidence on age-adjusted associations between multiple pre-existing health conditions and clearly defined COVID-19 outcomes separating the effects between the geographical regions.
UPDATED
CLINICAL CHARACTERISTICS
8/30/21
Rathore SS, Hussain N, Manju AH, et al. | J Med Virol
Aim: To evaluate the correlation between COVID-19 disease and pleural effusion.
CLINICAL CHARACTERISTICS
8/30/21
Treglia G, Cuzzocrea M, Giovanella L, et al. | Pharmaceuticals
Aim: To calculate the prevalence of hypermetabolic lymph nodes after COVID-19 infection.
CLINICAL CHARACTERISTICS
8/27/21
Ousseiran ZH, Fares Y, Chamoun WT | Int J Neurosci
Aim: To study and summarize the different neurological manifestations of this virus.
CLINICAL CHARACTERISTICS
8/27/21
Sarkar S, Kannan S, Khanna P, et al  | J Med Virol
Aim: To explore the utility of PLR as a prognostic predictor of COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
8/26/21
Qian W, Ye Y, Zuo L, et al. | Immunotherapy
Aim: To quantify the effects of immune checkpoint inhibitors (ICIs) on the prognosis of COVID-19.
CLINICAL CHARACTERISTICS
8/26/21
Saniasiaya J, Prepageran N | J Laryngol Otol
Aim: To outline the impact on quality of life in coronavirus disease 2019 patients with olfactory dysfunction.
CLINICAL CHARACTERISTICS
8/26/21
Kyiakoulis KG, Kollias A, Kyrakoulis IG, et al. | Curr Vasc Pharmacol
Aim: To identify published guidance reports by national and international societies regarding thromboprophylaxis strategies in COVID-19 patients in different settings (outpatients, hospitalized, post-discharge).
CLINICAL CHARACTERISTICS
8/23/21
Sullivan BN, Fischer T | Front Aging Neurosci
Aim: To gain insight into the types of neurological complications associated with SARS-CoV-2 infection and their possible relationship with age, sex, COVID-19 severity, and comorbidities.
CLINICAL CHARACTERISTICS
8/23/21
An W, Kang J, Wang Q, et al. | J Infect Public Health
Aim: To systematically investigate the relationship between cardiac biomarkers and COVID-19 severity and mortality.
CLINICAL CHARACTERISTICS
8/23/21
Ghorbani SS, Taherpour N, Bayat S, et al. | J Med Virol
Aim: To review the evidence on the frequency and definitions of re-infection rates, recurrence, and hospital readmission following SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
8/23/21
Yan Q, Qiu D, Liu X, et al. | Front Pediatr
Aim: To examine the pooled prevalence of smell or taste dysfunctions among children with COVID-19.
CLINICAL CHARACTERISTICS
8/23/21
Bhattacharyya A, Sarma P, Sharma DJ, et al. | Indian J Pharmacol
Aim: To review the evidence on COVID-19-associated mucormycosis.
CLINICAL CHARACTERISTICS
8/23/21
Mashayekhi F, Sairafianpour F, Mohammad AP, et al. | Int J Clin Pract
Aim: To review the evidence on presentations of severe potential life-threatening skin eruptions in COVID-19.
CLINICAL CHARACTERISTICS
8/23/21
Han T, Ma S, Sun C, et al. | Arch Med Res
Aim: To further explore queries about effects of anti-diabetic agents on mortality and poor composite outcomes of COVID-19 in diabetic patients.
CLINICAL CHARACTERISTICS
8/17/21
Finsterer J, Scorza FA, Scorza C, et al. | Bosn J Basic Med Sci
Aim: To summarize and discuss the recent advances concerning the clinical presentation, pathophysiology, diagnosis, treatment, and outcomes of SARS-CoV-2 associated cranial nerve mononeuropathies or polyneuropathies. 
CLINICAL CHARACTERISTICS
8/16/21
Ismail II, Salama S | J Neurol
Aim: To investigate the available evidence regarding the different types of CNS demyelination in association with SARS-CoV-2 infection, and the proposed pathophysiological mechanisms in these cases.
CLINICAL CHARACTERISTICS
8/16/21
Sunjaya AP, Allida SM, Di Tanna GL, et al. | Eur Respir J
Aim: To review the evidence on whether people with asthma at a higher risk of being infected, hospitalised or of poorer clinical outcomes from COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
8/16/21
Karaoulanis SE, Christodoulou NG | Psychiatriki
Aim: To clarify whether patients with schizophrenia spectrum disorders are at greater risk for poor COVID-19 outcomes.
CLINICAL CHARACTERISTICS
8/16/21
Alsagaff MY, Oktaviono YH, Dharmadjati BB, et al.  | J Arrythm
Aim: To evaluate the latest evidence on the association of ECG on admission and the poor outcomes in COVID?19.
CLINICAL CHARACTERISTICS
8/16/21
Maiese A, Manetti AC, Bosetti C, et al. | Brain Pathol
Aim: To review the evidence on the neuropathological features of COVID-19.
CLINICAL CHARACTERISTICS
8/16/21
Patanavanich R, Glantz SA  | BMC Public Health
Aim: To compare the association between smoking and COVID-19 disease progression between unadjusted analyses with adjusted analyses to examine whether smoking is an independent risk factor.
CLINICAL CHARACTERISTICS
8/16/21
Abate V, Casoria A, Rendina D, et al. | Semin Thromb Hemost
Aim: To describe the prevalence and the clinical characteristics of SMH in COVID-19 patients.
CLINICAL CHARACTERISTICS
8/13/21
Kazemi SN, Hajikhani B, Didar H, et al. | PLoS One
Aim: To understand better the potential effects of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) on fetal loss in infected mothers presented with abortion following this infection.
CLINICAL CHARACTERISTICS
8/13/21
AbdelHamid S, Refaat AA, Benjamin AM, et al. | Environ Sci Pollut Res Int
Aim: To study the impact of host or viral epigenetic modulation on COVID-19 infection susceptibility and/or outcome.
UPDATED
CLINICAL CHARACTERISTICS
8/13/21
Llamas M, Garo ML, Giovanella L | Clin Chem Lab Med
Aim: To assess the prognostic role of fT3 serum levels in patients with COVID-19.
CLINICAL CHARACTERISTICS
8/12/21
Sah P, Fitzpatrick MC, Zimmer CF, et al. | Proc Natl Acad Sci USA
Aim: To review the evidence on laboratory-confirmed infections to estimate the percentage of SARS-CoV-2 infections that are truly asymptomatic. 
CLINICAL CHARACTERISTICS
8/12/21
Huth SF, Cho S, Robba C, et al. | Front Neurol
Aim: To review the evidence on the neurologic manifestations identified in hospitalised COVID-19 patients and provide a preliminary estimate of disease prevalence.
CLINICAL CHARACTERISTICS
8/12/21
Sen S, Kanna NB, Kumar J, et al. | Int Ophthalmol
Aim: To summarize all retinal manifestations secondary to COVID-19 disease recorded till date since the beginning of the pandemic.
CLINICAL CHARACTERISTICS
8/11/21
Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. | Sci Rep
Aim: To identify studies assessing long-term effects of COVID-19 and estimates the prevalence of each symptom, sign, or laboratory parameter of patients at a post-COVID-19 stage.
UPDATED
CLINICAL CHARACTERISTICS
8/10/21
Chung EY, Palmer SC, Natale P, et al. | Am J Kidney Dis
Aim: To assess the incidence and outcomes of COVID-19 in people with CKD.
CLINICAL CHARACTERISTICS
8/10/21
Yang Y, Cai Z, Zhang J | Front Endocrinol
Aim: To determine the association between insulin injection and the outcomes of COVID-19.
CLINICAL CHARACTERISTICS
8/10/21
Qian Z, Lu S, Luo X, et al. | Front Med
Aim: To summarize the current existing evidence on the outcome of critically ill patients with COVID-19 as well as to evaluate the effectiveness of clinical interventions.
CLINICAL CHARACTERISTICS
8/9/21
Athanasios A, Daley I, Patel A, et al. | Eur Neurol
Aim: To review the prevalence of cerebrovascular accident in COVID-19 patients.
CLINICAL CHARACTERISTICS
8/9/21
Alves VP, Casemiro FG, Araujo BG, et al. | Int J Environ Res Public Health
Aim: To evaluate the factors associated with mortality of elderly Brazilians and Italians diagnosed with the new coronavirus who resided in institutions or who were hospitalized as a result of the disease.
UPDATED
CLINICAL CHARACTERISTICS
8/9/21
Gómez CA, Sun CK, Tsai IT, et al. | Sci Rep
Aim: To determine, in patients with coronavirus disease 2019 (COVID-19) infection, the associations of pulmonary embolism (PE) with mortality and risk factors for PE as well as the therapeutic benefit of anticoagulant prophylaxis.
UPDATED
CLINICAL CHARACTERISTICS
8/9/21
Cabreira V, Abreu P, Soares-Dos-Reis R, et al. | Vaccines
Aim: To review the evidence on the incidence and outcomes of COVID-19 in MS patients on DMTs.
CLINICAL CHARACTERISTICS
8/9/21
Ho TC, Chang CC, Chan HP, et al. | Pathogens
Aim: To analyze the pulmonary findings of [18F]FDG PET/CT on asymptomatic COVID-19 patients.
CLINICAL CHARACTERISTICS
8/9/21
Sadiq Z, Rana S, Mahfoud Z, et al. | Clin Imaging
Aim: To determine the most common appearances of lung abnormalities in COVID-19 patients.
CLINICAL CHARACTERISTICS
8/9/21
Prada L, Santos CD, Baião RA, et al. | J Clin Pharmacol
Aim: To systematically evaluate the risk of SARS-CoV-2 infection and mortality and the risk of severe coronavirus disease 2019 (COVID-19) associated with previous exposure to NSAIDs. 
UPDATED
CLINICAL CHARACTERISTICS
8/7/21
Probst LF, Guerrero ATG, de Queiroz Cardoso AI, et al. | Syst Rev
Aim: To analyze the effectiveness of decontamination methods for mask reuse. 
CLINICAL CHARACTERISTICS
8/5/21
Zhang Z, Ai G, Chen L, et al. | BMC Infect Dis
Aim: To explore the association of immunological features with COVID-19 severity.
CLINICAL CHARACTERISTICS
8/4/21
Tsheten T, Clements ACA, Gray DJ, et al. | BMC Infect Dis
Aim: To collate and synthesise current knowledge on the clinical features and outcomes of COVID-19 and dengue virus co-infection.
CLINICAL CHARACTERISTICS
8/4/21
Vitalakumar D, Sharma A, Kumar A, et al. | ACS Chem Neurosci
Aim: To conduct a meta-analysis of clinical studies associated with neurological problems in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
8/4/21
Cosentino G, Todisco M, Hota N, et al. | Eur J Neurol
Aim: To review the evidence on neuropathological findings and their clinical correlations in COVID-19.
CLINICAL CHARACTERISTICS
8/3/21
Yadav AK, Ghosh S, Dubey S | Med J Armed Forces India
Aim: To summarize and synthesize evidence from all available case series and case reports published on re-positive COVID-19 cases.
UPDATED
CLINICAL CHARACTERISTICS
8/3/21
Wang JG, Zhong ZJ, Li M, et al. | Biochem Res Int
Aim: To describe the clinical symptoms, laboratory findings, treatment, and outcomes of coronavirus disease 2019-related multisystem inflammatory syndrome in children to provide a reference for clinical practice.
CLINICAL CHARACTERISTICS
8/3/21
Taheri Soodejani M, Basti M, Tabatabaei SM, et al. | Int J Mol Epidemiol Genet
Aim: To investigate published literature about the association between measles, mumps, and rubella (MMR) vaccine and COVID-19. 
CLINICAL CHARACTERISTICS
8/3/21
Moore N, Bosco-Levy P, Thurin N, et al. | Drug Saf
Aim: To collate the evidence regarding the possible risks associated with the use of NSAIDs in COVID-19.
CLINICAL CHARACTERISTICS
8/3/21
Ferreira de Araújo JL, Menezes D, Saraiva-Duarte JM, et al. | Rev Med Virol
Aim: To review genetic association studies evaluating Covid-19 severity or susceptibility to SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
8/3/21
Wu D, Wang VY, Chen YH, et al. | Auris Nasus Larynx
Aim: To determine how initial symptoms of OGD can be used to screen patients for COVID-19 laboratory testing.
CLINICAL CHARACTERISTICS
8/2/21
Katzenschlager S, Zimmer AJ, Gottschalk C, et al. | PLoS One
Aim: To assess demographic, laboratory and clinical indicators as predictors for severe courses of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
8/2/21
Ansari Ramandi MM, Yarmohammadi H, Beikmohammadi S, et al. | J Cardiovasc Thorac Res
Aim: To gather all possible cardiovascular manifestations of the coronavirus family in the literature. 
UPDATED
CLINICAL CHARACTERISTICS
8/2/21
SeyedAlinaghi S, Karimi A, MohsseniPour M, et al.  | Immun Inflamm Dis
Aim: To investigate the impact of COVID-19 on patients infected with HIV.
CLINICAL CHARACTERISTICS
8/1/21
Kow CS, Hasan SS | Therapie
Aim: To summarize the overall effect of DPP-4 inhibitors on the clinical outcomes in patients with COVID-19.
CLINICAL CHARACTERISTICS
7/29/21
Ceban F, Nogo D, Carvalho IP, et al. | JAMA Psychiatry
Aim: To assess whether preexisting mood disorders are associated with a higher risk of COVID-19 susceptibility, hospitalization, severe complications, and death.
UPDATED
CLINICAL CHARACTERISTICS
7/29/21
Zinellu A, Paliogiannis P, Carru C, et al. | Adv Med Sci
Aim: To review the evidence on the international normalized ratio (INR) in COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/29/21
Shenoy S | World J Crit Care Med
Aim: To identify whether quantitative SARS-CoV-2 viral load assay correlates with clinical outcome in COVID-19 infections.
CLINICAL CHARACTERISTICS
7/28/21
Zhu Y, Xing W, Wang H, et al. | Infect Dis
Aim: To analyze the differences of the baseline characteristics and therapeutic features between STEMI patients admitted before and after the start of the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
7/28/21
Azab MA, Hasaneen SF, Hanifa H, et al. | Interdiscip Neurosurg
Aim: To report a case manifested as post-COVID-19 optic neuritis, in addition to make a quantitative analysis (meta-analysis) for the published similar case reports around the world.
CLINICAL CHARACTERISTICS
7/28/21
Alanazi T, Alahmari N, Qubays F, et al. | J Pharmaceut Res Int
Aim: To investigate the published literature of OP related to COVID-19, estimates the prevalence of OP among COVID-19 patients, and assesses the risk or COVID-19 severity associated with OP.
CLINICAL CHARACTERISTICS
7/27/21
Goswami J, MacArthur TA, Sridharan M, et al. | Shock
Aim: To summarize and discuss the current literature on laboratory coagulation disruptions associated with COVID-19 and the clinical effects of thromboembolic events in COVID-19. 
CLINICAL CHARACTERISTICS
7/27/21
Szarpak L, Rafique Z, Gasecka A, et al. | Cardiol J
Aim: To establish a connection between vitamin D status and COVID-19 infection.
CLINICAL CHARACTERISTICS
7/27/21
Zhao R, Su Z, Komissarov AA, et al. | Front Immunol
Aim: To explore the relationships between the plasma D-dimer level on admission with demographics, laboratory tests, fatal cardiopulmonary function, radiology, interventions, complications, and outcomes.
CLINICAL CHARACTERISTICS
7/27/21
Shafiabadi Hassani N, Talakoob H, Karim H, et al. | J Magn Reson Imaging
Aim: To systematically review the main cardiac MRI findings in COVID-19 adult survivors.
CLINICAL CHARACTERISTICS
7/27/21
Rastogi A, Dogra H, Jude EB, et al. | Diabetes Metab Syndr
Aim: To identify the prevalence, risk factors and outcomes of lower extremity ischemic complications.
CLINICAL CHARACTERISTICS
7/27/21
Zahedi M, Yousefi M, Abounoori M, et al. | Iran J Med Sci
Aim: To establish the characteristics of liver function tests in COVID-19 patients.
CLINICAL CHARACTERISTICS
7/27/21
Zhang K, Zhang X, Ding W, et al. | Front Med
Aim: To evaluate the prognostic accuracy of the NEWS2 on predicting clinical deterioration for patients with COVID-19. 
UPDATED
CLINICAL CHARACTERISTICS
7/26/21
Karimi A, Nowroozi A, Alilou S, et al. | Urol J
Aim: To study the effect of androgen deprivation therapy (ADT) on COVID-19 in patients with prostate cancer.
UPDATED
CLINICAL CHARACTERISTICS
7/26/21
Shah K, Upadhyaya M, Kandre Y, et al. | QJM
Aim: To provide comprehensive overview of epidemiological, clinical and biomarker profile of COVID-19 infection in pediatric population.
CLINICAL CHARACTERISTICS
7/26/21
Purja S, Shin H, Lee JY, et al. | Arch Pharm Res
Aim: To examine the association between COVID-19 severity and loss of smell (LOS) in patients with COVID-19.
CLINICAL CHARACTERISTICS
7/26/21
Shah K, Varna PV, Pandya A, et al. | QJM
Aim: To study the relationship between vitamin D level, risk and severity of COVID-19 infection in pediatric population through systematic review.
CLINICAL CHARACTERISTICS
7/26/21
Conde-Agudelo A, Romero R | Am J Obstet Gynecol
Aim: To examine the relationship between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy and the risk of preeclampsia.
UPDATED
CLINICAL CHARACTERISTICS
7/26/21
Ferro A, Kotecha S, Auzinger G, et al. | Br J Oral Maxillofac Surg
Aim: To determine the cumulative incidence of complications, mortality, time to decannulation and ventilatory weaning.
CLINICAL CHARACTERISTICS
7/26/21
Zaffanello M, Piacentini G, Nosetti L, et al. | Thromb Res
Aim: To review the literature for thrombotic complications in children with COVID-19 infection and MIS-C.
CLINICAL CHARACTERISTICS
7/24/21
Bou-Karroum L, Khabsa J, Jabbour M, et al. | J Infect
Aim: To map travel policies implemented due to COVID-19 during 2020.
CLINICAL CHARACTERISTICS
7/23/21
Ghidini S, Gasperetti A, Winterton D, et al. | Int J Cardiovasc Imaging
Aim: To summarize current knowledge on TTE-based RV assessment in COVID-19.
CLINICAL CHARACTERISTICS
7/23/21
Moradi G, Gholami F, Rasouli MA, et al. | Med J Islam Repub Iran
Aim: To determine possible scenarios of Coronavirus 2019 (COVID-19) iceberg using published articles.
CLINICAL CHARACTERISTICS
7/22/21
McGrowder DA, Miller F, Cross MA, et al. | Diseases
Aim: To review the evidence on abnormal liver biochemistry tests in COVID-19 and the possible pathogenesis involved.
UPDATED
CLINICAL CHARACTERISTICS
7/22/21
Zhang D, Huang WJ, Lan MQ | Eur Rev Med Pharmacol Sci
Aim: To systematically review the role of SAA levels in distinguishing among patients with mild, severe, and critical COVID-19.
CLINICAL CHARACTERISTICS
7/22/21
Dioguardi M, Cazzolla AP, Arena C, et al. | Pediatr Rep
Aim: To summarize aspects of innate immunity by focusing on the role of ACE2 expression and viral infections in children in modulating the antibody response to SARS-CoV-2 infection. 
CLINICAL CHARACTERISTICS
7/22/21
Ganesh A, Reis IR, Varma M, et al. | Can J Neurol Sci
Aim: To review the evidence on the various neurological and atypical HEENT manifestations of COVID-19.
CLINICAL CHARACTERISTICS
7/22/21
Zuin M, Gentili V, Cervellati C, et al. | Infect Dis Rep
Aim: To investigate the possible difference in the SARS-CoV-2 viral load between asymptomatic and symptomatic COVID-19 patients.
CLINICAL CHARACTERISTICS
7/20/21
Gupta S, Jawanda MK, Taneja N, et al. | J Clin Neurosci
Aim: To evaluate the reported cases of COVID-19 positive patients, presented with Bell's palsy as the only major neurological manifestation, and to investigate the association of SARS-CoV2 and Bell's palsy.
CLINICAL CHARACTERISTICS
7/20/21
Kulkarni AV, Tevethia HV, Premkumar M, et al. | EClinicalMedicine
Aim: To analyse the outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in LT recipients.
CLINICAL CHARACTERISTICS
7/20/21
Vai B, Mazza MG, Delli Colli C, et al. | Lancet Psychiatry
Aim: To assess the specific risks of COVID-19-related mortality, hospitalisation, and intensive care unit (ICU) admission associated with any pre-existing mental disorder, and specific diagnostic categories of mental disorders, and exposure to psychopharmacological drug classes.
UPDATED
CLINICAL CHARACTERISTICS
7/20/21
Cirillo N | J Infect Public Health
Aim: To facilitate a timely understanding of the differences in the prevalence of gustatory disturbances (GD) in individuals infected with SARS-CoV-2.
UPDATED
CLINICAL CHARACTERISTICS
7/19/21
Andrianto, Al-Farabi MJ, Nugraha RA, et al. | Microvasc Res
Aim: To assess biomarkers of endothelial cells in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/19/21
Rashedi S, Keykhaei M, Pazoki M, et al. | Nutr Clin Pract
Aim: To ascertain risk indicators of in-hospital mortality and severity as well as to provide a comprehensive systematic review and meta-analysis to investigate the prognostic significance of the prognostic nutrition index (PNI) as a predictor of adverse outcomes in hospitalized coronavirus disease 2019 (COVID-19) patients.
CLINICAL CHARACTERISTICS
7/19/21
Maddaloni E, D'Onofrio L, Siena A, et al. | Intern Emerg Med
Aim: To clarify the association of cardiovascular disease with Covid-19 outcomes.
CLINICAL CHARACTERISTICS
7/19/21
Kim PH, Kim M, Suh CH, et al. | Korean J Radiol
Aim: To evaluate the incidence of radiologically demonstrated neurologic complications and detailed neuroimaging findings associated with COVID-19.
CLINICAL CHARACTERISTICS
7/19/21
van Kessel SAM, Olde Hartman TC, Lucassen PLBJ, et al. | Fam Pract
Aim: To create an overview of the nature and frequency of persistent symptoms experienced by patients after mild COVID-19 infection.
CLINICAL CHARACTERISTICS
7/16/21
Yilma M, Taye G, Kifle A, et al. | Ethopian Journal of Health Development
Aim: To get cohesive understanding on hospitalization, recovery, death, incubation period and severity of COVID-19.
CLINICAL CHARACTERISTICS
7/16/21
Iwamura APD, Tavares da Silva MR, Hümmelgen AL, et al.  | Rev Med Virol
Aim: To collate and critically appraise the literature relating to the inflammatory and immunological parameters of the SARS-CoV-2.
CLINICAL CHARACTERISTICS
7/16/21
El-Qushayri AE, Ghozy S, Reda A, et al. | Rev Med Virol
Aim: To review the impact of PD on the prognosis of Covid-19 patients.
CLINICAL CHARACTERISTICS
7/15/21
Karakike E, Giamarellos-Bourboulis EJ, Kyprianou M, et al. | Crit Care Med
Aim: To describe the prevalence of coronavirus disease 2019-related sepsis.
UPDATED
CLINICAL CHARACTERISTICS
7/15/21
Saragih ID, Advani S, Saragih IS, et al. | Geriatr Nurs
Aim: To study the impacts of frailty on COVID-19 outcomes.
UPDATED
CLINICAL CHARACTERISTICS
7/15/21
Mir A, Farmanfarma KK, Salehiniya H, et al. | Monaldi Arch Chest Dis
Aim: To investigate laboratory and demographic findings among patients with COVID-19 worldwide.
CLINICAL CHARACTERISTICS
7/15/21
de Medeiros KS, da Silva LAS, de Araujo Macedo LT, et al. | Rev Assoc Med Bras
Aim: To study the clinical features and morbidity, and mortality outcomes of COVID-19 patients with HIV/AIDS coinfection.
CLINICAL CHARACTERISTICS
7/15/21
Yetmar Z, Chesdachai S, Kashour T, et al. | Open Forum Infect Dis
Aim: To examine the association between prior statin use and outcomes of patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/14/21
Yassin A, Ghzawi A, Al-Mistarehi AH, et al. | Future Sci OA
Aim: To describe the mortality difference between acute ischemic stroke (AIS) and non-AIS groups within COVID-19 patients.
CLINICAL CHARACTERISTICS
7/13/21
Nasa P, Juneja D, Jain R, et al. | Asian Cardiovasc Thorac Ann
Aim: To analyse the types of air leaks in COVID-19 and their outcomes.
CLINICAL CHARACTERISTICS
7/13/21
Wu X, Xu Y, Jin L, et al. | Front Med
Aim: To investigate the mortality of patients with COVID-19 in relation to preexisting asthma and other allergic diseases associated with changes in respiratory function.
CLINICAL CHARACTERISTICS
7/13/21
Zinellu A, Sotgia S, Carru C, et al. | Front Cardiovasc Med
Aim: To conduct a meta-regression of studies reporting plasma BNP or NT-proBNP concentrations in COVID-19 patients with different disease severity.
CLINICAL CHARACTERISTICS
7/13/21
Barman A, Roy SS, Sasidharan SK, et al. | Spinal Cord Ser Cases
Aim: To summarise the clinical features and prognosis of persons with spinal cord injury (SCI) infected with COVID-19.
CLINICAL CHARACTERISTICS
7/13/21
Dadashi M, Khaleghnejad S, Abedi Elkhichi P, et al.  | Front Med
Aim: To systematically review the literature on COVID-19 co-infections with the influenza virus (type A and/or B).
CLINICAL CHARACTERISTICS
7/13/21
Akobeng AK, Grafton-Clarke C, Abdelgadir I, et al. | Frontline Gastroenterol
Aim: To summarise the published evidence on the gastrointestinal manifestations of COVID-19 in children and to determine the prevalence of gastrointestinal symptoms.
UPDATED
CLINICAL CHARACTERISTICS
7/13/21
Hariyanto TI, Lugito NPH, Yanto TA, et al. | Endocr Metab Immune Disord Drug Targets
Aim: To evaluate the possible association between insulin and the poor composite development of COVID-19.
CLINICAL CHARACTERISTICS
7/13/21
Raeisi T, Mozaffari H, Sepehri N, et al. | Eat Weight Disord
Aim: To evaluate the global prevalence of obesity in COVID-19 patients and to investigate whether obesity is a risk factor for the COVID-19, COVID-19 severity, and its poor clinical outcomes including hospitalization, intensive care unit (ICU) admission, need for mechanical ventilation, and mortality.
CLINICAL CHARACTERISTICS
7/12/21
Shi C, Wang L, Ye J, et al. | BMC Infect Dis
Aim: To assess the potential predictors of mortality in patients with COVID-19.
CLINICAL CHARACTERISTICS
7/12/21
Savage HR, Santos VS, Edwards T, et al. | PLoS Negl Trop Dis
Aim: To review the evidence on the proportion of individuals with SARS-CoV-2 neutralising antibodies after infection and how this proportion varies with selected covariates.
CLINICAL CHARACTERISTICS
7/12/21
Kollias A, Kyriakoulis KG, Kyriakoulis IG, et al. | Atherosclerosis
Aim: To review the evidence regarding statin treatment and COVID-19 related mortality.
CLINICAL CHARACTERISTICS
7/12/21
Mansory E, Srigunapalan S, Lazo-Langner A | TH Open
Aim: To evaluate the epidemiology of VTE in hospitalized intensive care unit (ICU) and non-ICU patients.
UPDATED
CLINICAL CHARACTERISTICS
7/10/21
Umashankar A, Prakash P, Prabhu P | Indian J Otolaryngol Head Neck Surg
Aim: To review case reports related to sudden sensorineural hearing loss and COVID-19.
CLINICAL CHARACTERISTICS
7/9/21
Schwartzberg L, Advani S, Clancy DC, et al. | Skin Health Dis
Aim: To summarize cutaneous manifestations associated with COVID?19.
UPDATED
CLINICAL CHARACTERISTICS
7/9/21
Barssoum K, Victor V, Salem A, et al. | Echocardiography
Aim: To provide an overview of current findings and recommendations in cardiovascular imaging in patients with COVID-19.
CLINICAL CHARACTERISTICS
7/9/21
Rathore SS, Rojas GA, Sondhi M, et al. | Int J Clin Pract
Aim: To compile and illustrate clinical characteristics, diagnostic findings, management, and outcomes manifesting in myocarditis linked with Covid-19.
CLINICAL CHARACTERISTICS
7/8/21
Ramlah R | Ann Hepatobiliary Pancreat Surg
Aim: To determine the relationship between COVID-19 and acute pancreatitis.
CLINICAL CHARACTERISTICS
7/8/21
Najt P, Richards HL, Fortune D | Brain Behav Immun Health
Aim: To synthesise the potential evidence of the brain correlates of SARS-CoV-2.
UPDATED
CLINICAL CHARACTERISTICS
7/8/21
Gaythorpe K, Bhatia S, Mangal T, et al. | Sci Rep
Aim: To review the evidence on the susceptibility of children to SARS-CoV-2 infection, the severity and clinical outcomes in children with SARS-CoV-2 infection, and the transmissibility of SARS-CoV-2 by children.
UPDATED
CLINICAL CHARACTERISTICS
7/8/21
Ulloque-Badaracco JR, Salas-Tello WI, Al-Kassab-Cordova A, et al. | Int J Clin Pract
Aim: To evaluate the prognostic value of the NLR in patients diagnosed with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/8/21
Chisale MRO, Ramazanu S, Mwale SE, et al. | Rev Med Virol
Aim: To estimate the seroprevalence of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in residents of African countries and explore its associated factors.
UPDATED
CLINICAL CHARACTERISTICS
7/7/21
Soltani S, Faramarzi S, Zandi M, et al. | New Microbes New Infect
Aim: To systematically review and identify the pooled prevalence of the bacterial coinfection in the related articles.
CLINICAL CHARACTERISTICS
7/7/21
Zinellu A, Sotgia S, Fois AG, et al. | Adv Med Sci
Aim: To review the evidence on serum CK-MB concentrations in COVID-19 patients with different disease severity, based on clinical guidelines or need for hospitalization, mechanical ventilation, or transfer to the ICU, and survival status during follow up.
CLINICAL CHARACTERISTICS
7/7/21
Pardhan S, Wood S, Vaughan M, et al. | Front Med
Aim: To examine the adjusted risk of COVID-19 related hospitalsation, intensive care unit (ICU) admission, and mortality in patients with vs. without asthma or COPD.
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Kremer D, Pieters TT, Verhaar MC, et al. | Am J Transplant
Aim: To assess all current evidence to provide an updated and robust insight in the clinical course and outcome of COVID-19 in KTR.
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Lassi ZS, Ana A, Das JK, et al. | J Glob Health
Aim: To determine the clinical presentation, risk factors, and pregnancy and perinatal outcomes in pregnant women with confirmed COVID-19 and identify if these are different based on COVID-19 severity.
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Correia de Sá T, Soares C, Rocha M | World J Gastrointest Surg
Aim: To review and to explore the relationship between SARS-CoV-2 infection and AP, and to provide an overview of the existing literature on possible mechanisms of SARS-CoV-2-induced pancreatic lesion.
CLINICAL CHARACTERISTICS
7/6/21
Lee AC, Tse Li W, Apostol L, et al. | Comput Struct Biotechnol J
Aim: To examine the extent that age influences correlation results and by analyzing patients with severe COVID-19 and patients who died from COVID-19 separately.
CLINICAL CHARACTERISTICS
7/6/21
Alhumaid S, Al Mutair A, Al Alawi Z, et al. | Pathogens
Aim: To calculate the prevalence of coinfections with bacteria, fungi, and respiratory viruses in patients with SARS-CoV-2.
CLINICAL CHARACTERISTICS
7/6/21
Omidi F, Hajikhani B, Kazemi SN, et al. | Front Cardiovasc Med
Aim: To systematically review the current published literature to evaluate clinical and paraclinical characteristics of CMPs in patients infected with SARS-CoV-2.
CLINICAL CHARACTERISTICS
7/6/21
Dube R, Kar SS | BMJ Paediatr Open
Aim: To determine the effects of confirmed cases of COVID-19 in pregnant women from the foetal perspective by estimation of mother to child transmission, perinatal outcome and possible teratogenicity.
CLINICAL CHARACTERISTICS
7/6/21
Eljaaly K, Malibary H, Alsulami S, et al. | Pathogens
Aim: To describe the characteristics of clinical trials that focused on COVID-19 patients with cytokine release syndrome (CRS) and the variability in CRS definitions.
CLINICAL CHARACTERISTICS
7/6/21
Fernández Villalobos NV, Ott JJ, Klett-Tammen CJ, et al. | Syst Rev
Aim: To review the evidence on the relation between individual co-morbidities and disease severity (e.g., as measured by ICU admission) and further identify potential interactions with age.
CLINICAL CHARACTERISTICS
7/6/21
Wibowo A, Pranata R, Lim MA, et al. | Int J Infect Dis
Aim: To compare the level of von Willebrand Factor (vWF) antigen in patients with poor outcome compared to those without. 
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Lee SA, Park R, Yang JH, et al. | Sci Rep
Aim: To investigate the association between RAAS blockade exposure and COVID-19-related AKI in hospitalized patients through meta-analysis.
CLINICAL CHARACTERISTICS
7/6/21
Singh AK, Singh R, Joshi SR, et al. | Diabetes Metab Syndr
Aim: To find out the patient's characteristics having mucormycosis and COVID-19.
CLINICAL CHARACTERISTICS
7/6/21
Mude W, Oguoma VM, Nyanhanda T, et al. | J Glob Health
Aim: To review the evidence on disparities in prevalence, hospitalisation, and deaths from COVID-19 by racial minority populations.
CLINICAL CHARACTERISTICS
7/6/21
Foret T, Dufrost V, du Mont LS, et al. | Curr Rheumatol Rep
Aim: To analyze the frequency of aPL in COVID-19 patients in different settings and to evaluate their persistence over time and to analyze the role of aPL during the infection in particular their participation in thrombotic events.
CLINICAL CHARACTERISTICS
7/6/21
Romero Starke K, Mauer R, Karskens E, et al. | Int J Environ Res Public Health
Aim: To collect evidence on the impact of temperature and humidity on COVID-19 mortality. 
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Beukes E, Ulep AJ, Eubank T, et al. | J Clin Med
Aim: To systematically review what has been published regarding tinnitus during the coronavirus disease 2019 (COVID-19) pandemic up to March 2021.
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Akbar MR, Pranata R, Wibowo A, et al. | Front Med
Aim: To assess the prognostic value of hyponatremia in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/2/21
Zein AFMZ, Sulistiyana CS, Khasanah U, et al. | Postgrad Med J
UPDATED
CLINICAL CHARACTERISTICS
7/1/21
Melo AKG, Milby KM, Caparroz ALMA, et al. | PLoS One
Aim: To describe the laboratory parameters and biomarkers of the cytokine storm syndrome associated with severe and fatal COVID-19 cases.
UPDATED
CLINICAL CHARACTERISTICS
7/1/21
Ciapponi A, Bardach A, Comande D, et al.  | PLoS One
Aim: To summarize the best evidence regarding the effect of COVID-19 on maternal and child health.
UPDATED
CLINICAL CHARACTERISTICS
7/1/21
Taylor EH, Marson EJ, Elhadi M, et al. | Anaesthesia
Aim: To determine factors associated with mortality among adults with COVID-19 admitted to intensive care.
CLINICAL CHARACTERISTICS
7/1/21
Kula B, Clancy CJ, Nguyen MG, et al. | Lancet Microbe
Aim: To establish the prevalence of autopsy-proven tissue-invasive IMD and analyse individual-level data to assess potential risk factors.
UPDATED
CLINICAL CHARACTERISTICS
7/1/21
Sitek AN, Ade JM, Chiarella SE, et al. | Allergy Asthma Proc
Aim: To review the evidence on whether asthma is a risk factor associated with worse outcomes among patients with COVID-19.
CLINICAL CHARACTERISTICS
7/1/21
MH Aghdam, Hosseinzadeh R | Rev Med Microbiol
Aim: To discuss the involvement of the body's systems during COVID-19 infection comprehensively.
CLINICAL CHARACTERISTICS
7/1/21
Agrafiotis AC, Rummens P, Lardinois I | J Thorac Dis
Aim: To systematically review all the cases of spontaneous pneumothorax that occurred in healthy patients with no underlying lung disease and who did not receive invasive mechanical ventilation.
CLINICAL CHARACTERISTICS
6/30/21
Arian M, Valinejadi A, Vakilian F | Iran J Public Health
Aim: To report the findings of the first Electrocardiography (ECG), before therapy initiation and receiving medication in COVID-19 patients, and to compare them with the ECG findings of healthy men.
CLINICAL CHARACTERISTICS
6/29/21
Iqbal U, Anwar H, Siddiqui Hux, et al. | Clin Endosc
Aim: To evaluate the outcomes of COVID-19 patients with signs and symptoms of acute gastrointestinal bleeding (GIB).
CLINICAL CHARACTERISTICS
6/29/21
Crafa A, Cannarella R, Condorelli RA, et al. | EClinicalMedicine
Aim: To assess whether hypovitaminosis D is a risk factor for developing SARS-CoV-2 infection and whether it affects the worsening of the clinical course of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
6/28/21
Ramadan MS, Bertolino L, Zampino R, et al. | Clin Microbiol Infect
Aim: To assess the range of cardiac sequelae after COVID-19 recovery.
CLINICAL CHARACTERISTICS
6/28/21
Song WL, Zou N, Guan WH, et al. | World J Pediatr
Aim: To assess clinical profiles of COVID-19 in family clusters with children.
CLINICAL CHARACTERISTICS
6/28/21
Teles Abrao Trad A, Ibirogba ER, Elrefaei A, et al. | Hypertens Pregnancy
Aim: To add to the growing evidence on SARS-CoV-2 infection during pregnancy, so as to better inform clinical decision making and optimize patient outcomes.
CLINICAL CHARACTERISTICS
6/28/21
Mark EG, McAleese S, Golden WC, et al. | Pediatr Infect Dis J
Aim: To review outcomes in pregnant women with COVID-19 and neonates with perinatal exposure.
CLINICAL CHARACTERISTICS
6/28/21
Figueiro-Filho EA, Yudin M, Farine D, et al. | J Perinat Med
Aim: To identify the most significant studies reporting on COVID-19 during pregnancy and to provide an overview of SARS-CoV-2 infection in pregnant women and perinatal outcomes.
CLINICAL CHARACTERISTICS
6/28/21
Silva CRACD, Oliveira LV, Lopes LP, et al. | Rev Assoc Med Bras
Aim: To review the immunological aspects of the 2019 coronavirus disease (COVID-19) in pregnancy.
CLINICAL CHARACTERISTICS
6/28/21
Kim CNH, Hutcheon J, van Schalkwyk J, et al. | Am J Obstet Gynecol
Aim: To estimate the CFR of pregnant women infected with SARS-CoV-2 admitted to the intensive care unit (ICU). 
CLINICAL CHARACTERISTICS
6/28/21
Irani M, Pakfetrat A, Mask MK, et al. | J Educ Health Promot
Aim: To evaluate the association of COVID-19 and perinatal outcomes in pregnant women.
CLINICAL CHARACTERISTICS
6/28/21
Fernández-de-Las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, et al. | Eur J Intern Med
Aim: To analyze the prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized patients recovered from COVID-19 .
CLINICAL CHARACTERISTICS
6/28/21
Bellou V, Tzoulaki I, van Smeden M, et al. | Eur Respir J
Aim: To present a state-of-the-art systematic review and meta-analysis on the prognostic factors for adverse outcomes in COVID-19 patients.
CLINICAL CHARACTERISTICS
6/25/21
Ren X, Wang X, Ge Z, et al. | Int J Immunopathol Pharmacol
Aim: To examine immune function status-related manifestations and laboratory indicators of COVID-19 patients with recurrent virus PCR positivity.
UPDATED
CLINICAL CHARACTERISTICS
6/25/21
Bobrovitz N, Arora R, Cao C, et al.  | PLoS ONE
Aim: To synthesize seroprevalence data to better estimate the burden of SARS-CoV-2 infection, identify high-risk groups, and inform public health decision making.
UPDATED
CLINICAL CHARACTERISTICS
6/25/21
Zinellu A, Mangoni A | Front Immunol
Aim: To investigate possible differences in the serum concentrations of two routinely measured complement components, C3 and C4, in COVID-19 patients with different severity and survival status.
UPDATED
CLINICAL CHARACTERISTICS
6/25/21
Yamamoto S, Saito M, Tamura A, et al. | PLoS One
Aim: To evaluate existing evidence on the association between the microbiome and COVID-19 in humans and summarize this data in the pandemic era.
UPDATED
CLINICAL CHARACTERISTICS